unlik
area
diagnost
laboratori
clinic
microbiolog
scienc
interpret
judgment
becom
complex
less
even
advent
laboratori
autom
integr
genom
proteom
microbiolog
interpret
result
still
depend
qualiti
specimen
receiv
analysi
whether
one
suspect
prokaryot
eukaryot
etiolog
agent
featur
document
microb
tend
uniqu
suit
adapt
environ
antibiot
host
respons
appli
pressur
encourag
surviv
laboratori
instrument
may
may
detect
mutat
present
challeng
clinic
interpret
clearli
microb
grow
multipli
die
quickli
event
occur
preanalyt
specimen
manag
process
result
analysi
compromis
interpret
could
mislead
physician
advanc
practic
provid
need
confid
result
provid
microbiolog
laboratori
accur
signific
clinic
relev
anyth
less
commun
standard
care
laboratori
provid
level
qualiti
howev
laboratori
requir
microbiolog
specimen
properli
select
collect
transport
optim
analysi
interpret
result
interpret
microbiolog
depend
entir
qualiti
specimen
submit
analysi
specimen
manag
left
chanc
collect
specimen
microbiolog
analysi
must
awar
physician
need
patient
care
well
laboratori
need
provid
accur
result
includ
ensur
tabl
transport
issu
gener
guid
collect
devic
temperatur
ideal
transport
time
specimen
arriv
laboratori
analysi
quickli
possibl
collect
tabl
elementari
level
physician
need
answer
basic
question
laboratori
patient
ill
caus
microb
suscept
profil
organ
therapi
target
meet
need
laboratori
requir
specimen
appropri
select
collect
transport
laboratori
analysi
caught
middl
physician
laboratori
requir
medic
personnel
actual
select
collect
specimen
may
know
understand
physician
laboratori
need
work
enhanc
qualiti
specimen
everyon
job
commun
physician
nurs
laboratori
staff
encourag
open
punit
motiv
consequ
diagnosi
infecti
diseas
best
achiev
appli
indepth
knowledg
medic
laboratori
scienc
along
principl
epidemiolog
pharmacokinet
antibiot
integr
strateg
view
hostparasit
interact
clearli
best
outcom
patient
result
strong
partnership
clinician
microbiolog
specialist
document
illustr
promot
partnership
emphas
import
appropri
specimen
manag
clinic
relev
result
one
valuabl
laboratori
partner
infecti
diseas
diagnosi
certifi
microbiolog
specialist
particularli
specialist
certifi
diplom
american
board
medic
microbiolog
american
board
patholog
american
board
medic
laboratori
immunolog
equival
certifi
organ
clinician
recommend
medic
institut
provid
kind
leadership
microbiolog
laboratori
provid
formal
access
level
laboratori
expertis
consult
microbiolog
specimen
select
collect
respons
medic
personnel
usual
laboratori
although
certifi
specialist
may
call
upon
consult
assist
impact
proper
specimen
manag
patient
care
enorm
key
accur
laboratori
diagnosi
confirm
directli
affect
patient
care
patient
outcom
influenc
therapeut
decis
impact
hospit
infect
control
patient
length
stay
hospit
laboratori
cost
influenc
antibiot
stewardship
drive
laboratori
effici
clinician
medic
personnel
consult
laboratori
ensur
select
collect
transport
storag
patient
specimen
collect
manag
properli
throughout
text
caveat
relev
specif
specimen
diagnost
protocol
infecti
diseas
diagnosi
howev
strateg
tenet
specimen
manag
test
microbiolog
stand
commun
standard
care
set
microbiolog
apart
laboratori
depart
chemistri
hematolog
specimen
poor
qualiti
must
reject
microbiologist
act
correctli
respons
call
physician
clarifi
resolv
problem
specimen
submiss
physician
demand
laboratori
report
everyth
grow
provid
irrelev
inform
could
result
inaccur
diagnosi
inappropri
therapi
background
nois
commens
microbiota
must
avoid
possibl
mani
bodi
site
normal
commens
microbiota
easili
contamin
inappropri
collect
specimen
complic
interpret
therefor
specimen
site
lower
respiratori
tract
sputum
nasal
sinus
superfici
wound
fistula
other
requir
care
collect
laboratori
requir
specimen
swab
specimen
actual
tissu
aspir
fluid
alway
specimen
choic
especi
surgeri
swab
specimen
choic
mani
specimen
swab
pick
extran
microb
hold
extrem
small
volum
specimen
ml
make
difficult
get
bacteria
fungi
away
swab
fiber
onto
media
inoculum
swab
often
uniform
across
sever
differ
agar
plate
swab
expect
nasopharynx
diagnos
viral
respiratori
infect
flock
swab
becom
valuabl
tool
specimen
collect
shown
effect
dacron
rayon
cotton
swab
mani
situat
flock
natur
swab
allow
effici
releas
content
evalu
laboratori
must
follow
procedur
manual
face
legal
challeng
procedur
manual
support
literatur
especi
evidencebas
literatur
request
laboratori
provid
test
apart
procedur
manual
place
everyon
legal
risk
specimen
collect
prior
administr
antibiot
antibiot
start
microbiota
chang
etiolog
agent
impact
lead
potenti
mislead
cultur
result
suscept
test
done
clinic
signific
isol
microorgan
recov
cultur
microbiolog
laboratori
result
report
accur
signific
clinic
relev
laboratori
set
technic
polici
purview
medic
staff
good
commun
mutual
respect
lead
collabor
polici
specimen
must
label
accur
complet
interpret
result
reliabl
label
eye
wound
help
interpret
result
without
specif
site
clinic
inform
eg
dog
bite
wound
right
forefing
microbiolog
laboratori
polici
manual
avail
time
medic
personnel
review
consult
would
particularli
help
encourag
nurs
staff
review
specimen
collect
manag
portion
manual
facilit
collabor
laboratori
microbiolog
expertis
specimen
collect
personnel
may
know
littl
microbiolog
laboratori
need
establish
confirm
diagnosi
import
welcom
activ
engag
microbiolog
laboratori
integr
part
healthcar
team
encourag
hospit
laboratori
facil
boardcertifi
laboratori
specialist
hand
avail
optim
infecti
diseas
laboratori
diagnosi
document
organ
bodi
system
although
mani
organ
capabl
caus
diseas
bodi
system
may
redund
mention
organ
propens
infect
multipl
site
one
uniqu
featur
document
abil
assist
clinician
specif
suspicion
regard
possibl
etiolog
agent
caus
specif
type
diseas
term
clinician
use
throughout
document
also
includ
licens
advanc
practic
provid
anoth
uniqu
featur
chapter
target
recommend
precaut
regard
select
collect
specimen
analysi
diseas
process
easi
access
critic
inform
specif
bodi
site
consult
tabl
content
within
chapter
tabl
describ
specimen
need
regard
varieti
etiolog
agent
one
may
suspect
caus
ill
test
method
tabl
list
prioriti
order
accord
recommend
author
review
room
temperatur
specifi
certain
time
period
hour
expect
sampl
refriger
time
unless
specifi
otherwis
section
almost
specimen
viru
detect
transport
wet
ice
frozen
test
delay
hour
although
specimen
viral
transport
media
may
transport
room
temperatur
rapid
hour
deliveri
laboratori
assur
document
endors
infecti
diseas
societi
america
idsa
american
societi
microbiolog
asm
offici
guidelin
idsa
rather
authorit
guid
recommend
util
microbiolog
laboratori
infecti
diseas
diagnosi
collabor
effort
clinician
laboratori
expert
focus
optimum
use
laboratori
posit
patient
outcom
term
recommend
use
document
grade
recommend
would
found
guidelin
rather
prefer
indic
approach
use
applic
futur
modif
document
expect
diagnost
microbiolog
dynam
rapidli
chang
disciplin
pediatr
paramet
updat
concord
pediatr
clinic
practic
guidelin
polici
ed
red
book
publish
american
academi
pediatr
comment
recommend
integr
appropri
section
diagnosi
bloodstream
infect
bsi
one
critic
function
clinic
microbiolog
laboratori
great
major
etiolog
agent
bsi
convent
blood
cultur
method
provid
posit
result
within
hour
incub
day
seldom
requir
modern
autom
continuousmonitor
blood
cultur
system
media
use
includ
recoveri
histor
fastidi
organ
hacek
haemophilu
aggregatibact
cardiobacterium
eikenella
kingella
bacteria
brucella
speci
spp
microorgan
mycobacteria
dimorph
fungi
requir
longer
incub
period
other
may
requir
special
cultur
media
nonculturebas
method
although
filament
fungi
often
requir
special
broth
media
lysiscentrifug
vial
detect
candida
spp
grow
well
standard
blood
cultur
broth
unless
patient
antifung
therapi
unfortun
blood
cultur
patient
suspect
candidemia
yield
posit
result
almost
half
patient
tabl
provid
summari
diagnost
method
bsi
etiolog
agent
infect
endocard
convent
blood
cultur
method
suffic
howev
less
common
etiolog
agent
detect
current
blood
cultur
method
common
etiolog
agent
cultureneg
endocard
bartonella
spp
coxiella
burnetii
often
detect
convent
serolog
test
howev
molecular
amplif
method
may
need
detect
organ
well
other
eg
tropheryma
whipplei
bartonella
spp
rare
instanc
cultureneg
endocard
polymeras
chain
reaction
pcr
dna
sequenc
valv
tissu
may
help
determin
etiolog
agent
volum
blood
obtain
blood
cultur
request
also
known
blood
cultur
set
consist
bottl
procur
singl
venipunctur
one
cathet
draw
import
variabl
recov
bacteria
fungi
adult
pediatr
patient
bloodstream
infect
adult
ml
blood
per
cultur
set
depend
manufactur
instrument
recommend
may
requir
cultur
bottl
depend
system
neonat
adolesc
ageand
weightappropri
volum
blood
cultur
see
tabl
recommend
volum
second
import
determin
number
blood
cultur
set
perform
given
septic
episod
gener
adult
suspicion
bsi
blood
cultur
set
obtain
evalu
septic
episod
time
blood
cultur
order
dictat
patient
acuiti
urgent
situat
blood
cultur
set
obtain
sequenti
short
time
interv
minut
empir
therapi
initi
less
urgent
situat
obtain
blood
cultur
set
may
space
sever
hour
skin
contamin
blood
cultur
bottl
common
costli
healthcar
system
frequent
confus
clinician
minim
risk
contamin
blood
cultur
commens
skin
microbiota
meticul
care
ml
blood
per
cultur
adult
inject
least
blood
cultur
bottl
g
inocul
cultur
vial
transport
asap
rt
laboratori
earli
incub
inocul
vial
direct
detect
candida
spp
magnet
reson
assay
may
use
infant
children
blood
cultur
set
see
much
blood
conveni
obtain
children
volum
depend
weight
child
c
organ
usual
surviv
inocul
cultur
vial
even
incub
immedi
malassezia
spp
requir
lipid
supplement
lysiscentrifug
recommend
recoveri
filament
dimorph
fungi
h
lysiscentrifug
isol
blood
cultur
vial
ml
blood
inocul
directli
lysiscentrifug
cultur
vial
lysiscentrifug
cultur
vial
transport
laboratori
asap
process
within
h
blood
inocul
mycobacteria
cultur
use
afbspecif
blood
cultur
bottl
ml
blood
inocul
directli
afbspecif
blood
cultur
bottl
inocul
cultur
vial
transport
laboratori
asap
earli
incub
taken
skin
prepar
prior
venipunctur
addit
new
product
avail
allow
divers
discard
first
millilit
blood
like
contain
skin
contamin
consensu
guidelin
expert
panel
recommend
peripher
venipunctur
prefer
techniqu
obtain
blood
cultur
base
data
show
blood
obtain
fashion
less
like
contamin
blood
obtain
intravascular
cathet
devic
sever
studi
document
iodin
tinctur
chlorin
peroxid
chlorhexidin
glucon
chg
superior
povidoneiodin
prepar
skin
disinfect
blood
cultur
iodin
tinctur
chg
requir
second
exert
antisept
effect
compar
minut
povidoneiodin
prepar
two
recent
studi
document
equival
contamin
rate
iodin
tinctur
chg
chg
recommend
use
infant
month
age
povidoneiodin
follow
alcohol
recommend
blood
cultur
contamin
skin
flora
collect
common
contamin
rate
exceed
laboratori
polici
procedur
abbrevi
workup
report
common
blood
cultur
contamin
eg
coagulaseneg
staphylococci
viridan
group
streptococci
diphtheroid
bacillu
spp
b
anthraci
procedur
may
includ
abbrevi
identif
organ
absenc
suscept
test
comment
instruct
clinician
contact
laboratori
cultur
result
thought
clinic
signific
requir
addit
workup
suscept
result
physician
expect
call
notifi
laboratori
everi
time
blood
cultur
becom
posit
sinc
specimen
often
repres
lifethreaten
infect
physician
wish
notifi
specif
time
arrang
must
made
physician
deleg
healthcar
profession
receiv
call
relay
report
key
point
laboratori
diagnosi
bacteremia
fungemia
volum
blood
collect
time
critic
disinfect
venipunctur
site
chlorhexidin
iodin
tinctur
adult
children
month
old
chlorhexidin
recommend
children
month
old
use
povidoneiodin
alcohol
draw
blood
cultur
initi
antimicrobi
therapi
catheterdrawn
blood
cultur
higher
risk
contamin
fals
posit
submit
cathet
tip
cultur
without
accompani
blood
cultur
obtain
venipunctur
never
refriger
blood
prior
incub
use
blood
cultur
set
adult
least
aerob
anaerob
use
aerob
bottl
children
consid
aerob
anaerob
clinic
relev
streptococcu
pneumonia
gramposit
organ
facult
anaerob
organ
may
grow
best
anaerob
bottl
faster
time
detect
diagnosi
catheterassoci
bsi
often
one
exclus
microbiolog
gold
standard
diagnosi
exist
although
number
differ
microbiolog
method
describ
avail
data
allow
firm
conclus
made
rel
merit
variou
diagnost
techniqu
fundament
diagnosi
catheterassoci
bsi
document
bacteremia
clinic
signific
posit
cultur
indwel
cathet
segment
tip
absenc
posit
blood
cultur
unknown
next
essenti
diagnost
compon
demonstr
infect
caus
cathet
usual
requir
exclus
potenti
primari
foci
bsi
investig
conclud
cathet
tip
cultur
poor
predict
valu
perform
numer
diagnost
techniqu
cathet
cultur
describ
may
provid
adjunct
evid
catheterassoci
bsi
howev
potenti
pitfal
make
interpret
result
problemat
routin
cultur
intraven
cathet
tip
time
cathet
remov
clinic
valu
done
although
perform
laboratori
method
describ
includ
follow
time
posit
perform
routin
laboratori
standard
blood
cultur
bc
obtain
ml
blood
less
collect
inocul
singl
aerob
blood
cultur
bottl
time
one
cathet
port
one
peripher
venipunctur
process
continuousmonitor
bc
system
bc
grow
organ
bc
drawn
devic
becom
posit
hour
bc
drawn
venipunctur
high
probabl
catheterassoci
bsi
quantit
bc
perform
routin
laboratori
one
cathet
port
one
peripher
venipunctur
obtain
time
use
lysiscentrifug
isol
pour
plate
method
bc
grow
organ
bc
drawn
devic
organ
bc
drawn
venipunctur
high
probabl
catheterassoci
bsi
cathet
tip
segment
cultur
semiquantit
method
maki
et
al
use
commonli
interpret
requir
accompani
peripher
bc
howev
meticul
techniqu
need
reduc
contamin
obtain
correct
length
cm
distal
cathet
tip
method
detect
organ
colon
outsid
cathet
roll
onto
agar
plate
number
coloni
count
organ
may
intralumin
miss
modif
maki
method
describ
method
util
vortex
cathet
tip
endolumin
brush
perform
routin
laboratori
biofilm
format
cathet
tip
prevent
antimicrobi
therapi
clear
agent
within
biofilm
thu
requir
remov
cathet
elimin
organ
infect
mycot
aneurysm
infect
vascular
graft
may
result
posit
blood
cultur
definit
diagnosi
requir
microscop
visual
andor
cultur
recoveri
etiolog
agent
repres
biopsi
graft
materi
tabl
numer
virus
bacteria
rickettsia
fungi
parasit
implic
etiolog
agent
pericard
myocard
mani
patient
pericard
overwhelm
major
patient
myocard
etiolog
diagnosi
never
made
patient
treat
empir
select
instanc
import
clinic
defin
specif
caus
infect
microbiolog
diagnosi
pursu
aggress
unfortun
howev
avail
diagnost
resourc
quit
limit
firm
diagnost
guidelin
given
common
clinic
import
pathogen
list
tabl
microbiolog
diagnosi
less
common
etiolog
agent
requir
especi
special
techniqu
method
necessari
consult
laboratori
director
undertaken
consider
overlap
pericard
myocard
respect
etiolog
agent
diseas
manifest
clinic
microbiolog
test
valu
establish
etiolog
diagnosi
infect
within
central
nervou
system
cn
outlin
section
infect
categor
follow
mening
enceph
focal
infect
brain
parenchyma
cn
shunt
infect
subdur
empyema
epidur
abscess
suppur
intracrani
thrombophleb
organ
usual
enter
cn
cross
mucos
barrier
bloodstream
follow
penetr
bloodbrain
barrier
rout
infect
includ
direct
extens
contigu
structur
movement
along
nerv
introduct
foreign
devic
usual
tube
cerebrospin
fluid
csf
collect
lumbar
punctur
diagnost
studi
first
tube
highest
potenti
contamin
skin
flora
sent
microbiolog
laboratori
direct
smear
cultur
molecular
studi
minimum
ml
csf
sent
immedi
collect
microbiolog
laboratori
steril
contain
bacteri
test
larger
volum
ml
increas
sensit
cultur
requir
optim
recoveri
mycobacteria
fungi
specimen
volum
less
requir
multipl
test
request
priorit
test
must
provid
laboratori
whenev
possibl
specimen
cultur
obtain
prior
initi
antimicrobi
therapi
csf
gram
stain
prepar
cytocentrifug
posit
result
call
patient
care
area
immedi
identif
suscept
test
bacteria
recov
cultur
routin
perform
unless
contamin
collect
process
suspect
clinic
microbiolog
laboratori
perform
test
list
tabl
especi
true
serolog
mani
molecular
diagnost
test
avail
us
food
drug
administr
fda
clear
naat
mani
agent
limit
requir
laboratorydevelop
test
use
variabl
sensit
specif
although
fdaclear
multiplex
pcr
target
organ
avail
diagnos
mening
enceph
consid
replac
cultur
sinc
clinic
experi
assay
limit
specif
issu
report
expens
data
interpret
challeng
associ
nextgener
sequenc
prevent
widespread
use
technolog
time
serolog
diagnosi
base
csf
serum
antibodi
index
rise
acut
convalesc
immunoglobulin
g
igg
titer
singl
posit
immunoglobulin
igm
detect
antibodi
csf
may
indic
cn
infect
blood
contamin
transfer
antibodi
across
bloodbrain
barrier
submiss
acut
day
onset
symptom
convalesc
week
acut
serum
sampl
recommend
serum
separ
red
cell
soon
possibl
key
point
laboratori
diagnosi
cn
infect
whenev
possibl
collect
specimen
prior
initi
antimicrobi
therapi
two
bc
also
obtain
bacteri
mening
suspect
inform
microbiolog
laboratori
unusu
organ
possibl
eg
nocardia
fungi
mycobacteria
special
procedur
necessari
refriger
csf
csf
tube
submit
bacteri
cultur
molecular
test
attempt
collect
much
sampl
possibl
multipl
studi
minimum
recommend
ml
priorit
multipl
test
request
smallvolum
sampl
common
etiolog
agent
acut
mening
virus
echovirus
parechovirus
bacteria
streptococcu
diagnosi
acut
mening
due
hiv
condit
often
aris
earli
stage
hiv
retrovir
syndrom
best
establish
base
compat
csf
find
ie
mild
csf
lymphocytosi
mildli
elev
csf
protein
level
normal
glucos
combin
definit
evid
recent
hiv
infect
see
section
xiv
hiv
diagnosi
tabl
patient
age
factor
ie
immunostatu
undergon
neurosurgeri
trauma
associ
specif
pathogen
molecular
test
replac
viral
cultur
diagnosi
enterovir
mening
routin
reli
detect
bacteria
csf
gram
stain
bacteri
cultur
order
sensit
gram
stain
diagnosi
bacteri
mening
patient
receiv
antimicrobi
therapi
patient
receiv
treatment
bacteri
antigen
test
csf
longer
recommend
order
laboratori
provid
servic
earli
incorrect
assumpt
held
select
antigen
test
csf
may
valu
patient
receiv
therapi
prior
specimen
collect
neg
gram
stain
neg
cultur
result
longer
recommend
patient
suspect
bacteri
mening
least
blood
cultur
perform
therapi
delay
organ
expect
caus
chronic
mening
symptom
last
week
includ
mycobacterium
tuberculosi
fungi
spirochet
tabl
sensit
nucleic
acid
amplif
test
naat
tuberculosi
nonrespiratori
specimen
may
poor
cultur
also
request
report
sensit
cultur
diagnos
tubercul
mening
highest
yield
acidfast
bacilli
afb
smear
afb
cultur
occur
larg
volum
ml
csf
use
perform
test
cryptococc
antigen
test
replac
india
ink
stain
rapid
diagnosi
mening
caus
cryptococcu
neoforman
cryptococcu
gattii
readili
avail
laboratori
test
sensit
perform
csf
rather
serum
sensit
specif
cryptococc
antigen
test
falseneg
falseposit
result
may
occur
exampl
patient
human
immunodefici
viru
hiv
aid
complement
fixat
test
perform
csf
recommend
diagnosi
coccidioid
mening
sinc
direct
fungal
smear
cultur
often
neg
detect
coccidioid
antibodi
csf
immunodiffus
lower
specif
complement
fixat
enceph
infect
brain
parenchyma
caus
abnorm
cerebr
function
alter
mental
statu
behavior
speech
disturb
sensori
motor
deficit
despit
advanc
molecular
technolog
diagnosi
cn
infect
etiolog
agent
enceph
often
identifi
california
enceph
project
identifi
definit
probabl
etiolog
agent
immunocompet
patient
enrol
viral
bacteri
prion
parasit
fungal
possibl
caus
identifi
addit
patient
immunostatu
travel
exposur
histori
insect
anim
water
sexual
guid
test
infecti
diseas
societi
america
idsa
practic
guidelin
provid
detail
list
risk
factor
associ
specif
etiolog
agent
although
diagnosi
specif
viral
caus
usual
base
test
perform
csf
test
specimen
collect
site
may
help
viru
commonli
identifi
caus
enceph
herp
simplex
viru
hsv
sensit
specif
naat
hsv
enceph
earli
data
show
hsv
cultur
csf
case
report
falseneg
hsv
naat
basi
recommend
collect
anoth
csf
specimen
day
later
repeat
test
hsv
enceph
continu
suspect
sensit
naat
perform
csf
enteroviru
enceph
sensit
cultur
recoveri
throat
stool
circumstanti
etiolog
evid
addit
naat
specif
parechovirus
recommend
young
children
perform
characterist
molecular
test
caus
viral
enceph
well
establish
serolog
repeat
molecular
test
may
requir
tabl
focal
parenchym
brain
infect
start
cerebr
progress
necrosi
surround
fibrou
capsul
broad
categori
pathogenesi
contigu
spread
otiti
media
sinus
mastoid
dental
infect
trauma
neurosurg
complic
hematogen
spread
distant
site
infect
skin
pulmonari
pelvic
intraabdomin
esophag
endocard
brain
abscess
immunocompet
host
usual
caus
bacteria
tabl
wider
array
organ
encount
immunocompromis
individu
shunt
place
divert
csf
treatment
hydrocephalu
proxim
portion
place
cerebr
ventricl
intracrani
cyst
subarachnoid
space
lumbar
region
distal
portion
may
intern
periton
vascular
pleural
space
extern
five
shunt
becom
infect
tabl
potenti
rout
shunt
infect
includ
contamin
time
placement
contamin
distal
portion
retrograd
breakdown
skin
shunt
hematogen
seed
blood
cultur
also
collect
shunt
termin
vascular
space
ventriculoatri
shunt
cn
shunt
infect
caus
bacteria
fungi
like
caus
shunt
infect
immunocompromis
patient
receiv
total
parenter
nutrit
steroid
broadspectrum
antibiot
cultur
shunt
drain
compon
remov
perform
unless
patient
symptom
cn
infect
cranial
subdur
empyema
cranial
epidur
abscess
neurosurg
emerg
usual
caus
bacteria
streptococci
staphylococci
aerob
gramneg
bacilli
anaerob
often
polymicrobi
tabl
mycobacteria
fungi
rare
caus
predispos
condit
includ
sinus
otiti
media
mastoid
neurosurgeri
head
trauma
subdur
hematoma
mening
infant
pathogenesi
spinal
epidur
abscess
includ
hematogen
spread
skin
urinari
tract
mouth
mastoid
lung
infect
direct
extens
vertebr
osteomyel
disciti
trauma
magnet
reson
imag
optim
diagnost
procedur
suppur
intracrani
thrombophleb
etiolog
agent
may
recov
cerebrospin
fluid
blood
cultur
caus
organ
similar
cranial
epidur
abscess
cranial
subdur
empyema
empir
antimicrobi
therapi
usual
base
predispos
clinic
condit
spectrum
ocular
infect
rang
superfici
may
treat
symptomat
empir
topic
antimicrobi
therapi
sightthreaten
infect
requir
aggress
surgic
intervent
either
topic
parenter
antimicrobi
therapi
infect
may
occur
anatom
structur
surround
eye
conjunct
blephar
canalicul
dacryocyst
orbit
periorbit
cellul
surfac
eye
kerat
within
globe
eye
endophthalm
uveitisretin
recommend
laboratori
diagnosi
ocular
infect
often
base
studi
small
number
clinic
specimen
examin
evid
base
mani
recommend
limit
studi
compar
multipl
diagnost
approach
determin
optim
mean
detect
infecti
etiolog
kerat
endophthalm
hamper
small
specimen
size
final
frequent
pretreat
topic
antibacteri
agent
complic
laboratori
diagnosi
bacteri
conjunct
kerat
key
point
laboratori
diagnosi
ocular
infect
specimen
label
specif
anatom
sourc
ie
conjunctiva
cornea
eye
gram
stain
use
diagnosi
conjunct
swab
per
site
may
appropri
pair
specimen
uninfect
eye
use
control
assist
cultur
gram
stain
interpret
swab
specimen
routin
use
provid
minimum
amount
materi
consult
laboratori
regard
suspici
agent
corneal
scrape
prefer
kerat
diagnosi
organ
part
indigen
microflora
usual
involv
conjunct
may
involv
postsurg
kerat
endophthalm
ocular
infect
may
involv
one
eye
etiolog
may
differ
clinician
must
clearli
mark
specimen
eye
sampl
especi
patient
bilater
diseas
collect
specimen
anatom
structur
surround
eye
typic
done
use
swab
tabl
commonli
collect
specimen
conjunctiva
cultur
aerob
bacteria
detect
chlamydia
virus
either
cultur
naat
commonli
perform
although
none
yet
fda
approv
detect
eye
specimen
sinc
direct
microscop
examin
may
use
preliminari
diagnosi
conjunct
obtain
dual
swab
one
cultur
one
smear
prepar
recommend
smear
may
made
gram
stain
calcofluor
stain
fungi
acanthamoeba
direct
fluoresc
antibodi
dfa
chlamydia
trachomati
appropri
transport
media
provid
laboratori
avail
collect
site
specimen
submit
chlamydia
andor
viral
cultur
naat
although
naat
test
prefer
diagnosi
viral
ocular
infect
increas
sensit
rapid
turnaround
time
viral
cultur
request
specimen
submit
ice
use
viral
transport
medium
especi
specimen
transport
prolong
specimen
obtain
either
surfac
globe
eye
almost
alway
collect
ophthalmologist
specimen
type
includ
swab
ulcer
corneal
scrape
impress
membran
cultur
biopsi
anterior
chamber
aspir
vitreou
aspirateswash
volum
specimen
alway
limit
specimen
limit
make
necessari
laboratori
priorit
procedur
depend
organ
sought
alway
done
discuss
ophthalmologist
collect
specimen
infecti
diseas
consult
appropri
particularli
import
major
pathogen
groupsvirus
parasit
bacteria
mycobacteria
fungican
caus
ocular
infect
epidemiolog
clinic
present
use
narrow
organ
sought
laboratori
test
request
limit
specimen
size
seen
scrape
biopsi
laboratori
ophthalmologist
may
agre
inocul
specimen
onto
media
prepar
smear
bedsid
case
laboratori
suppli
necessari
media
slide
ophthalmologist
suppli
store
clinic
oper
suit
readi
access
surgeon
laboratori
respons
assur
materi
outdat
meet
qualiti
control
standard
aspir
anterior
chamber
vitreou
optim
specimen
detect
anaerob
bacteria
viral
agent
submit
syring
needl
remov
syring
place
leakproof
outer
contain
transport
inject
fluid
small
steril
vial
provid
laboratori
prefer
principl
specimen
collect
transport
describ
conjunctiv
specimen
appli
specimen
well
orbit
cellul
almost
alway
complic
sinus
organ
associ
includ
streptococcu
pneumonia
nontyp
haemophilu
influenza
streptococcu
pyogen
moraxella
spp
anaerob
bacteria
aspergillu
spp
mucoral
formerli
zygomycet
periorbit
cellul
usual
aris
result
either
local
trauma
bacteremia
often
caus
staphylococcu
aureu
pyogen
pneumonia
diagnosi
infect
either
base
posit
blood
cultur
case
orbit
cellul
cultur
drainag
materi
aspir
subperiost
region
sinus
blephar
canalicul
dacryocyst
superfici
infect
gener
selflimit
organ
associ
infect
predominantli
gramposit
bacteria
although
variou
gramneg
bacteria
anaerob
fungi
recov
limit
mani
studi
infect
microbiolog
data
control
popul
frequent
lack
organ
commonli
recov
part
indigen
skin
microflora
coagulas
neg
staphylococci
diphtheroid
attribut
pathogen
role
organ
condit
difficult
cultur
site
rare
submit
diagnost
workup
cultur
canalicul
consid
concret
recov
canalicular
compress
canaliculotomi
recommend
strategi
diagnosi
superfici
infect
similar
conjunct
case
conjunct
caus
bacteria
virus
typic
associ
upper
respiratori
tract
infect
distinct
clinic
present
bacteri
viral
conjunct
coupl
selflimit
natur
infect
determin
etiolog
infrequ
attempt
test
request
diagnosi
bacteri
conjunct
often
compromis
prior
use
empir
antibacteri
therapi
sexual
activ
patient
present
bacteri
conjunct
aggress
diagnost
workup
gram
stain
cultur
risk
n
gonorrhoea
conjunct
sightthreaten
infect
result
perfor
globe
develop
world
trachoma
form
conjunct
due
specif
strain
c
trachomati
lead
caus
blind
especi
children
offlabel
use
commerci
naat
assay
use
detect
agent
research
set
certain
organ
part
indigen
skin
mucou
membran
microflora
coagulaseneg
staphylococci
corynebacterium
spp
viridan
streptococci
gener
consid
nonpathogen
recov
conjunctiv
mucosa
consid
normal
flora
specimen
taken
surfac
interior
eye
organ
along
cutibacterium
propionibacterium
acn
consid
pathogen
especi
patient
postcataract
lasik
surgeri
adenoviru
etiolog
agent
pink
eye
highli
transmiss
varieti
set
almost
alway
clinic
diagnosi
although
epidemiolog
purpos
cultur
naat
done
case
neonat
conjunct
due
neisseria
gonorrhoea
c
trachomati
herp
simplex
viru
commerci
naat
n
gonorrhoea
c
trachomati
fda
approv
specimen
type
cultur
case
c
trachomati
dfa
test
avail
use
pseudomona
aeruginosa
rare
lifethreaten
caus
neonat
conjunct
hospit
infant
corneal
infect
usual
occur
distinct
patient
popul
ocular
trauma
foreign
object
postsurg
complic
corneal
surgeri
patient
practic
poor
hygien
associ
extendedwear
contact
lens
postvaccin
kerat
wellrecogn
complic
vaccinia
vaccin
consid
appropri
clinic
set
corneal
infect
also
result
reactiv
herp
virus
includ
hsv
varicella
zoster
viru
import
note
use
dye
topic
anesthet
may
inhibit
naat
reaction
use
diagnos
kerat
eye
surfac
thoroughli
rins
nonbacteriostat
salin
specimen
naat
obtain
tabl
common
corneal
infect
occur
patient
improperli
use
contact
len
system
patient
usual
treat
antimicrobi
agent
prior
obtain
specimen
bacteri
cultur
ophthalmologist
favor
cultur
contact
len
solut
case
howev
cultur
solut
case
recommend
frequenc
fals
posit
pseudomona
aeruginosa
common
caus
sporad
contact
lensassoci
kerat
outbreak
kerat
due
contamin
contact
len
care
solut
recent
report
fusarium
acanthamoeba
sporad
case
acanthamoeba
kerat
increas
associ
improp
contact
len
use
postsurg
kerat
infect
frequent
due
either
coagulaseneg
staphylococci
c
acn
set
organ
consid
contamin
potenti
pathogen
kerat
postcorn
transplant
commonli
due
candida
spp
case
due
part
wide
use
corneal
hold
medium
contain
antifung
agent
cultur
plate
includ
sheep
blood
agar
plate
chocol
agar
plate
inocul
directli
materi
collect
kimura
spatula
directli
patient
bedsid
time
corneal
scrape
obtain
usual
appli
agar
surfac
number
small
c
shape
inocula
suffici
sampl
avail
smear
glass
slide
may
also
prepar
patient
bedsid
plate
inocul
inocul
plate
slide
prepar
transport
directli
microbiolog
laboratori
c
laboratori
notifi
nocardia
spp
suspect
cultur
plate
may
incub
longer
period
normal
thu
enhanc
chanc
recov
slowgrow
organ
addit
media
bcye
enhanc
recoveri
nocardia
least
one
cultur
plate
slant
contain
nonselect
fungal
growth
medium
inocul
directli
patient
bedsid
time
corneal
scrape
obtain
suffici
sampl
avail
smear
glass
slide
may
also
prepar
patient
bedsid
attempt
platessl
inocul
inocul
platessl
slide
prepar
transport
directli
microbiolog
laboratori
smear
stain
calcofluorkoh
laboratori
examin
fungal
element
f
corneal
swab
specimen
use
inocul
agar
plate
contain
nonnutrit
medium
patient
bedsid
transport
immedi
laboratori
laboratori
plate
overlaid
lawn
viabl
escherichia
coli
member
enterobacteriacea
ie
cocultiv
prior
incub
altern
plate
seed
bacteria
inocul
bit
corneal
scrape
materi
drop
suspens
scrape
sampl
steril
salin
kerat
follow
trauma
due
foreign
object
frequent
caus
organ
found
environ
includ
group
environment
gramneg
rod
p
aeruginosa
nocardia
spp
mold
includ
dematiac
fungi
environment
mycobacteria
corneal
biopsi
recommend
patient
kerat
persist
worsen
small
seri
n
organ
found
neg
corneal
scrape
howev
pathogen
detect
histopatholog
n
cultur
n
acanthamoeba
sp
n
fungi
n
repres
organ
detect
histopatholog
endophthalm
aris
either
exogen
introduct
pathogen
eye
follow
trauma
surgeri
result
endogen
introduct
pathogen
across
bloodey
barrier
depend
upon
mode
pathogenesi
spectrum
caus
agent
vari
tabl
specimen
diagnosi
endophthalm
obtain
aspir
aqueou
abbrevi
afb
acidfast
bacilli
bcye
buffer
charcoal
yeast
extract
koh
potassium
hydroxid
rt
room
temperatur
among
long
list
bacteri
caus
endophthalm
streptococcu
agalactia
listeria
monocytogen
neisseria
meningitidi
occur
almost
exclus
result
endogen
seed
eye
bacteria
list
may
caus
endophthalm
either
secondari
trauma
surgeri
follow
hematogen
seed
b
cultur
plate
includ
sheep
blood
agar
plate
chocol
agar
plate
inocul
directli
patient
bedsid
time
corneal
scrape
obtain
see
footnot
b
tabl
suffici
sampl
avail
smear
glass
slide
may
also
prepar
patient
bedsid
plate
inocul
inocul
plate
slide
prepar
transport
directli
microbiolog
laboratori
c
laboratori
notifi
nocardia
spp
suspect
special
media
use
routin
cultur
plate
incub
day
common
mycobacterium
sp
recov
intraocular
infect
chelona
occur
almost
exclus
complic
surgic
procedur
e
acidfast
smear
mycobacteri
cultur
perform
postsurg
infect
eye
agar
lowensteinjensen
agar
slant
inocul
patient
bedsid
suffici
clinic
sampl
remain
smear
prepar
slant
smear
prepar
transport
directli
laboratori
process
inocul
slant
prepar
smear
bedsid
still
unus
specimen
remain
transport
steril
contain
immedi
laboratori
rt
inocul
broth
media
subsequ
instrumentbas
process
f
among
fungi
list
candida
albican
candida
glabrata
candida
spp
caus
endogen
endophthalm
result
hematogen
seed
eye
fungi
list
typic
caus
infect
follow
traumat
inocul
eye
g
least
one
cultur
plate
slant
contain
nonselect
fungal
growth
medium
inocul
directli
patient
bedsid
time
corneal
scrape
obtain
suffici
sampl
avail
smear
glass
slide
may
also
prepar
patient
bedsid
platessl
inocul
inocul
platessl
slide
prepar
transport
directli
microbiolog
laboratori
smear
stain
calcofluorkoh
laboratori
examin
fungal
element
fluid
vitreou
fluidwash
via
biopsi
specimen
amount
aqueou
vitreou
fluid
small
discret
must
exercis
determin
agent
specimen
examin
altern
vitrectomi
surgic
procedur
allow
collect
compar
larg
fluid
volum
ml
wash
vitreou
nonbacteriostat
balanc
salt
solut
membran
filtrat
postop
endophthalm
often
caus
gramposit
organ
coagulaseneg
staphylococci
predomin
chronic
postop
endophthalm
due
c
acn
organ
routin
dismiss
contamin
postcorn
endophthalm
due
primarili
candida
spp
gramposit
organ
candida
major
gramposit
organ
resist
antimicrobi
present
cornea
hold
medium
environment
organ
dematiac
fungi
fusarium
spp
bacillu
cereu
nocardia
spp
mycobacterium
chelona
glucosefer
gramneg
rod
commonli
encount
patient
exogen
endophthalm
endogen
endophthalm
associ
bacteremia
fungemia
usual
caus
organ
respons
bsi
exampl
candida
albican
relat
speci
aspergillu
spp
aureu
pneumonia
enterobacteriacea
especi
klebsiella
pneumonia
p
aeruginosa
virus
parasit
rare
found
caus
endophthalm
howev
case
trauma
sever
immunosuppress
infect
due
agent
herp
virus
toxoplasma
gondii
toxocara
spp
echinococcu
spp
onchocerca
volvulu
occur
typic
involv
uvea
retina
inform
diagnosi
ocular
infect
caus
volvulu
see
section
xvc
inflamm
characterist
uveitisretin
typic
due
either
autoimmun
condit
idiopath
infrequ
due
infect
almost
alway
caus
endogen
microb
access
eye
via
breach
bloodey
barrier
uveiti
retin
like
endogen
endophthalm
local
manifest
system
infect
diagnosi
etiolog
system
infect
coupl
care
ocular
examin
prefer
perform
ophthalmologist
specif
infecti
diseas
expertis
import
caus
uveitisretin
includ
gondii
cytomegaloviru
cmv
hsv
varicella
zoster
viru
tuberculosi
treponema
pallidum
toxocara
cani
rubella
addit
agent
consid
pediatr
toxoplasma
gondii
common
infecti
caus
retin
diagnosi
typic
made
clinic
ground
support
serolog
industri
world
presenc
gondii
igg
lack
specif
diagnosi
ocular
toxoplasmosi
therefor
serolog
valuabl
set
acut
infect
patient
ocular
examin
pathognomon
toxoplasmosi
demonstr
retinochoroid
major
case
comparison
intraocular
antibodi
level
aqueou
humor
serum
found
use
mean
diagnos
ocular
toxoplasmosi
although
consist
accur
specimen
need
test
obtain
experienc
ophthalmologist
invas
procedur
unlik
techniqu
use
outsid
research
set
naat
blood
vitreou
aqueou
fluid
sensit
intraocular
antibodi
determin
specimen
test
may
easili
obtain
sensit
naat
rang
report
patient
gondii
retin
depend
upon
sequenc
use
specimen
test
note
total
number
specimen
test
studi
small
increas
evid
diagnost
valu
naat
gondii
retin
sinc
advent
highli
activ
antiretrovir
treatment
cmv
retin
becom
much
less
frequent
nevertheless
case
occur
hiv
patient
either
fail
hiv
therapi
aidspres
diagnosi
addit
cmv
retin
wellrecogn
complic
bone
marrow
solid
organ
transplant
less
frequent
recent
due
improv
preemptiv
detect
therapi
cmv
retin
frequent
diagnos
clinic
characterist
lesion
seen
ophthalmolog
examin
quantit
cmv
naat
perform
peripher
blood
also
use
tool
diagnosi
manag
infect
patient
detect
cmv
viral
load
higher
likelihood
retin
diseas
progress
high
cmv
viral
load
increas
mortal
patient
undetect
cmv
viral
load
low
likelihood
viru
resist
antivir
agent
interlaboratori
variat
viral
quantif
repres
posit
cmv
viral
load
high
cmv
viral
load
vari
among
laboratori
physician
consult
laboratori
perform
cmv
viral
load
assist
test
interpret
patient
ocular
syphili
may
present
normal
csf
may
frequent
cn
find
associ
either
acut
syphilit
mening
neurosyphili
patient
syphilit
uveiti
typic
high
rapid
plasma
reagin
rpr
titer
cell
count
total
protein
glucos
along
vener
diseas
research
laboratori
vdrl
test
csf
recommend
clinic
set
syphilit
uveiti
suspect
final
metagenom
analysi
begin
appli
research
set
diagnosi
unusu
case
uveiti
diagnost
approach
like
avail
diagnosi
endophthalm
uveiti
retin
near
futur
infect
variou
space
tissu
occur
head
neck
divid
aris
odontogen
oropharyng
exogen
sourc
odontogen
infect
caus
commonli
endogen
periodont
gingiv
flora
infect
includ
peritonsillar
pharyng
abscess
deep
space
abscess
retropharyng
parapharyng
submandibular
sublingu
space
cervic
lymphaden
complic
odontogen
infect
occur
hematogen
spread
direct
extens
result
septic
jugular
vein
thrombophleb
lemierr
syndrom
bacteri
endocard
intracrani
abscess
acut
mediastin
accur
etiolog
diagnosi
depend
upon
collect
aspir
biopsi
inflammatori
materi
affect
tissu
tissu
space
avoid
contamin
mucos
microbiota
specimen
place
anaerob
transport
contain
support
recoveri
anaerob
bacteria
aerob
facult
bacteria
surviv
anaerob
transport
request
gramstain
smear
standard
anaerob
cultur
allow
laboratorian
evalu
adequaci
specimen
identifi
inflammatori
cell
provid
earli
presumpt
etiolog
diagnosi
identifi
morpholog
pattern
indic
mix
aerob
anaerob
infect
addit
spirochet
often
involv
odontogen
infect
recov
routin
anaerob
cultur
seen
stain
smear
infect
caus
oropharyng
flora
includ
epiglott
mastoid
inflamm
salivari
tissu
suppur
parot
epiglotti
may
swell
dramat
epiglott
chanc
sudden
occlus
trachea
epiglotti
disturb
attempt
collect
swab
specimen
blood
cultur
prefer
sampl
diagnosi
epiglott
swab
attempt
set
avail
appropri
emerg
respons
oropharyng
flora
also
extend
tissu
middl
ear
mastoid
nasal
sinus
caus
acut
infect
aspir
materi
salin
lavag
close
space
tissu
tissu
scrape
prefer
specimen
must
transport
steril
contain
tissu
transport
steril
condit
kept
moist
ad
drop
steril
nonbacteriostat
salin
although
rare
implic
anaerob
bacteri
pathogen
suspect
anaerob
transport
requir
note
filament
fungi
common
caus
chronic
sinus
may
recov
swab
even
obtain
endoscop
endoscop
aspir
tissu
scrape
specimen
choic
microbiolog
analysi
alway
best
submit
actual
specimen
swab
specimen
infect
caus
exogen
pathogen
part
oral
flora
includ
malign
otiti
externa
mastoid
anim
bite
trauma
irradi
burn
complic
surgic
procedur
mucos
flora
may
play
etiolog
role
infect
frequent
gramneg
bacilli
staphylococci
key
point
laboratori
diagnosi
head
neck
soft
tissu
infect
swab
specimen
choic
specimen
submit
tissu
fluid
aspir
possibl
resist
swab
case
epiglott
use
anaerob
transport
contain
anaerob
suspect
keep
tissu
specimen
moist
transport
follow
tabl
includ
common
soft
tissu
tissu
space
infect
head
neck
origin
odontogen
oropharyng
exogen
sourc
optimum
approach
establish
etiolog
diagnosi
condit
provid
tabl
b
infect
upper
respiratori
tract
usual
involv
ear
mucu
membran
line
nose
throat
epiglotti
sinus
infect
involv
nose
throat
caus
virus
see
section
xiv
test
inform
inappropri
util
antibiot
viral
infect
major
driver
increas
antibiot
resist
proper
diagnosi
infecti
syndrom
environ
must
involv
laboratori
test
determin
etiolog
thu
inform
proper
therapi
key
point
laboratori
diagnosi
upper
respiratori
tract
infect
swab
recommend
otiti
media
sinus
submit
aspir
cultur
case
otiti
media
diagnos
clinic
treat
without
cultur
support
throat
specimen
requir
firm
thorough
sampl
throat
tonsil
avoid
cheek
gum
teeth
haemophilu
influenza
staphylococcu
aureu
neisseria
meningitidi
streptococcu
pneumonia
etiolog
agent
acut
pharyng
identifi
report
throat
cultur
nasopharyng
cultur
accur
predict
etiolog
agent
sinus
otiti
media
om
singl
frequent
condit
caus
pediatr
patient
taken
healthcar
provid
given
antibiot
acut
om
effus
c
note
nucleic
acid
test
usual
avail
local
must
sent
refer
laboratori
result
longer
turnaround
time
laboratori
alert
bartonella
cultur
request
appropri
media
avail
time
specimen
arriv
laboratori
even
yield
bartonella
cultur
low
avail
bartonella
nucleic
acid
test
sensit
portion
specimen
sent
histopatholog
laboratori
h
e
warthinstarri
stain
clinic
variant
om
like
bacteri
etiolog
result
like
benefit
antimicrobi
therapi
tabl
streptococcu
pneumonia
nontyp
haemophilu
influenza
moraxella
catarrhali
common
bacteri
caus
om
aureu
streptococcu
pyogen
pseudomona
aeruginosa
occur
less
commonli
turicella
otitidi
staphylococcu
auriculari
emerg
pathogen
thought
caus
om
addit
studi
need
determin
true
signific
organ
chronic
suppur
om
associ
higher
rate
complic
acut
om
pseudomona
aeruginosa
aureu
common
pathogen
chronic
om
varieti
respiratori
virus
known
caus
om
howev
exist
pathogen
specif
therapi
result
littl
reason
attempt
establish
etiolog
diagnosi
patient
viral
etiolog
effort
determin
caus
om
best
reserv
patient
like
bacteri
etiolog
recent
onset
bulg
tympan
membran
pain
exud
respond
prior
cours
antimicrobi
therapi
patient
immunolog
defici
acut
ill
patient
repres
specimen
middl
ear
fluid
obtain
either
tympanocentesi
patient
otorrhea
myringotomi
tube
collect
drainag
minitip
swab
directli
clean
ear
canal
cultur
pharynx
nasopharynx
anterior
nare
nasal
drainag
materi
valu
attempt
establish
etiolog
diagnosi
bacteri
om
tabl
rhinosinus
prefer
term
encompass
acut
chronic
diseas
affect
approxim
adult
popul
unit
state
annual
direct
cost
manag
acut
chronic
rhinosinus
exceed
us
billion
per
year
etiolog
agent
rhinosinus
vari
base
upon
durat
symptom
whether
commun
acquir
nosocomi
origin
tabl
streptococcu
pneumonia
nontyp
h
influenza
moraxella
catarrhali
common
bacteri
caus
acut
maxillari
sinus
role
respiratori
virus
sinus
need
studi
patient
acut
sinus
upper
respiratori
viru
detect
earli
ill
staphylococcu
aureu
gramneg
bacilli
streptococcu
spp
anaerob
bacteria
associ
frequent
subacut
chronic
healthcareassoci
sinus
role
fungi
etiolog
agent
controversi
possibl
due
numer
public
use
poor
sampl
collect
method
thu
recov
fungal
agent
immunocompet
host
fungi
associ
often
chronic
sinus
though
signific
fungal
presenc
chronic
sinus
frequent
uncertain
invas
sinus
due
fungal
infect
sever
immunocompromis
person
uncontrol
diabet
patient
often
sever
carri
high
mortal
rate
attempt
establish
etiolog
diagnosi
sinus
typic
reserv
patient
complic
infect
chronic
diseas
patient
serious
ill
immunocompromis
continu
deterior
clinic
despit
extend
cours
antimicrobi
therapi
recurr
bout
acut
rhinosinus
clear
episod
swab
recommend
collect
sinu
specimen
sinc
aspir
much
product
true
etiolog
agent
specimen
choic
endoscop
obtain
swab
recov
bacteri
pathogen
rare
detect
caus
fungi
maxillari
sinus
antral
punctur
sinu
aspir
though
seldom
done
adult
swab
materi
drain
middl
meatu
obtain
endoscop
guidanc
repres
adequ
specimen
cultur
middl
meatu
drainag
specimen
recommend
pediatr
patient
due
colon
normal
microbiota
overlap
potenti
respiratori
tract
pathogen
examin
nasal
drainag
materi
valu
attempt
determin
caus
maxillari
sinus
surgic
procedur
necessari
obtain
specimen
repres
infect
frontal
sphenoid
ethmoid
sinus
establish
fungal
etiolog
endoscop
sinu
aspir
recommend
often
unproduct
fungal
agent
tissu
biopsi
may
product
acut
pharyng
account
roughli
outpati
visit
healthcar
provid
unit
state
respons
million
patient
visit
pharyng
viral
need
treat
pharyng
adult
children
due
group
streptococci
differ
epidemiolog
variou
infecti
agent
relat
age
patient
season
year
accompani
sign
symptom
presenc
absenc
system
diseas
insuffici
establish
definit
etiolog
diagnosi
clinic
epidemiolog
ground
alon
consequ
result
laboratori
test
play
central
role
guid
therapeut
decis
tabl
antimicrobi
therapi
warrant
patient
pharyng
proven
bacteri
etiolog
streptococcu
pyogen
group
streptococcu
common
bacteri
caus
pharyng
carri
potenti
seriou
sequela
primarili
children
left
undiagnos
inadequ
treat
sever
laboratori
test
includ
cultur
rapid
antigen
test
molecular
method
use
establish
etiolog
diagnosi
pharyng
due
organ
past
decad
antral
punctur
use
method
sampl
maxillari
sinus
c
anaerob
transport
vial
good
aerob
anaerob
bacteria
rapid
antigen
test
pyogen
use
extens
evalu
patient
pharyng
test
technic
nondemand
gener
reliabl
often
perform
point
care
method
accuraci
clinic
relev
depend
appropri
sampl
techniqu
consensu
among
profession
societi
neg
rapid
antigen
test
pyogen
children
confirm
cultur
molecular
assay
although
gener
necessari
neg
test
result
adult
due
lower
risk
complic
new
guidelin
suggest
either
convent
cultur
confirm
neg
rapid
antigen
test
result
cultur
use
achiev
maxim
sensit
diagnosi
pyogen
pharyng
adult
laboratori
accredit
colleg
american
pathologist
requir
back
neg
rapid
antigen
test
cultur
rapid
clinic
laboratori
improv
amend
clia
waiv
method
molecular
group
streptococcu
test
provid
improv
sensit
may
requir
cultur
confirm
though
yet
incorpor
consensu
guidelin
role
nongroup
streptococci
particular
group
c
g
caus
pharyng
controversi
numer
commerci
avail
direct
antigen
test
vari
term
sensit
eas
use
specif
test
employ
dictat
swab
transport
system
use
pediatr
patient
direct
antigen
test
neg
direct
antigen
test
known
sensit
second
throat
swab
examin
sensit
direct
naat
cultur
mean
arbitr
possibl
falseneg
direct
antigen
test
result
secondari
test
necessarili
requir
adult
conveni
mean
facilit
algorithm
test
streptococcu
pyogen
pediatr
patient
collect
dual
swab
initi
recogn
second
swab
discard
direct
antigen
test
posit
b
direct
amplifi
naat
streptococcu
pyogen
sensit
direct
antigen
test
result
neg
direct
naat
result
arbitr
secondari
test
swab
transport
devic
compat
naat
use
direct
nucleic
acid
probe
test
usual
perform
enrich
broth
cultur
thu
requir
longer
turnaround
time
amplifi
test
pointofcar
use
quit
rapid
c
detect
group
c
g
streptococci
accomplish
throat
cultur
patient
exist
concern
etiolog
role
organ
larg
coloni
type
identifi
tini
coloni
demonstr
group
c
g
antigen
streptococcu
anginosu
milleri
group
check
laboratori
determin
routin
look
arcanobacterium
haemolyticum
neisseria
gonorrhoea
corynebacterium
diphtheria
caus
pharyng
limit
epidemiolog
set
laboratori
routin
recov
organ
throat
swab
specimen
clinic
suspicion
exist
one
pathogen
laboratori
notifi
appropri
measur
appli
e
use
naat
detect
gonorrhea
throat
specimen
current
offlabel
use
test
may
valid
use
laboratori
probabl
caus
pharyng
immunocompromis
patient
numer
rapid
test
base
detect
hsvspecif
antigen
direct
fluoresc
antibodi
directli
clinic
materi
develop
nonspecif
stain
tzanck
test
insensit
recommend
swab
use
aggress
collect
materi
base
multipl
pharyng
lesion
place
swab
transport
devic
compat
test
perform
cultur
may
use
immunocompromis
patient
h
hsv
serolog
use
primarili
immunostatu
exposur
statu
test
igm
serolog
longer
recommend
howev
mani
healthcar
provid
consid
organ
signific
base
therapeut
decis
detect
rare
case
poststreptococc
glomerulonephr
infect
speci
report
therefor
includ
guidanc
detect
group
c
g
streptococci
larg
coloni
produc
sinc
streptococcu
anginosu
group
characterist
yield
pinpoint
coloni
caus
pharyng
pharyng
swab
specimen
indic
done
set
organ
consid
signific
outbreak
epidemiolog
associ
case
pharyng
recoveri
organ
multipl
patient
outbreak
investig
arcanobacterium
haemolyticum
also
caus
pharyng
less
commonli
occur
often
teenag
young
adult
caus
highli
suggest
scarlatinaform
rash
patient
neisseria
gonorrhoea
corynebacterium
diphtheria
specif
patient
epidemiolog
set
may
also
caus
pharyng
respiratori
virus
common
caus
pharyng
adult
pediatr
popul
howev
unnecessari
defin
specif
etiolog
patient
pharyng
due
respiratori
virus
sinc
exist
pathogendirect
therapi
agent
hsv
hiv
epsteinbarr
viru
ebv
may
also
caus
pharyng
epidemiolog
clinic
implic
infect
due
hsv
hiv
ebv
circumst
may
aris
import
attempt
determin
individu
patient
infect
caus
one
agent
recent
studi
shown
relationship
fusobacterium
necrophorum
pharyng
patient
case
throat
infect
could
prelud
lemierr
syndrom
fusobacterium
necrophorum
anaerob
organ
requir
addit
media
use
anaerob
isol
identif
procedur
laboratori
prepar
use
throat
specimen
notifi
laboratori
suspect
diagnosi
etiolog
agent
appropri
procedur
avail
absenc
anaerob
capabl
laboratori
would
sent
refer
laboratori
respiratori
tract
infect
among
common
infecti
diseas
list
caus
agent
continu
expand
new
pathogen
syndrom
recogn
section
describ
major
etiolog
agent
microbiolog
approach
diagnosi
bronchiti
bronchiol
communityacquir
pneumonia
cap
hospitalacquir
pneumonia
hap
ventilatorassoci
pneumonia
vap
infect
pleural
space
bronchopulmonari
infect
patient
cystic
fibrosi
pneumonia
immunocompromis
host
reader
refer
variou
practic
guidelin
written
recent
year
infecti
diseas
societi
america
american
thorac
societi
american
societi
microbiolog
among
clinic
practic
group
describ
clinic
featur
diagnost
approach
patient
manag
aspect
mani
syndrom
tabl
summar
import
caveat
obtain
specimen
diagnosi
respiratori
infect
key
point
laboratori
diagnosi
lower
respiratori
tract
infect
naat
larg
replac
rapid
antigen
test
cultur
respiratori
viru
detect
laboratori
contact
specif
instruct
prior
collect
specimen
fastidi
pathogen
bordetella
pertussi
first
morn
expector
sputum
alway
best
bacteri
cultur
blood
cultur
accompani
sputum
specimen
may
occasion
help
particularli
highrisk
patient
cap
rang
pathogen
caus
exacerb
lung
diseas
cystic
fibrosi
patient
expand
specimen
mycobacteri
fungal
cultur
collect
patient
immunocompromis
host
broad
diagnost
approach
base
upon
invas
obtain
specimen
suggest
bronchoscopi
wash
optim
diagnost
specimen
pediatr
tabl
list
etiolog
agent
diagnost
approach
bronchiol
acut
bronchiti
acut
exacerb
chronic
bronchiti
pertussi
clinic
syndrom
involv
inflamm
tracheobronchi
tree
bronchiol
common
lower
respiratori
infect
children
virus
alon
combin
constitut
major
caus
syndrom
character
bronchospasm
wheez
result
acut
inflamm
airway
edema
increas
mucu
product
acut
bronchiti
larg
due
viral
pathogen
less
frequent
caus
mycoplasma
pneumonia
chlamydia
pneumonia
pertussi
classic
known
whoop
cough
caus
bordetella
pertussi
consid
adolesc
young
adult
paroxysm
cough
naat
combin
cultur
recommend
test
choic
b
pertussi
detect
current
fdaclear
platform
b
pertussi
detect
center
diseas
control
prevent
cdc
suggest
best
practic
use
molecular
test
pertussi
detect
http
wwwcdcgovpertussisclin
diagnostictestingdiagnosispcrbestpracticeshtml
check
laboratori
regard
avail
perform
characterist
includ
certain
limit
c
rapid
antigen
test
respiratori
viru
detect
lack
sensit
depend
upon
product
specif
recent
metaanalysi
rapid
influenza
antigen
test
show
pool
sensit
pool
specif
consid
screen
test
minimum
neg
result
verifi
anoth
method
specimen
qualiti
critic
optim
test
specimen
type
depend
upon
viru
sought
gener
throat
swab
least
desir
care
taken
preserv
cell
use
vtm
transport
specimen
steril
contain
wet
ice
soon
possibl
collect
e
sever
fdaclear
assay
avail
time
two
assay
comprehens
multiplex
panel
contain
mycoplasma
pneumonia
chlamydia
pneumonia
part
comprehens
respiratori
syndrom
panel
one
singleplex
assay
pneumonia
avail
laboratori
specif
clinician
check
laboratori
valid
specimen
sourc
collect
transport
perform
characterist
turnaround
time
gener
avoid
calcium
algin
swab
minitip
swab
nucleic
acid
amplif
test
f
sensit
nonbacterem
patient
pneumococc
pneumonia
sensit
bacterem
case
pneumococc
pneumonia
specif
adult
howev
studi
report
falseposit
rate
children
np
carriag
evid
pneumonia
adult
chronic
obstruct
pulmonari
diseas
g
cottontip
calcium
algin
swab
accept
contain
substanc
inhibit
polymeras
chain
reaction
h
plate
specimen
bedsid
ideal
rare
done
sever
type
transport
media
accept
includ
casamino
acid
solut
ami
transport
medium
reganlow
transport
medium
hardi
diagnost
streptococcu
pneumonia
haemophilu
influenza
play
establish
role
acut
bronchiti
along
moraxella
catarrhali
figur
promin
case
acut
exacerb
chronic
bronchiti
sever
fdaapprov
naat
platform
avail
detect
broad
rang
respiratori
virus
atyp
bacteria
associ
respiratori
syndrom
larg
replac
rapid
antigen
detect
test
cultur
institut
perform
characterist
vari
among
variou
panel
singleplex
naat
specimen
sourc
may
also
vari
depend
upon
assay
reader
becom
familiar
platform
offer
respect
institut
approv
specimen
sourc
collect
devic
transport
requir
respiratori
syncyti
viru
human
rhinoviru
human
metapneumoviru
human
coronaviru
type
parainfluenza
viru
signific
caus
bronchiol
infant
young
children
coinfect
uncommon
observ
case
sever
molecular
panel
detect
bacteri
caus
pneumonia
resist
marker
current
clinic
trial
diagnosi
cap
base
presenc
specif
symptom
suggest
radiograph
featur
pulmonari
infiltr
andor
pleural
effus
care
obtain
microbiolog
data
support
diagnosi
often
fail
provid
etiolog
agent
tabl
list
common
caus
cap
less
common
etiolog
may
need
consid
depend
upon
recent
travel
histori
exposur
vector
anim
transmit
zoonot
pathogen
sin
nombr
viru
hantaviru
pulmonari
syndrom
yersinia
pesti
pneumon
plagu
endem
western
unit
state
rational
attempt
establish
etiolog
identif
pathogen
focu
antibiot
manag
particular
patient
addit
identif
certain
pathogen
legionella
spp
influenza
virus
agent
bioterror
import
public
health
signific
idsaamerican
thorac
societi
at
practic
guidelin
current
revis
consid
diagnost
test
option
patient
hospit
patient
requir
admiss
pretreat
blood
cultur
cultur
gram
stain
goodqual
sampl
expector
sputum
diseas
sever
urinari
antigen
test
pneumonia
legionella
pneumophila
avail
recommend
children
agreement
adult
recommend
respect
obtain
blood
cultur
sputum
cultur
differ
slightli
laboratori
test
test
viral
pathogen
recommend
outpati
inpati
set
although
weak
recommend
children
appropri
sign
symptom
mycoplasma
pneumonia
test
indic
sever
molecular
assay
avail
pneumonia
detect
least
one
assay
also
detect
chlamydia
pneumonia
urinari
antigen
test
pneumonia
detect
recommend
use
children
poor
specif
test
laboratori
must
mechan
place
screen
sputum
sampl
accept
exclud
heavili
contamin
oropharyng
microbiota
repres
deepli
expector
sampl
prior
set
routin
bacteri
cultur
poorqual
specimen
provid
mislead
result
reject
interpret
would
compromis
endotrach
aspir
bronchoscop
obtain
sampl
includ
minibronchoalveolar
lavag
bal
use
combicath
kol
bio
medic
instrument
chantilli
virginia
similar
technolog
may
requir
hospit
patient
intub
unabl
produc
adequ
sputum
sampl
thoracentesi
perform
patient
pleural
effus
mycobacteri
infect
differenti
diagnosi
cap
fail
respond
therapi
typic
cap
pathogen
mycobacterium
tuberculosi
although
declin
unit
state
recent
year
still
import
pathogen
among
immigr
popul
mycobacterium
avium
complex
also
import
among
patient
hiv
especi
patient
chronic
lung
diseas
cystic
fibrosi
middleag
elderli
thin
women
hospitalacquir
ventilatorassoci
pneumonia
hap
vap
respect
frequent
caus
multidrugresist
gramneg
bacteria
bacteri
pathogen
asid
respiratori
virus
may
nosocomi
transmit
virus
fungi
rare
caus
hap
vap
immunocompet
patient
tabl
list
organ
commonli
associ
pneumonia
immunocompet
patient
hap
vap
idsaat
guidelin
recommend
noninvas
sampl
respiratori
tract
hap
vap
nonventil
patient
specimen
could
includ
obtain
spontan
expector
sputum
induct
nasotrach
suction
uncoop
patient
ventil
patient
endonasotrach
aspir
prefer
determin
caus
pneumonia
reli
upon
initi
gram
stain
semiquantit
cultur
endotrach
aspir
sputum
smear
lack
inflammatori
cell
cultur
absent
potenti
pathogen
high
neg
predict
valu
cultur
endotrach
aspir
like
contain
true
pathogen
also
consist
grow
mixtur
speci
bacteria
specimen
obtain
bronchoscop
techniqu
may
lead
addit
unnecessari
antibiot
therapi
quantit
assess
invas
obtain
sampl
bal
fluid
protect
specimen
brush
specimen
often
perform
bacteri
growth
threshold
diagnost
pneumonia
quantiti
threshold
consist
colon
gener
accept
threshold
follow
endotrach
aspir
colonyform
unit
cfu
ml
bal
fluid
cfuml
protect
specimen
brush
sampl
cfuml
quantit
studi
requir
extens
laboratori
work
special
procedur
smaller
laboratori
may
accommod
therefor
endors
guidanc
despit
studi
show
decreas
antibiot
util
quantit
cultur
bronchial
wash
appropri
routin
bacteri
cultur
age
popul
among
factor
result
increas
incid
pleural
infect
infecti
caus
pleural
effus
differ
communityacquir
hospitalacquir
diseas
larg
multicent
studi
adult
patient
pleural
infect
assess
streptokinas
treatment
major
pathogen
recov
decreas
order
frequenc
anginosu
group
aureu
anaerob
bacteria
streptococci
enterobacteriacea
pneumonia
among
patient
hospitalacquir
infect
aureu
top
list
least
half
methicillin
resist
follow
enterobacteriacea
streptococci
anginosu
group
pneumonia
enterococcu
spp
anaerob
tabl
summar
major
pathogen
signific
accumul
fluid
pleural
space
sampl
thoracentesi
specimen
hand
carri
immedi
laboratori
place
appropri
anaerob
transport
media
transport
institut
bedsid
inocul
blood
cultur
bottl
becom
establish
practic
accept
shown
increas
sensit
manufactur
guidelin
follow
respect
volum
inocul
whether
supplement
requir
enhanc
recoveri
fastidi
pathogen
pneumonia
blood
cultur
bottl
use
addit
sampl
sent
microbiolog
laboratori
gram
stain
cultur
nonbacteri
pathogen
indic
even
optimum
handl
occur
cultur
may
fail
yield
organ
laboratorydevelop
naat
target
pneumococc
gene
encod
pneumolysin
autolysin
fluid
pediatr
case
pleural
infect
use
fluid
sent
cell
count
ph
protein
glucos
lactat
dehydrogenas
ldh
cholesterol
valu
assist
determin
transud
exud
process
subsequ
manag
syndrom
recent
metaanalysi
show
best
predictor
exud
pleural
fluid
cholesterol
level
mgdl
ldh
ul
ratio
pleural
fluid
cholesterol
serum
cholesterol
infect
result
exud
polymorphonuclear
leucocyt
pmn
empyema
within
pleural
caviti
tuberculosi
fungal
pathogen
thought
like
caus
pleural
biopsi
sent
cultur
histopatholog
increas
diagnost
sensit
alway
notifi
laboratori
suspicion
tuberculosi
appropri
safeti
precaut
employ
recent
publish
idsaat
cdc
guidelin
diagnosi
tuberculosi
adult
children
weakli
recommend
measur
adenosin
anaerob
cultur
done
specimen
obtain
protect
brush
cathet
transport
anaerob
transport
contain
place
brush
ml
prereduc
broth
prior
transport
b
sensit
nonbacterem
patient
pneumococc
pneumonia
sensit
bacterem
case
pneumococc
pneumonia
specif
adult
howev
studi
report
falseposit
rate
children
np
carriag
evid
pneumonia
adult
chronic
obstruct
pulmonari
diseas
c
us
food
drug
administr
fda
clear
test
current
avail
avail
laboratori
specif
provid
need
check
laboratori
optim
specimen
sourc
perform
characterist
turnaround
time
perform
characterist
test
review
refer
e
sever
fdaclear
naat
platform
current
avail
vari
approv
specimen
requir
rang
analyt
detect
reader
check
laboratori
regard
avail
perform
characterist
includ
certain
limit
perform
characterist
test
review
refer
c
may
crossreact
endem
mycos
deaminas
ada
free
pleural
fluid
endors
base
upon
sensit
specif
ada
respect
determin
sever
metaanalys
figur
free
sensit
specif
respect
stress
qualiti
evid
low
marker
use
conjunct
hematolog
chemic
paramet
diagnost
test
naat
cultur
histolog
pleural
biopsi
perform
ada
develop
countri
shown
quit
variabl
relat
multipl
factor
includ
type
method
use
likelihood
tuberculosi
fals
posit
result
patient
caus
lymphocyt
pleural
effus
rheumatoid
diseas
mesothelioma
histoplasmosi
patient
cystic
fibrosi
cf
suffer
chronic
lung
infect
due
disrupt
exocrin
function
allow
clear
microorgan
enter
distal
airway
lung
spectrum
organ
associ
diseas
continu
expand
studi
microbiom
demonstr
complex
synergi
easili
cultivat
noncultivat
organ
tabl
list
frequent
isol
pathogen
patient
popul
earli
childhood
infect
caus
organ
frequent
seen
noncf
pediatr
popul
pneumonia
h
influenza
aureu
organ
methicillinresist
staphylococcu
aureu
mrsa
significantli
increas
preval
point
later
childhood
adolesc
p
aeruginosa
becom
import
pathogen
involv
chronic
lung
infect
concomit
lung
destruct
follow
p
aeruginosa
strain
adapt
hypox
stress
retain
mucoid
secret
convert
biofilm
mode
growth
mucoid
coloni
nosocomi
pathogen
stenotrophomona
maltophilia
achromobact
xylosoxidan
achromobact
ruhlandii
may
acquir
hospit
clinic
visit
burkholderia
cepacia
complex
import
pathogen
patient
burkholderia
cenocepacia
highli
pathogen
respons
rapid
declin
death
subset
patient
acquir
virul
clone
special
microbiolog
techniqu
requir
recov
differenti
b
cepacia
complex
mucoid
p
aeruginosa
strain
less
common
gramneg
organ
appear
increas
frequenc
recoveri
whose
role
pathogenesi
cf
lung
diseas
still
unclear
includ
burkholderia
gladioli
ralstonia
spp
cupriavidu
spp
inquilinu
spp
pandoraea
reader
refer
parkin
floto
refer
discuss
pathogen
within
cf
microbiota
cf
patient
surviv
adulthood
opportunist
pathogen
nontubercul
mycobacteria
ntm
isol
increas
frequenc
rang
preval
patient
age
year
avium
complex
mycobacterium
abscessu
complex
commonli
encount
ntm
evid
suggest
abscessu
avium
complex
contribut
lung
destruct
treat
cultur
repeatedli
posit
mycobacteri
cultur
ad
routin
cultur
obtain
patient
year
age
present
exacerb
incid
mycobacterium
spp
like
underestim
due
failur
routin
assess
patient
organ
aspergillu
fumigatu
common
fungu
recov
cf
patient
caus
primarili
allerg
bronchopulmonari
diseas
scedosporium
apiospermum
may
caus
similar
syndrom
exophiala
dermatitidi
report
center
caus
chronic
colon
cf
airway
trichosporon
mycotoxinivoran
pathogen
propens
caus
diseas
patient
cf
tabl
summar
organ
like
caus
exacerb
pulmonari
symptom
cf
patient
number
environment
nonfer
gramneg
bacilli
frequent
recov
sputum
patient
role
cf
lung
diseas
either
unknown
time
unlik
signific
organ
includ
tabl
laboratori
spend
resourc
pathogen
proven
like
play
signific
role
pulmonari
declin
patient
advanc
cancer
treatment
transplant
immunolog
therapi
autoimmun
diseas
hiv
expand
popul
sever
immunocompromis
patient
pulmonari
infect
common
syndrom
contribut
sever
morbid
mortal
among
group
patient
virtual
potenti
pathogen
may
result
signific
ill
challeng
clinician
microbiologist
rapidli
differenti
infecti
noninfecti
caus
pulmonari
infiltr
likelihood
specif
infect
may
affect
recent
administ
prophylaxi
tabl
focus
major
infecti
etiolog
like
interest
immunocompromis
host
patient
still
vulner
usual
bacteri
viral
caus
cap
hap
addit
fungi
herpesvirus
protozoa
play
signific
role
consid
rapid
noninvas
test
urin
serum
antigen
test
rapid
viral
diagnost
reveal
definit
procedur
sampl
lung
requir
sever
diagnost
procedur
perform
usual
patient
initi
undergo
bronchoscopi
bal
without
transbronchi
biopsi
infiltr
focal
import
wedg
scope
pulmonari
segment
correspond
abnorm
radiograph
otherwis
diffus
diseas
scope
usual
wedg
right
middl
lobe
lingula
suggest
microbiolog
laboratori
collabor
infecti
diseas
physician
pulmonologist
develop
algorithm
process
sampl
includ
test
major
categori
pathogen
summar
tabl
cytolog
analysi
histopatholog
often
need
interpret
signific
posit
naat
cultur
herpesvirus
exampl
definit
diagnos
filament
fungi
note
howev
histopatholog
alon
sensit
enough
diagnos
fungal
infect
accompani
immunostain
cultur
avail
naat
addit
serum
bal
galactomannan
serum
test
may
help
howev
cytolog
andor
histopatholog
quit
use
distinguish
condit
pulmonari
hemorrhag
reject
infecti
caus
infiltr
transthorac
needl
aspir
comput
tomographyguid
biopsi
pleuralbas
lesion
open
lung
likewis
may
consid
less
invas
diagnost
unrev
gastrointestin
infect
includ
wide
varieti
diseas
present
well
infecti
agent
mani
infect
particularli
noninflammatori
diarrhea
acut
gastroenter
short
durat
laboratori
test
recommend
section
address
laboratori
approach
establish
etiolog
diagnosi
esophag
gastriti
gastroenter
proctiti
key
point
laboratori
diagnosi
gastrointestin
infect
specimen
choic
diagnos
diarrheal
ill
diarrheal
stool
form
stool
swab
notabl
except
pediatr
swab
accept
fece
note
swab
toxin
nucleic
acid
amplif
test
c
difficil
done
diarrheal
stool
form
stool
unless
physician
note
patient
ileu
tabl
see
tabl
see
tabl
addit
bacteri
pathogen
interest
esophag
often
caus
noninfecti
condit
gastroesophag
reflux
diseas
infecti
caus
often
seen
patient
impair
immun
tabl
fungal
microscopi
calcofluor
potassium
hydroxid
koh
bacteri
examin
gram
stain
esophag
brush
histopatholog
examin
viral
cultur
esophag
biopsi
establish
diagnosi
case
helicobact
pylori
associ
atroph
gastriti
peptic
ulcer
diseas
gastric
cancer
diagnosi
h
pylori
infect
critic
treatment
decreas
morbid
test
recommend
patient
peptic
ulcer
diseas
gastric
mucosaassoci
lymphoid
tissu
lymphoma
earli
gastric
cancer
patient
dyspepsia
noninvas
test
option
invas
noninvas
test
tabl
avail
aid
diagnosi
invas
test
gram
stain
cultur
endoscopi
tissu
histopatholog
stain
direct
test
ureas
requir
collect
biopsi
sampl
obtain
endoscopi
patient
receiv
antimicrobi
agent
proton
pump
inhibitor
week
prior
collect
pose
greater
risk
patient
cultur
although
routin
perform
allow
antimicrobi
suscept
test
advantag
noninvas
assay
urea
breath
test
stool
antigen
determin
patient
avoid
endoscopi
gastric
biopsi
also
use
test
organ
erad
therapi
collect
specimen
urea
breath
test
may
perform
clinic
assay
sensit
approxim
compar
invas
assay
stool
antigen
test
report
sensit
sensit
higher
adult
children
noninvas
assay
also
use
test
organ
erad
therapi
urea
breath
test
somewhat
higher
sensit
stool
antigen
detect
serodiagnosi
lower
sensit
specif
use
test
cure
therapi
gastrointestin
infect
encompass
wide
varieti
symptom
recogn
infecti
agent
tabl
appropri
diagnost
approach
diarrheal
ill
determin
patient
age
statu
sever
diseas
durat
type
ill
time
year
geograph
locat
fecal
test
use
cultur
cultureindepend
method
indic
sever
bloodi
febril
dysenter
nosocomi
persist
diarrheal
ill
commun
laboratori
requir
determin
organ
method
screen
paramet
includ
part
routin
enter
pathogen
cultur
cultureindepend
method
laboratori
abil
cultur
salmonella
shigella
campylobact
test
shiga
toxinproduc
escherichia
coli
cultur
independ
method
often
routin
avail
clostridium
difficil
although
avail
may
routin
employ
bacteri
viral
caus
gastrointestin
infect
stool
cultur
often
fail
detect
caus
agent
necessari
cultureindepend
method
recommend
adjunct
method
specimen
choic
diarrheal
stool
ie
take
shape
contain
multipl
stool
specimen
rare
indic
detect
stool
pathogen
studi
adult
patient
submit
specimen
enter
pathogen
detect
first
sampl
time
second
specimen
bring
posit
rate
pediatr
patient
first
specimen
detect
enter
pathogen
thu
one
sampl
children
second
select
adult
patient
may
consid
rectal
swab
less
sensit
stool
specimen
cultur
method
employ
recommend
cultur
adult
symptomat
pediatr
patient
rectal
swab
stool
cultur
equival
abil
detect
fecal
pathogen
rectal
swab
shown
sensit
stool
specimen
cultur
independ
method
employ
although
test
fdaclear
use
stool
cultur
indic
detect
invas
bacteri
enter
pathogen
cultur
method
employ
laboratori
routin
detect
salmonella
shigella
campylobact
recent
shiga
toxinproduc
e
coli
stool
submit
cultur
salmonella
spp
take
hour
recov
identifi
genu
alon
specif
serotyp
usual
perform
public
health
laboratori
level
recommend
test
detect
shiga
toxin
test
specif
detect
shiga
toxinproduc
e
coli
shiga
toxinproduc
serotyp
includ
part
routin
test
howev
set
test
may
requir
specif
request
test
detect
e
coli
detect
increas
number
isol
report
may
detect
e
coli
screen
algorithm
limit
test
bloodi
stool
may
also
miss
isol
screen
stool
toxinproduc
e
coli
recommend
pediatr
patient
detect
vibrio
yersinia
unit
state
usual
special
request
requir
addit
media
incub
condit
commun
laboratori
necessari
laboratori
report
indic
enter
pathogen
would
detect
laboratori
encourag
provid
enter
pathogen
isol
public
health
laboratori
andor
cdc
pulsedfield
gel
analysi
wholegenom
sequenc
nation
surveil
purpos
cultur
method
must
use
test
cure
select
use
multiplex
naat
stool
pathogen
sensit
posit
report
agent
either
cultur
recov
isol
stool
provid
public
health
laboratori
cultur
epidemiolog
followup
cultur
independ
method
becom
increasingli
avail
nucleic
acid
amplif
assay
vari
singleplex
highli
multiplex
assay
imper
commun
laboratori
determin
organ
detect
cultur
independ
method
detect
pathogen
littl
hour
compar
hour
often
requir
cultur
assay
report
sensit
cultur
result
much
higher
rate
detect
highli
multiplex
assay
allow
detect
mix
infect
import
pathogen
unclear
may
allow
detect
pathogen
enteroaggreg
e
coli
sapoviru
indic
therapi
unclear
cultureindepend
method
use
test
cure
detect
viabl
nonviabl
organ
botul
intox
protein
exotoxin
botulinum
toxin
produc
clostridium
botulinum
caus
lifethreaten
flaccid
paralysi
diagnosi
usual
confirm
hospit
microbiolog
laboratori
made
clinic
criteria
allow
prompt
initi
essenti
antitoxin
therapi
microbiolog
diagnosi
depend
upon
detect
botulinum
toxin
serum
patient
wound
infant
foodborn
diseas
stool
patient
infant
foodborn
diseas
gastric
contentsvomitu
patient
foodborn
diseas
toxin
detect
perform
mani
public
health
laboratori
cdc
cultur
perform
fece
wound
yield
low
laboratori
lack
necessari
expertis
isol
identifi
organ
numer
method
employ
laboratori
diagnosi
infect
caus
clostridium
difficil
toxigen
cultur
probabl
sensit
specif
assay
two
biopsi
antrum
biopsi
posterior
corpu
steril
contain
rt
immedi
abbrevi
rt
room
temperatur
patient
ingest
cocktail
contain
clabel
urea
minut
later
breath
sampl
obtain
analyz
presenc
clabel
co
indic
presenc
h
pylori
stomach
b
gram
stain
cultur
properli
collect
transport
biopsi
specimen
sensit
histopatholog
examin
usual
unavail
consid
inappropri
c
agarbas
rapid
ureas
test
slightli
lower
sensit
offer
advantag
provid
rapid
result
may
perform
point
care
laboratori
test
perform
gastric
fluid
orogastr
brush
string
specimen
lower
sensit
perform
biopsi
specimen
detect
c
difficil
although
detect
toxigen
organ
specif
infect
slow
labor
intens
routin
perform
commun
hospit
set
compar
toxigen
cultur
cytotoxin
assay
sensit
cytotoxin
assay
requir
hour
also
labor
intens
thu
toxin
detect
either
enzym
immunoassay
eia
immunochromatograph
method
wide
use
clinic
practic
assay
report
sensit
significantli
faster
result
avail
hour
util
assay
detect
toxin
toxin
b
improv
sensit
glutam
dehydrogenas
gdh
antigen
assay
sensit
poor
specif
naat
detect
c
difficil
report
sensit
reduc
turnaround
time
reduc
cost
improv
accuraci
c
difficileassoci
diseas
laboratori
employ
algorithm
util
gdh
rapid
screen
test
follow
simultan
part
test
platform
eia
toxin
b
detect
without
cytotoxin
test
naat
arbitr
discrep
gdh
eia
toxin
result
algorithm
allow
rapid
report
neg
specimen
sensit
cytotoxin
test
naat
could
result
delay
depend
laboratori
test
algorithm
employ
naat
detect
viabl
nonviabl
organ
decreas
identif
colon
patient
laboratori
perform
naat
test
test
detect
toxin
product
diarrheal
stool
specimen
form
stool
rectal
swab
requir
diagnosi
c
difficil
diseas
colon
specimen
loos
enough
take
shape
contain
form
stool
appropri
reject
laboratori
proviso
form
stool
patient
ileu
potenti
toxic
megacolon
note
physician
test
institut
agre
upon
limit
criteria
stool
submiss
toxin
eia
part
multistep
algorithm
defin
recommend
naat
test
alon
repeat
test
patient
previous
posit
test
cure
appropri
repeat
test
patient
neg
naat
perform
least
day
presenc
asymptomat
carriag
routin
test
perform
children
year
age
particularli
year
infant
toxigen
c
difficil
colon
nearli
infant
first
year
life
asymptomat
rate
around
year
age
approach
healthi
adult
presenc
diarrhea
difficult
assess
age
group
loos
unform
stool
difficult
discrimin
howev
data
suggest
c
difficil
may
caus
diseas
infant
children
year
age
test
caus
pursu
first
c
difficil
test
perform
altern
caus
symptom
sever
clinic
present
consist
c
difficil
infect
sinc
increas
c
difficileassoci
diseas
increas
morbid
mortal
report
unit
state
canada
unit
kingdom
epidem
strain
toxinotyp
iii
north
american
pulsedfield
gel
electrophoresi
pfge
type
pcr
ribotyp
carri
binari
toxin
gene
cdta
cdtb
delet
tcdc
produc
toxin
toxin
b
commerci
avail
fdaclear
naat
binari
toxin
tcdc
delet
gene
identifi
strain
epidemiolog
purpos
sever
diseas
believ
due
toxin
hyperproduct
associ
binari
toxin
diseas
sever
controversi
number
specimen
submit
parasitolog
examin
may
controversi
subject
histor
use
convent
microscop
procedur
recommend
specimen
collect
period
submit
ova
parasit
p
examin
option
costeffect
test
today
includ
examin
second
specimen
first
neg
patient
remain
symptomat
third
specimen
submit
patient
continu
p
neg
symptomat
target
use
immunoassay
test
naat
common
parasit
base
geographi
patient
demograph
physician
request
also
use
screen
neg
patient
continu
symptom
patient
specif
risk
factor
requir
full
p
examin
immunoassay
giardia
sensit
enough
singl
specimen
may
need
data
avail
number
specimen
requir
rule
infect
naat
perform
specimen
preserv
use
often
suppli
laboratori
depend
need
perform
immunoassay
procedur
special
stain
naat
specimen
manufactur
recommend
specimen
fix
imper
laboratori
consult
assur
proper
transport
condit
util
polyvinyl
alcohol
gold
standard
microscop
examin
howev
due
presenc
mercur
chlorid
modif
employ
mercuri
develop
none
modifi
preserv
allow
stain
provid
level
microscop
detail
although
experi
accept
altern
routin
procedur
pathogen
entamoeba
histolytica
differenti
nonpathogen
entamoeba
dispar
use
morpholog
criteria
laboratori
report
may
indic
e
histolyticadispar
immunoassay
naat
differenti
organ
viral
caus
gastroenter
often
short
durat
selflimit
viral
shed
may
persist
resolut
symptom
although
includ
part
multiplex
naat
test
routin
perform
except
immunocompromis
patient
infect
control
purpos
outbreak
investig
immunocompromis
host
laboratori
test
cmv
consid
use
quantit
naat
perform
plasma
note
neg
naat
rule
possibl
cmv
diseas
repeat
test
may
requir
proctiti
commonli
due
sexual
transmit
agent
result
analgenit
contact
although
abscess
perirect
wound
infect
may
present
similar
symptom
one
sampl
usual
suffici
diagnosi
tabl
section
design
optim
activ
microbiolog
laboratori
achiev
best
approach
identif
microorgan
associ
periton
intraperiton
abscess
hepat
splenic
abscess
pancreat
biliari
tract
infect
molecular
analys
begin
use
defin
microbiom
gastrointestin
genitourinari
tract
contemporari
cultur
protocol
sure
evolv
accommod
new
emerg
inform
futur
use
gene
amplif
sequenc
identif
microorgan
infect
like
show
everi
organ
current
identifi
cultur
sever
time
number
cultiv
use
current
technolog
remain
focus
contemporari
method
current
avail
diagnost
microbiolog
laboratori
tabl
outlin
like
agent
entiti
tabl
best
evalu
situat
exist
techniqu
tabl
factor
consid
collect
specimen
laboratori
diagnosi
intraabdomin
infect
key
point
laboratori
diagnosi
intraabdomin
infect
laboratori
need
specimen
swab
specimen
suffici
quantiti
specimen
must
collect
allow
microbiolog
laboratori
perform
necessari
request
test
mycobacterium
tuberculosi
naat
test
adjunct
cultur
never
order
alon
current
commerci
method
fdaclear
intraabdomin
specimen
laboratori
must
valid
test
use
tuberculosi
present
usual
sign
dissemin
diseas
must
thoroughli
investig
case
spontan
bacteri
periton
sbp
sourc
invad
organ
unknown
syndrom
also
seen
patient
preexist
risk
factor
cirrhosi
ascit
sbp
ascit
fluid
infect
without
evid
intraabdomin
focu
tend
monomicrob
usual
caus
aerob
organ
intestin
tract
therefor
anaerob
cultur
less
valuabl
suffici
fluid
eg
ml
avail
obtain
allow
concentr
centrifug
cytospin
gram
stain
evalu
minimum
least
ml
periton
fluid
swab
fluid
collect
asept
transport
laboratori
prior
administr
antimicrobi
agent
addit
laboratori
test
includ
fluid
analysi
protein
cell
count
differenti
lactat
concentr
ph
along
set
blood
cultur
identif
concomit
bacteremia
tabl
altern
sbp
infect
ascit
fluid
tend
monomicrob
aerob
blood
cultur
bottl
inocul
fluid
volum
depend
upon
blood
cultur
system
presenc
singl
organ
reason
certain
gram
stain
may
use
prior
broth
inocul
evalu
morpholog
organ
present
specimen
sinc
differenti
sbp
secondari
periton
may
uncertain
may
benefici
submit
periton
fluid
steril
contain
convent
cultur
stain
well
inocul
blood
cultur
bottl
bedsid
fluid
mass
spectrometri
sequenc
pcr
use
identifi
isol
present
specimen
techniqu
avail
laboratori
next
year
nextgener
sequenc
abl
analyz
specimen
determin
total
microbi
load
speci
morpholog
type
note
gram
stain
broth
inocul
caveat
use
blood
cultur
bottl
fluid
blood
system
evalu
purpos
furthermor
broth
cultur
accur
reflect
bacteri
burden
varieti
organ
time
specimen
obtain
presenc
true
pathogen
may
obscur
overgrowth
rapidli
grow
organ
neg
cultur
result
presenc
indic
infect
prompt
evalu
fastidi
slowli
grow
organ
mycobacterium
spp
fungi
chlamydia
trachomati
neisseria
gonorrhoea
diagnosi
secondari
periton
depend
upon
identifi
sourc
invad
microorganismsusu
genitourinari
gastrointestin
flora
numer
caus
secondari
periton
includ
iatrogen
provid
need
check
laboratori
optim
specimen
turnaround
time
accident
trauma
perfor
appendix
diverticuli
typhliti
intraabdomin
abscess
complic
bariatr
surgeri
may
also
caus
secondari
periton
unlik
sbp
howev
secondari
periton
tend
polymicrob
may
includ
anaerob
flora
organ
aureu
n
gonorrhoea
mycobacterium
spp
unusu
set
common
etiolog
includ
aerob
anaerob
gramneg
rod
bacteroid
spp
e
coli
klebsiella
spp
gramposit
flora
clostridium
spp
enterococcu
spp
bifidobacterium
spp
peptostreptococcu
spp
infecti
complic
follow
bariatr
surgeri
frequent
due
gramposit
cocci
yeast
candida
spp
sinc
mani
obes
patient
prior
exposur
antibiot
multidrugresist
organ
concern
typhliti
suspect
c
difficil
toxin
test
stool
cultur
enter
pathogen
blood
cultur
request
addit
clostridium
septicum
consid
neutropen
enterocol
periton
fluid
sent
laboratori
anaerob
transport
system
gram
stain
aerob
anaerob
bacteri
cultur
inocul
blood
cultur
bottl
alon
periton
fluid
appropri
set
competit
bacteri
growth
broth
cultur
could
mask
recoveri
clinic
import
pathogen
tabl
cmv
possibl
caus
secondari
periton
microbiolog
laboratori
contact
arrang
special
process
cmv
concern
microbiolog
laboratori
also
contact
n
gonorrhoea
concern
special
process
naat
specimen
type
fdaclear
commerci
platform
test
necessari
polymicrob
natur
secondari
periton
clinician
healthcar
provid
expect
request
identif
suscept
test
organ
isol
rather
laboratori
provid
gener
descript
cultur
result
eg
mix
aerob
anaerob
intestin
flora
select
identif
certain
organ
mrsa
streptococcu
spp
multidrugresist
gramneg
bacilli
vancomycinresist
enterococci
vre
etc
guid
empir
antimicrobi
therapi
patient
respond
convent
therapi
addit
specimen
collect
examin
resist
organ
presenc
intraabdomin
abscess
entiti
refer
persist
recurr
periton
follow
unsuccess
treatment
secondari
periton
tertiari
periton
might
also
indic
presenc
intraabdomin
abscess
organ
refractori
broadspectrum
antimicrobi
therapi
vre
candida
spp
pseudomona
aeruginosa
biofilmproduc
bacteria
coagulaseneg
staphylococcu
spp
fluid
cultur
case
tertiari
periton
commonli
neg
bacteria
case
cultur
appropri
spontan
secondari
periton
may
help
evalu
dialysi
fluid
patient
suspect
periton
dialysisassoci
periton
pdap
essenti
ident
use
sbp
infect
tend
monomicrob
rare
anaerob
case
pdap
howev
list
like
suspect
organ
quit
differ
sbp
gramposit
bacteria
predominantli
staphylococcu
spp
lesser
extent
streptococcu
corynebacterium
spp
account
cultur
microorgan
gramneg
bacteria
mostli
e
coli
klebsiella
enterobact
spp
repres
posit
cultur
anaerob
compris
isol
fungi
especi
candida
spp
contribut
number
identifi
infect
anaerob
cultur
remain
neg
case
pdap
ml
dialys
collect
concentr
cultur
cytospin
gram
stain
evalu
analysi
protein
cell
count
differenti
tabl
blood
cultur
rare
posit
case
pdap
direct
inocul
dialys
concentr
dialys
aerob
blood
cultur
bottl
autom
detect
proven
effect
direct
plate
centrifug
fluid
consult
directli
microbiolog
laboratori
primari
cultur
fluid
neg
addit
cultur
slowli
grow
highli
fastidi
organ
mycobacterium
nocardia
filament
fungi
pursu
nocardia
concern
primari
cultur
plate
requir
prolong
incub
cultur
fungal
media
buffer
charcoal
yeast
extract
agar
primari
diagnost
dilemma
case
spaceoccupi
lesion
liver
distinguish
caus
parasit
e
histolytica
echinococcu
pyogen
abscess
caus
bacteria
fungi
locat
size
number
liver
abscess
often
help
differenti
purpos
major
right
lobe
seen
singl
multipl
loci
region
e
histolytica
diseas
endem
use
serolog
serum
antigen
detect
test
help
exclud
ameb
abscess
wherea
examin
stool
cyst
trophozoit
gener
tabl
liver
abscess
aspir
test
presenc
e
histolytica
antigen
well
submit
direct
microscop
evalu
parasit
ameb
diseas
unlik
abscess
aspir
content
submit
anaerob
transport
aerob
anaerob
bacteri
cultur
aerob
anaerob
bacteri
cultur
request
tabl
blood
cultur
also
help
establish
etiolog
collect
prior
institut
antimicrobi
therapi
occasion
patient
primari
genit
infect
due
n
gonorrhoea
c
trachomati
extens
diseas
involv
liver
capsul
adjac
peritoneum
fitzhughcurti
syndrom
unexpectedli
bacteria
commonli
associ
biliari
tract
infect
primarili
cholecyst
cholang
organ
recov
case
pyogen
liver
abscess
see
tabl
parasit
caus
includ
ascari
clonorchi
spp
parasit
inhabit
biliari
tree
lead
obstruct
minimum
cultur
aerob
bacteria
anaerob
aspir
collect
appropri
gram
stain
request
sign
sepsi
periton
present
blood
periton
cultur
obtain
well
patient
hiv
infect
list
potenti
agent
subsequ
microbiolog
evalu
need
expand
includ
cryptosporidium
microsporidia
cystoisospora
isospora
belli
cmv
avium
complex
identif
organ
requir
special
process
import
commun
laboratori
determin
test
avail
either
onsit
refer
laboratori
case
splenic
abscess
result
metastat
contigu
infecti
process
trauma
splenic
infarct
immunosuppress
infect
like
aerob
monomicrob
staphylococcu
spp
streptococcu
spp
enterococcu
spp
salmonella
spp
e
coli
commonli
isol
anaerob
bacteria
recov
cultureposit
case
aspir
process
similar
manner
pyogen
liver
abscess
includ
aerob
anaerob
cultur
gram
stain
concomitantli
collect
blood
cultur
set
tabl
unusu
caus
splenic
abscess
includ
bartonella
spp
brucella
melitensi
streptobacillu
moniliformi
nocardia
spp
burkholderia
pseudomallei
uncommon
outsid
southeast
asia
without
suggest
travel
histori
laboratori
notifi
b
melitensi
b
pseudomallei
possibl
due
need
increas
biosafetysecur
precaut
sinc
potenti
bioterror
agent
biliari
diseas
spectrum
organ
consid
need
expand
includ
mycobacterium
spp
fungi
includ
pneumocysti
jirovecii
parasit
immunocompromis
patient
case
acut
chronic
pancreat
produc
obstruct
autoimmun
alcohol
ingest
necrot
pancreat
tissu
gener
one
process
serv
nidu
infect
infecti
agent
associ
acut
pancreat
numer
divers
howev
superinfect
pancrea
often
caus
gastrointestin
flora
e
coli
klebsiella
spp
member
enterobacteriacea
enterococcu
spp
staphylococcu
spp
streptococcu
spp
candida
spp
necrot
tissu
pancreat
aspir
sent
aerob
bacteri
cultur
gram
stain
accompani
set
blood
cultur
tabl
antimicrobi
suscept
result
isol
organ
use
direct
therapi
reduc
likelihood
pancreat
sepsi
extens
infect
contigu
organ
mortal
steril
cultur
necrot
pancreat
tissu
unusu
may
trigger
consider
expand
search
fastidi
slowli
grow
organ
parasit
virus
osteomyel
aris
hematogen
seed
bone
distant
site
extens
bone
contigu
site
direct
inocul
microorgan
bone
surgeri
trauma
infect
nativ
joint
may
also
develop
rout
occur
hematogen
seed
infect
prosthet
joint
usual
acquir
contamin
time
arthroplasti
implant
may
occur
due
subsequ
hematogen
seed
extens
contigu
site
potenti
list
caus
agent
bone
joint
infect
divers
larg
predic
natur
pathogenesi
infect
host
bone
joint
infect
usual
monomicrobi
may
polymicrobi
key
point
laboratori
diagnosi
bone
joint
infect
swab
recommend
specimen
collect
aspir
andor
tissu
biopsi
prefer
blood
cultur
indic
detect
agent
osteomyel
nativ
joint
infect
routin
prosthet
joint
infect
diagnosi
joint
fluid
ideal
cultur
blood
cultur
bottl
prosthet
joint
infect
diagnosi
separ
tissu
sampl
submit
cultur
sonic
explant
prosthes
may
also
use
detect
pathogen
biofilm
anaerob
bacteria
suspect
includ
case
prosthet
joint
infect
anaerob
transport
contain
use
transport
tissu
fluid
laboratori
anaerob
cultur
perform
agent
bone
joint
infect
noncultur
poorli
cultur
requir
molecular
andor
serolog
method
detect
osteomyel
occur
follow
hematogen
spread
contamin
open
fractur
diabet
mellitu
vascular
insuffici
vertebr
osteomyel
spondylodisc
separ
consid
osteomyel
typic
suspect
clinic
ground
confirm
involv
imag
microbiolog
histopatholog
test
peripher
white
blood
cell
count
may
elev
erythrocyt
sediment
rate
esr
creactiv
protein
crp
often
elev
establish
etiolog
diagnosi
import
direct
appropri
clinic
manag
sinc
vari
microorgan
type
associ
antimicrobi
suscept
nearli
alway
requir
obtain
bone
microbiolog
evalu
accomplish
imagingguid
surgic
sampl
much
specimen
possibl
submit
laboratori
specimen
may
includ
piec
intact
bone
shave
scrape
andor
excis
aspir
necrot
materi
osteomyel
occur
contamin
open
fractur
organ
list
may
found
enterococci
fungi
ntm
altern
involv
microorgan
may
deriv
patient
skin
contamin
soil
andor
healthcar
environ
patient
diabet
osteomyel
typic
involv
foot
complic
chronic
foot
ulcer
posit
probetobon
test
associ
osteomyel
specimen
bone
cultur
aerob
anaerob
histolog
obtain
open
debrid
needl
punctur
transcutan
biopsi
reader
refer
guidelin
provid
greater
detail
diagnosi
diabet
foot
infect
vertebr
osteomyelitisdisc
space
infectionspondylodisc
often
hematogen
origin
eg
skin
soft
tissu
urinari
tract
intravascular
cathet
pulmonari
infect
site
occur
postop
follow
procedur
staphylococcu
aureu
coagulaseneg
staphylococci
commonli
involv
follow
gramneg
aerob
streptococci
candida
spp
patient
relev
risk
factor
mycobacterium
tuberculosi
occasion
ntm
brucella
spp
two
set
aerob
anaerob
bacterialcandid
blood
cultur
esr
crp
obtain
addit
brucella
blood
cultur
serolog
test
obtain
area
endem
brucellosi
fungal
blood
cultur
relev
epidemiolog
host
risk
factor
type
osteomyel
purifi
protein
deriv
test
releas
assay
may
consid
risk
tuberculosi
acknowledg
risk
falseposit
falseneg
result
patient
suspect
nativ
vertebr
osteomyel
base
clinic
laboratori
streptococcu
pneumonia
osteomyel
occur
often
pediatr
patient
infrequ
set
pneumococc
bacteremia
c
brucella
spp
recov
standard
aerob
bacteri
cultur
howev
laboratori
notifi
brucella
spp
consid
potenti
caus
osteomyel
cultur
examin
biolog
safeti
cabinet
concomit
serolog
test
recommend
chronic
endodont
infect
apic
abscess
may
extend
surround
bone
result
osteomyel
maxilla
mandibl
infect
caus
aerob
anaerob
bacteri
flora
oral
caviti
may
either
monomicrobi
polymicrobi
actinomyc
spp
recogn
pathogen
set
actinomyc
spp
suspect
specimen
transport
laboratori
anaerob
condit
cultur
incub
day
g
mycetoma
chronic
soft
tissu
infect
extrem
also
extend
contigu
bone
connect
tissu
occur
often
tropic
subtrop
climat
may
character
develop
drain
sinus
etiolog
agent
deriv
soil
sinu
tract
drainag
materi
present
may
repres
etiolog
underli
osteomyel
addit
stain
cultur
note
tabl
sinu
drainag
also
examin
grossli
microscop
presenc
sulfur
granul
characterist
diseas
furthermor
laboratori
notifi
possibl
nocardia
spp
pathogen
appropri
media
eg
middlebrook
agar
sabouraud
dextros
agar
buffer
charcoal
yeast
extract
inocul
facilit
recoveri
organ
imag
studi
aureu
staphylococcu
lugdunensi
brucella
bloodstream
infect
endem
set
posit
brucella
serolog
need
test
other
imagingguid
aspirationbiopsi
disc
space
vertebr
endplat
recommend
specimen
submit
gram
stain
aerob
anaerob
cultur
adequ
tissu
obtain
histopatholog
result
neg
inconclus
eg
corynebacterium
spp
isol
second
imagingguid
aspir
biopsi
percutan
endoscop
discectomi
drainag
procedur
open
excision
biopsi
consid
collect
addit
specimen
repeat
addit
test
reader
refer
guidelin
provid
greater
detail
diagnosi
nativ
vertebr
osteomyel
adult
joint
hematogen
seed
bacteria
seed
direct
inocul
contigu
focu
major
infect
monoarticular
staphylococcu
aureu
streptococcu
spp
common
caus
septic
arthriti
nativ
joint
follow
gramneg
bacilli
mainli
caus
septic
arthriti
neonat
elderli
inject
drug
user
immunocompromis
kingella
kinga
common
etiolog
bacteri
joint
infect
children
year
age
gonococc
arthriti
rare
virus
includ
parvoviru
chikungunya
viru
rubella
among
other
may
associ
arthriti
tabl
subacut
chronic
infecti
arthriti
may
caus
tuberculosi
ntm
borrelia
burgdorferi
candida
spp
blastomyc
sp
coccidioid
immiti
posadasii
histoplasma
spp
sporothrix
sp
cryptococcu
neoformansgattii
aspergillu
spp
among
other
septic
bursiti
usual
involv
prepatellar
olecranon
trochanter
bursa
usual
caus
aureu
although
peripheralblood
white
cell
count
esr
crp
often
elev
nonspecif
arthrocentesi
septic
joint
usual
reveal
purul
lowviscos
synovi
fluid
elev
neutrophil
count
tradit
synovi
fluid
leukocyt
count
consid
suggest
septic
arthriti
howev
lower
count
exclud
diagnosi
ideal
synovi
fluid
submit
gram
stain
cultur
aerob
anaerob
blood
cultur
bottl
synovi
fluid
studi
neg
biopsi
synovium
may
requir
gram
stain
aerob
anaerob
cultur
histopatholog
evalu
possibl
fungal
mycobacteri
stain
cultur
concomit
secondari
bacteremia
fungemia
occur
sporad
patient
septic
arthriti
thu
blood
cultur
collect
febril
episod
recommend
special
categori
bone
joint
infect
exist
prosthet
joint
infect
pji
may
involv
knee
hip
shoulder
elbow
prosthes
staphylococci
includ
aureu
also
coagulaseneg
staphylococci
especi
staphylococcu
epidermidi
particularli
common
caus
mani
organ
includ
streptococci
enterococci
aerob
gramneg
bacilli
anaerob
bacteria
eg
cutibacterium
acn
finegoldia
magna
fungi
involv
tabl
cutibacterium
acn
particularli
common
shoulder
arthroplasti
infect
diagnosi
pji
ideal
made
preoper
possibl
diagnosi
present
definit
infect
organ
pursu
time
revis
resect
arthroplasti
reader
refer
guidelin
provid
detail
diagnosi
pji
preoper
esr
crp
recommend
arthrocentesi
synovi
fluid
cell
count
differenti
cultur
ideal
aerob
anaerob
blood
cultur
bottl
criteria
interpret
synovi
fluid
cell
count
differenti
presenc
prosthet
joint
differ
nativ
joint
intraop
frozen
section
analysi
reliabl
diagnost
test
tissu
cultur
multipl
specimen
submit
aerob
anaerob
cultur
use
convent
plate
broth
cultur
cultur
tissu
aerob
anaerob
blood
cultur
bottl
tissu
process
number
way
includ
crush
stomach
bead
mill
process
use
glass
bead
two
intraop
cultur
combin
preoper
aspir
intraop
cultur
yield
organ
consid
definit
evid
pji
notabl
singl
posit
tissu
synovi
fluid
cultur
especi
organ
may
contamin
eg
coagulaseneg
staphylococci
c
acn
consid
evid
definit
pji
gram
stain
recommend
isol
c
acn
may
requir
cultur
incub
time
long
day
pathogenesi
pji
relat
presenc
microorgan
biofilm
implant
surfac
therefor
arthroplasti
resect
implant
compon
may
vortex
sonic
result
sonic
fluid
semiquantit
cultur
sinc
fungi
mycobacteria
extrem
rare
set
routin
sought
clinic
microbiolog
test
valu
establish
etiolog
diagnosi
infect
urinari
tract
cover
section
includ
specimen
laboratori
procedur
diagnosi
cystiti
pyelonephr
prostat
epididym
orchiti
special
test
avail
smaller
laboratori
may
sent
refer
laboratori
expect
longer
turnaround
time
result
key
point
laboratori
diagnosi
urinari
tract
infect
uti
urin
sit
room
temperatur
minut
hold
refriger
temperatur
cultur
within
minut
use
urin
transport
devic
boric
acid
preserv
reflex
cultur
posit
pyuria
screen
local
approv
polici
presenc
speci
bacteria
urin
specimen
usual
indic
contamin
time
collect
interpret
fraught
error
ask
laboratori
report
everyth
grow
without
first
consult
laboratori
provid
document
interpret
criteria
cultur
laboratori
procedur
manual
idsa
guidelin
diagnosi
treatment
uti
publish
american
societi
microbiolog
recommend
provid
diagnost
recommend
similar
present
tabl
differenti
cystiti
pyelonephr
requir
clinic
inform
physic
find
well
laboratori
inform
laboratori
perspect
spectrum
pathogen
similar
syndrom
cultur
urin
test
posit
pyuria
either
dipstick
test
leukocyt
esteras
indic
pmn
may
increas
likelihood
posit
cultur
occasion
sampl
yield
posit
screen
test
yield
neg
cultur
result
vice
versa
gram
stain
appropri
method
detect
pmn
urin
order
option
detect
high
number
gramneg
rod
patient
suspect
suffer
urosepsi
urin
easili
contamin
commens
flora
specimen
cultur
bacteri
urinari
tract
pathogen
collect
attent
minim
contamin
perin
superfici
mucos
microbiota
although
literatur
suggest
tradit
skin
cleans
prepar
collect
midstream
clean
catch
specimen
benefit
mani
laboratori
find
specimen
obtain
without
skin
cleans
routin
contain
mix
flora
store
properli
transport
within
hour
laboratori
yield
high
number
one
potenti
pathogen
cultur
determin
true
etiolog
agent
cultur
difficult
skin
cleans
still
recommend
use
urin
transport
media
vacuumfil
tube
refriger
immedi
collect
may
decreas
prolifer
small
number
contamin
organ
increas
number
interpret
result
straight
inandout
catheter
properli
prepar
patient
usual
provid
less
contamin
specimen
mix
enter
bacteria
high
number
recov
second
wellcollect
straightcatheter
sampl
patient
entericurinari
fistula
consid
laboratori
action
base
decis
arriv
dialogu
clinician
laboratori
specimen
urinari
cathet
place
hour
frequent
contain
colon
flora
due
rapid
biofilm
format
cathet
surfac
may
repres
infect
cultur
indwel
cathet
therefor
strongli
discourag
requir
specimen
must
taken
sampl
port
newli
insert
devic
cultur
foley
cathet
tip
clinic
valu
reject
collect
specimen
urinari
divers
ileal
loop
also
discourag
propens
locat
chronic
colon
chronic
nephrostomi
collect
bag
urin
collect
also
question
valu
multipl
organ
coagulaseneg
staphylococci
may
recov
patient
urinari
stent
may
pathogen
import
urologist
nephrologist
care
patient
complic
infect
discuss
special
need
request
microbiolog
director
supervisor
specimen
patient
may
contain
mix
flora
specif
interpret
criteria
document
specimen
type
laboratori
must
awar
document
special
interpret
standard
laboratori
routin
provid
antimicrobi
suscept
test
potenti
pathogen
signific
number
specimen
obtain
invas
mean
cystoscop
suprapub
aspir
clearli
identifi
workup
discuss
advanc
laboratori
especi
clinician
interest
recoveri
bacteria
concentr
cfu
per
millilit
identif
singl
potenti
pathogen
number
low
cfuml
may
signific
acut
urethr
syndrom
request
cultur
result
report
cfuml
coordin
laboratori
appropri
volum
urin
process
without
except
febril
infant
young
children
month
abnorm
urinalysi
coloni
count
cfuml
singl
organ
obtain
either
suprapub
aspir
catheter
consid
diagnost
recent
evid
would
suggest
cfu
ml
reliabl
detect
pyuria
would
pick
addit
signific
proport
children
true
uti
recoveri
yeast
usual
candida
spp
even
high
cfu
ml
infrequ
patient
actual
yeast
uti
thu
interpret
cultur
yield
yeast
standard
bacteri
pathogen
yeast
urin
may
rare
indic
system
infect
addit
test
must
conduct
confirm
eg
blood
cultur
level
recoveri
mycobacterium
tuberculosi
best
accomplish
firstvoid
morn
specimen
ml
requir
specif
request
laboratori
appropri
process
media
employ
detect
adenoviru
case
cystiti
usual
done
naat
test
typic
avail
tertiari
academ
center
refer
laboratori
polyoma
bk
viru
nephropathi
best
diagnos
quantit
molecular
determin
circul
viru
blood
rather
detect
viru
urin
test
usual
perform
tertiari
medic
center
refer
laboratori
acut
bacteri
prostat
defin
clinic
sign
physic
find
combin
posit
urin
prostat
secret
cultur
yield
usual
urinari
tract
pathogen
diagnosi
chronic
prostat
much
problemat
percentag
case
posit
cultur
obtain
much
lower
tradit
mearesstamey
specimen
obtain
collect
first
void
midstream
specimen
express
prostat
secret
epss
postprost
massag
urin
posit
higher
bacteri
count
ep
midstream
urin
variant
involv
midstream
ep
specimen
also
use
posit
test
infrequ
chronic
pelvic
pain
syndrom
frequent
caus
cultur
infecti
agent
rememb
prostat
massag
patient
acut
bacteri
prostat
may
precipit
bacteremia
andor
shock
tabl
summar
approach
laboratori
diagnosi
prostat
epididym
men
year
age
frequent
associ
sexual
transmit
pathogen
chlamydia
trachomati
ct
neisseria
gonorrhoea
gc
naat
sensit
rapid
diagnost
procedur
agent
commerci
avail
system
collect
kit
cultur
gc
recommend
antibiot
resist
concern
special
media
requir
antimicrobi
suscept
test
may
refer
public
health
laboratori
men
year
age
gramneg
gramposit
pathogen
similar
organ
caus
uti
prostat
may
caus
invas
infect
epididymi
testi
surgic
obtain
tissu
may
cultur
bacteri
pathogen
antimicrobi
suscept
test
perform
fungal
mycobacteri
diseas
uncommon
laboratori
diagnosi
requir
commun
clinician
laboratori
ensur
proper
medium
select
process
particularli
tissu
cultur
organ
bacteri
orchiti
may
caus
gramneg
gramposit
pathogen
frequent
extens
contigu
infect
epididymi
viral
orchiti
frequent
ascrib
mump
viru
diagnosi
made
igm
serolog
mump
antibodi
acut
convalesc
igg
serolog
viral
caus
epididymoorch
coxsacki
viru
rubella
viru
epsteinbarr
viru
varicella
zoster
viru
vzv
system
fungal
diseas
involv
epididymi
testi
includ
blastomycosi
histoplasmosi
coccidioidomycosi
mycobacterium
tuberculosi
may
also
involv
site
tabl
summar
approach
specimen
manag
case
epididym
orchiti
pointofcar
laboratori
test
identifi
microbiolog
etiolog
genit
infect
describ
addit
recommend
exist
screen
genit
infect
specif
risk
group
also
present
section
infect
categor
follow
cutan
genit
lesion
vagin
vaginosi
urethr
cervic
infect
femal
pelvi
includ
endometr
pelvic
inflammatori
diseas
pid
test
special
popul
pregnant
patient
children
men
sex
men
msm
note
applic
reader
refer
comprehens
guidelin
referenc
consider
overlap
symptom
sign
mani
genit
infect
clinic
diagnosi
alon
neither
sensit
specif
thu
diagnost
test
recommend
follow
reason
appropri
treatment
focus
erad
reduct
transmiss
well
symptomat
relief
specif
diagnosi
benefit
increas
therapeut
complianc
patient
patient
like
compli
partner
notif
provid
also
recogn
despit
diagnost
test
caus
genit
infect
symptom
may
specif
identifi
mani
infect
acquir
asymptomat
partner
unawar
infect
fact
patient
seem
fail
therapi
continu
exhibit
symptom
andor
posit
test
sexual
transmit
infect
sti
like
reinfect
sexual
partner
thu
referr
partner
specif
test
andor
direct
treatment
essenti
prevent
reinfect
especi
true
patient
may
pregnant
hiv
posit
final
vast
major
genit
infect
sti
communic
public
health
concern
patient
provid
note
posit
test
ct
gc
syphili
chancroid
hiv
requir
mycoplasma
genitalium
caus
nongonococc
urethr
male
cervic
pid
femal
acquisit
hepat
c
viru
sexual
transmiss
msm
resist
n
gonorrhoea
antimicrobi
genit
lesion
may
multipl
simultan
infecti
etiolog
make
challeng
diagnos
treat
properli
guidelin
cdc
recommend
patient
present
genit
lesion
evalu
serolog
test
syphili
well
diagnost
test
genit
herp
haemophilu
ducreyi
chancroid
preval
mani
genit
lesion
exhibit
inflammatori
epithelium
enhanc
transmiss
hiv
serolog
screen
hiv
infect
recommend
patient
well
tabl
show
diagnost
test
identifi
etiolog
common
genit
lesion
suspect
case
hsv
genit
lesion
viral
cultur
dfa
andor
naat
commonli
use
diagnosi
method
specif
test
vesicl
vari
among
laboratori
consult
laboratori
specimen
collect
appropri
mani
naat
fdaclear
prefer
diagnost
provid
type
sensit
especi
suboptim
collect
nonulc
vesicular
lesion
may
present
may
limit
specimen
sourc
abl
test
andor
patient
age
depend
naat
use
cultur
like
posit
patient
vesicular
vs
ulcer
lesion
specimen
obtain
first
episod
lesion
vs
recurr
lesion
specimen
immunosuppress
patient
rather
immunocompet
dfa
allow
assess
adequ
specimen
rapid
test
perform
onsit
isol
type
determin
sinc
recurr
rate
common
serolog
distinguish
unless
typespecif
glycoprotein
gbase
assay
request
pointofcar
test
test
sign
onlin
antibodyserolog
test
use
patient
popul
low
likelihood
hsv
infect
symptom
highrisk
histori
low
index
valu
posit
specif
often
yield
falseposit
result
one
studi
index
review
increas
cutoff
index
valu
yield
better
specif
similarli
earli
stage
infect
result
falseneg
result
children
present
genit
lesion
provid
assum
hsv
etiolog
consid
potenti
atyp
present
vzv
dfa
naat
best
detect
vzv
cultur
less
sensit
naat
fdaclear
assay
avail
time
write
although
laboratori
may
offer
laboratorydevelop
test
ldt
pregnant
patient
histori
genit
herp
assess
activ
lesion
time
deliveri
updat
consensu
guidelin
manag
women
abnorm
cervic
cytolog
lesion
test
hpv
well
use
genotyp
test
publish
updat
guidelin
discuss
massad
et
al
journal
lower
genit
tract
diseas
includ
correct
origin
guidelin
publish
avail
websit
http
wwwasccporgasccpguidelin
guidelin
comprehens
present
consid
optim
prevent
strategi
would
identifi
hpvrelat
abnorm
like
progress
invas
cancer
avoid
destruct
treatment
abnorm
destin
becom
cancer
updat
consensu
guidelin
frequent
ask
question
section
also
avail
http
www
asccporgconsensusguidelinesfaq
previou
guidelin
hpv
test
refer
valid
hpv
assay
place
drop
miner
oil
steril
scalpel
blade
allow
oil
flow
onto
papul
scrape
vigor
time
remov
top
papul
tini
fleck
blood
seen
oil
use
flat
side
scalpel
add
pressur
side
papul
push
mite
burrow
transfer
oil
scrape
onto
glass
slide
applic
stick
use
use
swab
absorb
materi
releas
onto
slide
best
result
scrape
papul
analyt
clinic
valid
cervic
cancer
verifi
precanc
cervic
intraepitheli
neoplasia
fda
test
hrhpv
type
associ
cervic
cancer
appropri
guidelin
lengthi
flowchart
figur
essenti
chang
retain
consensu
guidelin
list
essenti
chang
prior
manag
guidelin
relat
screen
includ
cytolog
papanicola
pap
smear
screen
accept
women
year
age
highrisk
hpv
test
unaccept
routin
manag
women
age
year
cotest
cytolog
hrhpv
prefer
women
year
age
highrisk
hpvneg
atyp
squamou
cell
undetermin
signific
ascu
result
follow
cotest
year
gener
result
cytolog
neg
hrhpv
posit
warrant
genotyp
identifi
patient
higher
risk
progress
cervic
cancer
prior
manag
guidelin
consensu
guidelin
manag
women
abnorm
cervic
screen
test
retain
includ
women
year
age
need
routin
cervic
screen
endocerv
specimen
liquid
cytolog
medium
higher
sensit
detect
signific
lesion
facilit
subsequ
hpv
test
patient
test
done
specimen
highrisk
hpv
test
recommend
age
routin
test
recommend
purpos
triag
women
year
age
ascu
asch
atyp
squamou
cell
exclud
highgrad
squamou
intraepitheli
lesion
test
hrhpv
type
associ
cervic
cancer
appropri
hpvneg
ascu
result
insuffici
allow
exit
screen
age
year
women
year
age
cotest
strategi
neg
cytolog
posit
hrhpv
reflex
genotyp
consid
followup
test
abnorm
cytolog
andor
posit
hrhpv
complic
reader
refer
american
societi
colposcopi
cervic
patholog
guidelin
manag
decis
free
teach
modul
avail
http
wwwasccporgasccpguidelin
addit
interim
clinic
guidanc
paper
publish
use
primari
hrhpv
test
cervic
cancer
screen
without
pap
overview
possibl
advantag
disadvantag
address
assess
larg
databas
show
major
advantag
primari
hrhpv
screen
altern
current
guidelin
detect
hrhpv
genotyp
allow
triag
effect
far
diseas
detect
number
screen
test
overal
colposcopi
perform
major
disadvantag
identifi
doubl
number
colposcopi
age
thu
primari
screen
recommend
age
year
primari
hrhpv
test
alon
allow
assess
specimen
adequaci
cotest
offer
pointcounterpoint
primari
screen
show
strategi
yet
fulli
accept
patient
cervix
remain
hysterectomi
hivinfect
patient
patient
receiv
one
hpv
vaccin
undergo
routin
pap
hpv
screen
manag
test
postpon
woman
menstruat
unit
state
test
syphili
commonli
perform
serolog
requir
test
tradit
test
consist
initi
screen
inexpens
nontreponem
test
ie
rpr
retest
reactiv
specimen
specif
expens
treponem
test
ie
treponema
pallidum
particl
agglutin
nontreponem
test
use
screen
test
confirm
high
percentag
falseposit
result
occur
mani
medic
condit
unrel
syphili
test
result
reactiv
indic
present
past
infect
mani
highvolum
clinic
laboratori
revers
test
sequenc
begin
test
algorithm
first
specif
treponem
test
eia
chemiluminesc
immunoassay
retest
reactiv
result
nontreponem
test
rpr
confirm
diagnosi
screen
treponem
test
identifi
person
previous
posit
treat
andor
partial
treat
syphili
well
yield
fals
posit
patient
low
likelihood
infect
followup
confirm
test
rpr
neg
requir
laboratori
perform
differ
treponemalspecif
test
guid
manag
decis
ie
fluoresc
treponem
antibodyabsorb
treponema
pallidum
seen
gram
stain
cultur
routin
laboratori
darkfield
exam
motil
spirochet
unavail
major
laboratori
chancroid
caus
gramneg
organ
h
ducreyi
lymphogranuloma
venereum
lgv
caus
c
trachomati
serovar
granuloma
inguinal
donovaniasi
caus
intracellular
gramneg
bacterium
klebsiella
granulomati
genit
ulcer
uncommon
unit
state
typic
diagnos
clinic
present
identif
highrisk
factor
exclus
common
genit
lesion
syphili
hsv
chancroid
may
identifi
gram
stain
cultur
recommend
perform
unless
laboratori
experienc
test
naat
c
trachomati
detect
lgv
serovar
specif
serovar
none
fdaclear
genit
ulcer
site
rectal
swab
patient
proctiti
recommend
test
avail
laboratori
valid
sourc
diagnos
bacteri
vaginosi
bv
alter
vagin
flora
vagin
caus
fungal
organ
vulvovagin
candidiasi
vvc
trichomona
vaginali
tv
often
consid
clinic
diagnost
group
overlap
sign
symptom
howev
mode
transmiss
andor
acquisit
necessarili
sti
vvc
may
bv
tv
number
pointofcar
test
perform
vagin
discharg
specimen
patient
healthcar
set
although
pointofcar
test
popular
sensit
specif
make
specif
diagnosi
vari
wide
assay
rapid
often
diagnost
poor
test
includ
ph
strip
test
score
gram
stain
bv
wet
mount
tv
koh
microscop
examin
vvc
bv
use
clinic
criteria
amsel
diagnost
criteria
equal
score
gram
stain
vagin
discharg
howev
score
gram
stain
specif
probe
hybrid
pointofcar
test
cultur
detect
presenc
g
vaginali
hallmark
organ
alter
vagin
flora
tabl
vvc
tv
presenc
pseudohypha
motil
trichomonad
respect
allow
diagnosi
howev
profici
microscop
examin
essenti
given
infect
may
mix
andor
present
atyp
manifest
unfortun
consist
microscop
examin
vagin
specimen
interpret
difficult
mani
laboratori
perform
wide
variat
sensit
tv
vvc
use
smear
examin
exist
rel
naat
cultur
respect
note
recent
public
util
naat
highlight
preval
trichomona
equal
greater
ct
gc
certain
patient
popul
point
grow
trend
toward
screen
tv
ct
gc
simultan
recent
microbiomebas
multiplex
naat
becom
avail
diagnosi
bv
valid
sever
refer
laboratori
one
commerci
product
fdaclear
preliminari
data
show
greater
specif
approach
compar
method
identifi
g
vaginali
well
consist
reproduc
well
standard
result
test
entiti
vaginosisvagin
shown
tabl
urethr
cervic
share
common
sign
symptom
infecti
etiolog
male
femal
patient
respect
sexual
activ
women
age
year
pregnant
similar
criteria
ct
laboratori
diagnosi
ct
gc
naat
prefer
assay
detect
increas
sensit
retain
specif
lowpreval
popul
pregnant
patient
abil
screen
noninvas
urin
specimen
vagin
specimen
women
either
provid
selfcollect
urin
specimen
men
prefer
specimen
sourc
msm
rectal
oropharyng
test
recommend
naat
sampl
genit
rectal
oropharyng
conjunctiv
current
fdaclear
requir
inhous
valid
provid
need
confirm
laboratori
sourc
test
gener
retest
patient
followup
test
ct
gc
test
cure
recommend
unless
special
circumst
exist
pregnanc
continu
symptom
howev
patient
higher
risk
sti
screen
within
month
initi
posit
test
possibl
reinfect
patient
repeat
infect
higher
risk
pid
requir
test
practic
andor
need
confirmatori
test
pediatr
patient
may
vari
state
state
especi
potenti
victim
assault
check
state
guidelin
appropri
provid
laboratori
perform
test
children
consult
recent
preval
studi
use
naat
shown
trichomona
common
ct
common
gc
certain
clinic
geograph
set
uniqu
high
presenc
women
men
incarcer
popul
addit
ulcer
natur
tv
infect
lead
sequela
similar
ct
gc
includ
perinat
complic
well
suscept
hiv
hsv
acquisit
transmiss
fdaclear
naat
allow
test
screen
specimen
use
ct
gc
test
significantli
improv
sensit
wet
mount
hybrid
test
mycoplasma
genitalium
recogn
pathogen
nongonococc
urethr
nonchlamydi
nongonococc
urethr
male
likewis
cervic
pid
femal
fifteen
percent
infect
may
due
organ
resist
firstlin
agent
rise
naat
may
best
option
detect
genitalium
due
issu
cultur
crossreact
serolog
test
fdaclear
assay
avail
multipl
laboratori
valid
molecular
assay
cultur
naat
ureaplasma
recommend
high
preval
colon
asymptomat
sexual
activ
peopl
pelvic
inflammatori
diseas
pid
spectrum
disord
seriou
infect
upper
genit
tract
reproduct
organ
uteru
fallopian
tube
ovari
includ
singl
combin
endometr
tuboovarian
abscess
salping
pid
sexual
transmit
natur
occur
highest
incid
age
lead
caus
infertil
women
http
wwwashasexualhealthorgstdsstispid
pid
clinic
difficult
identifi
patient
present
mild
nonspecif
symptom
find
symptom
physic
examin
cervic
motion
tender
well
criteria
elev
temperatur
mucopurul
discharg
increas
specif
posit
predict
valu
laboratori
test
diagnost
test
depend
clinic
sever
diseas
epidemiolog
risk
assess
whether
invas
procedur
laparoscopi
andor
endometri
biopsi
use
bacteri
test
perform
nonasept
collect
specimen
endocerv
dilat
curettag
limit
util
diagnos
pid
actinomyc
spp
part
normal
flora
often
seen
pap
smear
actinomyc
spp
associ
intrauterin
devic
iud
past
uncommon
usual
occur
commonli
set
patient
infect
time
insert
iud
iud
left
place
past
recommend
time
remov
typic
year
actinomyc
infect
suspect
laboratori
notifi
cultur
sampl
anaerob
includ
anaerob
broth
held
day
patient
suspect
pid
test
ct
gc
hiv
difficulti
diagnosi
well
signific
potenti
sequela
make
threshold
therapi
low
postpartum
endometr
suspect
patient
present
high
fever
occas
hour
apart
first
hour
deliveri
day
postdeliveri
abdomin
pain
uterin
tender
foul
lochia
usual
multiorgan
syndrom
infect
commonli
seen
patient
unplan
cesarean
deliveri
inabl
introduc
antibiot
quickli
postpartum
endometr
reduc
test
treat
symptomat
bv
late
pregnanc
associ
preterm
labor
prolong
deliveri
late
postpartum
endometr
suggest
possibl
chlamydia
chronic
sti
although
role
cultur
set
endometr
controversi
diagnost
test
consid
diagnosi
pid
postpartum
endometr
shown
tabl
children
sexual
assault
consider
refer
set
clinic
specif
deal
situat
reader
refer
refer
girardet
et
al
cdc
guidelin
naat
noninvas
specimen
yield
excel
result
msm
typic
genit
site
alway
infect
eg
urethra
urin
recommend
cdc
includ
screen
popul
number
site
gc
ct
includ
rectum
oropharynx
urethra
reader
refer
cdc
treatment
guidelin
recommend
review
extragenit
infect
caus
ct
gc
pregnant
patient
screen
hiv
syphili
hepat
b
surfac
antigen
ct
gc
highrisk
group
highgcpreval
area
routin
symptomat
patient
vaginosi
vagin
test
bv
trichomona
screen
group
b
streptococci
gb
occur
week
rectal
vagin
swab
specimen
submit
optim
identif
carrier
laboratori
typic
use
enrich
broth
select
media
enhanc
recoveri
gb
naat
avail
gb
sensit
optim
perform
enrich
broth
specimen
women
bacteriuria
gb
singl
pathogen
predomin
pathogen
isol
indic
high
carriag
increas
risk
transmiss
gb
neonat
treat
gb
prior
week
elimin
need
treat
time
deliveri
patient
assum
carrier
suscept
test
gb
routin
perform
recommend
patient
allerg
penicillin
group
streptococci
detect
gb
pcr
test
past
histori
sti
higherrisk
group
andor
clinic
present
consist
infect
assess
pathogen
warrant
ie
hsv
vesicular
lesion
present
although
rare
listeria
infect
pregnant
woman
usual
acquir
via
ingest
unpasteur
chees
food
pass
fetu
lead
diseas
death
neonat
due
nonspecif
symptom
diagnosi
difficult
blood
cultur
bacterem
mother
may
allow
detect
pathogen
time
antibiot
prophylaxi
screen
test
serolog
stool
cultur
pregnant
women
appropri
cutan
infect
often
refer
skin
soft
tissu
infect
ssti
occur
skin
protect
mechan
fail
especi
follow
trauma
inflamm
macer
excess
moistur
poor
blood
perfus
factor
disrupt
stratum
corneum
thu
compromis
skin
skin
structur
provid
point
entri
myriad
exogen
endogen
microbi
flora
produc
varieti
infect
infect
skin
soft
tissu
often
classifi
primari
pyoderma
infect
associ
underli
condit
skin
necrot
infect
repres
primari
cutan
infect
skin
includ
cellul
ecthyma
impetigo
follicul
common
form
ssti
cultur
indic
uncompl
infect
cellul
subcutan
abscess
treat
outpati
set
whether
cultur
benefici
manag
cellul
hospit
patient
uncertain
sensit
blood
cultur
set
low
cultur
indic
patient
requir
oper
incis
drainag
risk
deep
structur
underli
tissu
involv
case
therapeut
failur
section
cutan
infect
involv
skin
soft
tissu
expand
categor
follow
trauma
associ
surgic
site
burn
wound
fungal
human
anim
bite
devic
relat
although
major
infect
commonli
caus
aureu
pyogen
microorgan
includ
fungi
virus
import
requir
appropri
medic
therapeut
manag
import
clinician
familiar
extent
limit
servic
provid
support
laboratori
exampl
laboratori
provid
quantit
cultur
assess
wound
especi
burn
wound
desir
servic
procedur
avail
local
microbiolog
laboratori
consult
laboratori
arrang
made
transfer
specimen
qualifi
refer
laboratori
understand
turnaround
time
like
longer
thu
extend
time
receipt
result
major
factor
acquir
clinic
relev
cultur
associ
diagnost
test
result
acquisit
appropri
specimen
repres
group
diseas
discuss
section
guidelin
obtain
repres
specimen
summar
follow
key
point
laboratori
diagnosi
ssti
use
label
wound
alon
specif
bodi
site
type
wound
exampl
human
bite
wound
knuckl
specimen
choic
biopsi
sampl
advanc
margin
lesion
pu
alon
cursori
surfac
swab
inadequ
repres
diseas
process
ask
laboratori
report
everyth
grow
relianc
clinic
sign
symptom
alon
diagnosi
burn
wound
infect
challeng
unreli
sampl
burn
wound
either
surfac
swab
tissu
biopsi
cultur
recommend
monitor
presenc
extent
infect
tabl
quantit
cultur
either
specimen
recommend
optim
util
quantit
surfac
swab
requir
twiceweekli
sampl
site
accur
monitor
trend
bacteri
colon
major
limit
surfac
swab
quantit
cultur
microbi
growth
reflect
microbi
flora
surfac
wound
rather
advanc
margin
subcutan
deep
underli
damag
tissu
quantit
bacteri
cultur
tissu
biopsi
supplement
histopatholog
examin
better
ascertain
extent
microbi
invas
advis
quantit
bacteri
cultur
may
offer
laboratori
quantit
biopsi
cultur
consid
patient
graft
necessari
laboratori
provid
quantit
wound
cultur
servic
wound
care
center
predomin
manag
chronic
wound
obtain
clinic
relev
result
depend
upon
obtain
tissu
deep
within
wound
avoid
surfac
subsurfac
microbi
flora
essenti
colon
area
part
biofilm
collect
specimen
use
swab
discourag
due
signific
limit
swab
high
risk
contamin
surfac
subsurfac
contamin
limit
specimen
capac
lead
insuffici
quantiti
specimen
especi
cultur
fungal
mycobacteri
bacteriolog
request
prior
sampl
biopsi
wound
thoroughli
cleans
devoid
topic
antimicrobi
debri
affect
cultur
result
blood
cultur
collect
detect
system
diseas
secondari
wound
applic
naat
detect
list
virus
commonli
restrict
blood
andor
bodi
fluid
advis
clinician
determin
local
support
laboratori
valid
assay
laboratori
assess
perform
tissu
specimen
precaut
would
also
appli
molecular
detect
mrsa
except
one
fdaclear
test
aureu
mrsa
ssti
vre
human
oral
caviti
contain
mani
potenti
aerob
anaerob
pathogen
primari
sourc
pathogen
caus
infect
follow
human
bite
common
staphylococcu
spp
streptococcu
spp
clostridium
spp
pigment
anaerob
gramneg
rod
fusobacterium
spp
infect
common
pediatr
age
group
often
inflict
play
abus
adult
bite
wound
vari
superfici
abras
sever
manifest
includ
lymphang
local
abscess
septic
arthriti
tenosynov
osteomyel
rare
complic
includ
endocard
mening
brain
abscess
sepsi
accompani
dissemin
intravascular
coagul
especi
immunocompromis
patient
addit
challeng
acquir
repres
wound
specimen
aerob
anaerob
cultur
major
limit
cultur
potenti
mislead
inform
result
polymicrobi
natur
wound
import
gram
stain
perform
specimen
assess
presenc
indic
inflamm
eg
neutrophil
superfici
contamin
squamou
epitheli
cell
microorgan
swab
specimen
choic
mani
case
tabl
major
limit
swab
vs
tissu
biopsi
aspir
includ
greater
risk
contamin
surfacecolon
flora
limit
quantiti
specimen
acquir
dri
unless
place
appropri
transport
media
dilut
rare
microb
limit
yield
cultur
human
bite
wound
oral
caviti
anim
primari
sourc
potenti
pathogen
thu
anticip
etiolog
agent
highli
depend
upon
type
anim
inflict
bite
tabl
dog
cat
account
major
animalinflict
bite
wound
promin
group
microorgan
initi
consid
evalu
patient
pasteurella
spp
name
p
cani
dog
p
multocida
subsp
multocida
subsp
septica
cat
capnocytophaga
canimorsu
common
aerob
includ
streptococci
staphylococci
moraxella
spp
saprophyt
neisseria
spp
anim
bite
wound
often
polymicrobi
natur
includ
varieti
anaerob
due
complex
microbi
flora
anim
examin
cultur
organ
list
tabl
littl
benefit
sinc
organ
includ
commerci
identif
system
convent
autom
databas
matrixassist
laser
desorptionion
mass
spectrometri
proven
valuabl
identifi
organ
convent
phenotyp
system
fail
rabi
herp
b
infect
suspect
contact
local
state
public
health
laboratori
assist
advic
proceed
infect
trauma
usual
caus
exogen
environment
microbi
flora
due
individu
endogen
normal
flora
tabl
strongli
recommend
specimen
submit
cultur
within
first
hour
posttrauma
growth
specimen
collect
within
time
frame
like
repres
environment
flora
acquir
time
trauma
episod
motor
vehicl
accid
stab
gunshot
wound
etc
optim
time
acquir
cultur
immedi
debrid
trauma
site
strongli
recommend
initi
cultur
focu
common
pathogen
addit
test
reserv
uncommon
rare
infect
associ
special
circumst
eg
detect
vibrio
spp
follow
saltwat
exposur
patient
chronic
manifest
infect
respond
initi
cours
therapi
although
consid
quit
manner
extern
trauma
intraven
drug
user
inject
exogen
substanc
may
includ
spore
soil
contamin
caus
skin
soft
tissu
infect
rang
abscess
necrot
fasciiti
agent
similar
tabl
addit
clostridium
sordellii
c
botulinum
caus
wound
botul
agent
human
bite
wound
tabl
among
skin
popper
use
saliva
drug
diluent
surgic
site
infect
ssi
may
caus
endogen
flora
origin
exogen
sourc
healthcar
provid
environ
materi
manipul
incision
organspac
surgic
procedur
incision
infect
divid
superfici
skin
subcutan
tissu
deep
tissu
muscl
fascia
deep
incision
organspac
infect
ssi
associ
highest
morbid
reader
refer
cdc
guidelin
prevent
surgic
site
infect
specif
definit
ssi
http
microbi
agent
list
tabl
aureu
includ
mrsa
coagulaseneg
staphylococci
enterococci
isol
nearli
infect
although
enterococc
speci
commonli
isol
superfici
cultur
seldom
true
pathogen
regimen
includ
coverag
enterococci
success
surgic
site
infect
optim
clinic
relev
laboratori
result
resist
use
swab
surgic
procedur
instead
submit
tissu
fluid
aspir
common
intervent
devic
use
diagnost
therapeut
purpos
includ
intervent
radiolog
surgic
drain
former
consist
minim
invas
procedur
angiographi
balloon
angioplastyst
chemoembol
drain
insert
embol
thrombolysi
biopsi
radiofrequ
ablat
cryoablat
line
insert
inferior
vena
cava
filter
vertebroplasti
nephrostomi
placement
radiolog
insert
gastrostomi
dialysi
access
relat
intervent
transjugular
intrahepat
portosystem
shunt
biliari
intervent
endoven
laser
ablat
varicos
vein
perform
use
imag
guidanc
procedur
regard
either
diagnost
eg
angiogram
perform
treatment
purpos
eg
angioplasti
imag
use
direct
procedur
perform
needl
tini
instrument
eg
cathet
infect
result
procedur
rare
consid
evalu
patient
undergon
intervent
radiolog
constitut
risk
factor
infect
due
invas
natur
procedur
varieti
drainag
devic
use
remov
blood
serum
lymph
urin
pu
fluid
accumul
wound
bed
follow
procedur
eg
fluid
deep
wound
intracorpor
caviti
intraabdomin
postop
abscess
commonli
use
follow
abdomin
cardiothorac
neurosurgeri
orthoped
breast
surgeri
chest
abdomin
drain
also
use
trauma
patient
remov
fluid
accumul
help
prevent
seroma
subsequ
infect
routin
use
postop
surgic
drain
diminish
although
use
certain
situat
quit
necessari
type
drain
use
select
accord
qualiti
quantiti
drainag
fluid
amount
suction
requir
anatom
locat
anticip
amount
time
drain
need
tube
may
also
tailor
accord
aforement
specif
type
tube
includ
round
flat
silicon
rubber
blakechannel
triplelumen
sump
mechan
drainag
may
depend
graviti
bulb
suction
may
requir
hospit
wall
suction
portabl
suction
devic
drain
may
left
place
day
week
remov
infect
suspect
infecti
organ
may
colon
drain
tube
typic
depend
anatom
locat
posit
drain
superfici
intraperiton
within
organ
duct
fistula
indic
use
interpret
cultur
result
drain
place
day
may
difficult
due
presenc
colon
bacteria
yeast
drain
character
graviti
lowpressur
bulb
evacu
spring
reservoir
low
pressur
high
pressur
fluid
drain
optim
specimen
collect
submiss
microbiolog
laboratori
fluid
collect
asept
transport
laboratori
appropri
devic
blood
cultur
bottl
aerob
steril
leakproof
contain
ie
urin
cup
citratecontain
blood
collect
tube
prevent
clot
event
blood
present
expect
pathogen
graviti
drain
origin
potenti
bioterror
agent
suspici
notifi
laboratori
interest
safeti
c
clostridium
tetani
also
etiolog
agent
traumaassoci
infect
rare
case
usual
clinic
diagnosi
rather
laboratori
diagnosi
skin
gastrointestin
tract
remain
drain
type
skin
flora
repres
predomin
pathogen
presenc
fungi
mold
yeast
skin
pose
challeng
clinician
determin
repres
contamin
saprophyt
colon
true
clinic
infect
conveni
fungi
list
type
mycosi
produc
tabl
exampl
dermatophyt
typic
produc
tinea
ringworm
type
infect
dematiac
darkli
pigment
mold
yeastlik
fungi
caus
cutan
subcutan
form
mycosi
dimorph
fungi
gener
caus
system
mycosi
presenc
cutan
lesion
signifi
either
dissemin
primari
direct
inocul
infect
yeastlik
fungi
usual
agent
opportunist
type
mycos
also
manifest
primari
dissemin
diseas
true
opportunist
mold
eg
aspergillu
spp
fusarium
spp
addit
recommend
optim
specimen
associ
cultur
fungal
serolog
test
complement
fixat
immunodiffus
perform
parallel
independ
often
benefici
diagnos
agent
system
mycosi
specif
caus
histoplasma
coccidioid
case
activ
histoplasmosi
blastomycosi
urin
antigen
test
may
valu
identifi
dissemin
diseas
clinician
awar
dematiac
fungi
name
appear
darkli
pigment
laboratori
media
alway
appear
pigment
tissu
rather
hyalin
natur
help
differenti
dematiac
speci
fontanamasson
stain
histopatholog
perform
detect
small
quantiti
melanin
produc
fungi
uncommon
group
fungi
mistakenli
misidentifi
histolog
hyalin
mold
aspergillu
spp
highlight
import
correl
cultur
result
histolog
observ
determin
clinic
relev
sinc
observ
fungal
element
histopatholog
specimen
like
indic
activ
fungal
invas
clinic
microbiolog
test
valu
establish
etiolog
variou
arthropodborn
diseas
present
transmit
tick
like
requir
clinic
laboratori
support
tabl
borreliosi
includ
relaps
fever
borrelia
miyamotoi
infect
lyme
borreliosi
diseas
transmit
tick
human
lyme
borreliosi
lyme
diseas
primarili
due
infect
borrelia
burgdorferi
borrelia
mayonii
unit
state
multisystem
diseas
affect
skin
nervou
system
joint
heart
frequent
report
tickborn
diseas
northern
hemispher
commonli
earli
local
lyme
diseas
ld
diagnos
clinic
ground
includ
presenc
mycoplasma
homini
caus
infect
postjoint
surgeri
postabdomin
surgeri
particularli
cesarean
deliveri
seri
sternal
wound
infect
due
legionella
spp
trace
contamin
hospit
water
suppli
posthip
surgeri
legionella
infect
occur
skin
cleans
tap
water
proper
water
treatment
remov
risk
infect
erythema
migran
erythema
migran
em
expand
rash
previous
consid
pathognomon
lyme
borreliosi
howev
infect
mimic
dermatolog
present
eg
southern
tickassoci
rash
ill
cellul
diagnost
test
ld
patient
present
characterist
em
rash
alongsid
appropri
exposur
histori
contraind
antibodi
b
burgdorferi
may
yet
detect
lead
falseneg
result
undertreat
naat
ldassoci
borrelia
spp
avail
multipl
refer
laboratori
perform
test
whole
blood
blood
fraction
detect
earli
dissemin
late
stage
ld
recommend
due
low
sensit
specimen
sourc
notabl
except
naat
b
mayonii
newli
describ
agent
ld
associ
higher
level
spirochetemia
given
lack
serolog
assay
abl
detect
specif
antibodi
speci
naat
whole
blood
recommend
detect
b
mayonii
atyp
em
serolog
may
obtain
neg
one
may
obtain
convalesc
serum
continu
observ
see
em
becom
characterist
otherwis
naat
may
perform
em
biopsi
specimen
confirm
earli
local
ld
visual
appear
em
rash
question
serolog
test
use
test
algorithm
ttta
remain
test
methodolog
choic
earli
dissemin
late
stage
ld
ttta
current
recommend
cdc
involv
initi
eia
indirect
fluoresc
antibodi
ifa
screen
antibodi
ldassoci
borrelia
spp
follow
supplement
western
blot
immunoblot
test
specif
igmand
iggclass
antibodi
b
burgdorferi
sampl
posit
equivoc
eiaifa
screen
immunoblot
test
antibodi
b
burgdorferi
perform
standalon
test
specif
reduc
borrelia
burgdorferispecif
igg
igm
score
base
presenc
least
possibl
diagnost
igg
band
possibl
igm
band
follow
reach
threshold
posit
equivoc
screen
eia
igm
blot
clinic
meaning
patient
present
immunohistochem
stain
spot
fever
group
rickettsia
antigen
first
h
antibiot
therapi
initi
formalinfix
paraffinembed
specimen
skin
biopsi
prefer
maculopapul
contain
petechia
margin
eschar
autopsi
tissu
liver
spleen
lung
heart
brain
clot
tube
rt
h
day
longer
symptom
onset
due
high
rate
fals
posit
addit
seroposit
igmand
iggclass
antibodi
ldassoci
borrelia
spp
may
persist
month
year
year
follow
resolut
infect
sinc
posit
ttta
may
reflect
remot
exposur
rather
current
infect
recommend
symptomat
patient
appropri
exposur
histori
test
ld
final
multipl
ld
specialti
laboratori
emerg
recent
year
claim
expertis
tickborn
diseas
diagnosi
offer
ld
diagnost
assay
improv
sensit
laboratori
may
cliaapprov
offer
ld
diagnost
assay
use
method
interpret
criteria
valid
data
neither
made
public
avail
vet
highqual
peer
review
submiss
patient
specimen
laboratori
recommend
note
tickborn
diseas
caus
rickettsia
parkeri
emerg
organ
similar
clinic
present
atbf
msf
fever
headach
eschar
region
lymphadenopathi
state
laboratori
center
diseas
control
prevent
perform
naat
swab
biopsi
b
organ
best
detect
blood
patient
febril
subsequ
febril
episod
number
circul
spirochet
decreas
even
initi
episod
organ
seen
time
c
special
media
technic
expertis
requir
cultur
borrelia
spp
caus
relaps
fever
centrifugationbas
enrich
method
follow
giemsa
stain
rapid
viabl
approach
valuabl
immedi
diagnosi
howev
serolog
test
avail
public
health
privat
laboratori
acut
serum
obtain
within
day
onset
symptom
convalesc
serum
obtain
least
day
onset
symptom
submit
test
signific
earli
antibiot
treatment
blunt
antibodi
respons
antibodi
level
may
fall
quickli
month
exposur
secondari
em
lesion
primari
em
lesion
largevolum
ml
blood
plasma
specimen
respect
skin
biopsi
biopsi
sampl
taken
cultur
due
uneven
distribut
spirochet
disinfect
skin
prior
collect
submit
tissu
steril
salin
cultur
rare
perform
outsid
research
set
serolog
test
patient
earli
local
lyme
diseas
insensit
associ
low
neg
predict
valu
due
low
level
antibodi
present
stage
infect
accept
specimen
multipl
erythemata
borreli
lymphocytoma
lyme
carditi
lyme
arthriti
acrodermat
skin
biopsi
endomyocardi
biopsi
synovi
fluid
biopsi
skin
biopsi
respect
although
borrelia
detect
naat
blood
csf
use
diagnosi
lyme
diseas
specimen
sourc
limit
exampl
borrelia
dna
detect
blood
less
half
patient
earli
acut
stage
diseas
em
rash
present
symptom
lyme
diseas
present
month
spirochet
longer
found
blood
similarli
naat
test
csf
specimen
posit
onethird
us
patient
earli
neuroborreliosi
even
less
sensit
patient
late
neurolog
diseas
util
test
synovi
fluid
specimen
type
well
establish
consid
special
circumst
skin
biopsi
gener
recommend
patient
em
reason
diagnos
treat
basi
histori
clinic
sign
alon
k
commun
laboratori
paramount
import
ehrlichiosi
suspect
ensur
wrightstain
peripher
blood
smear
care
examin
intracytoplasm
inclus
morula
either
monocyt
neutrophil
band
l
serolog
test
anaplasma
phagocytophilum
associ
specif
crossreact
occur
patient
infect
ehrlichia
spp
rickettsia
rickettsia
coxiella
burnetii
among
other
newli
discov
ehrlichia
spp
report
caus
ehrlichiosi
minnesota
wisconsin
ehrlichia
close
relat
ehrlichia
muri
classic
relaps
fever
transmit
bite
soft
argasid
tick
burden
resid
travel
mainli
western
unit
state
although
sporad
case
occur
southcentr
state
louseborn
relaps
fever
endem
tropic
countri
may
becom
epidem
refuge
camp
travel
would
patient
might
present
louseborn
relaps
fever
diagnosi
would
similar
tickborn
relaps
fever
relaps
fever
present
recurr
fever
sever
day
durat
termin
crisi
resum
day
febril
episod
mark
presenc
larg
number
spirochet
peripher
blood
relaps
feverlik
borrelia
b
miyamotoi
transmit
hard
tick
transmit
agent
ld
caus
fever
less
characterist
present
may
confus
human
granulocyt
anaplasmosi
spirochet
spars
peripher
blood
usual
detect
naat
particularli
reversetranscript
pcr
rtpcr
recent
data
suggest
acut
convalesc
sera
patient
b
miyamotoi
infect
frequent
reactiv
firsttier
serolog
assay
ld
eg
eia
convalesc
sera
may
posit
b
burgdorferispecif
igm
blot
despit
test
b
miyamotoi
infect
use
b
burgdorferi
serolog
assay
recommend
unit
state
rickettsi
diseas
transmit
tick
includ
rocki
mountain
spot
fever
rmsf
due
rickettsia
rickettsii
mild
rmsf
rickettsia
parkeri
spot
fever
group
rickettsia
spp
human
granulocyt
anaplasmosi
anaplasma
phagocytophilum
human
monocyt
ehrlichiosi
ehrlichia
chaffeensi
ehrlichiosi
caus
ehrlichia
ewingii
ehrlichia
muri
although
clinic
similar
diseas
epidemiolog
etiolog
distinct
ill
endem
typhu
fleaborn
typhu
rickettsia
typhi
rickettsia
feli
respect
may
also
infect
peopl
unit
state
mainli
warmer
site
flea
common
throughout
year
rare
epidem
typhu
rickettsia
prowazekii
case
record
unit
state
contact
fli
squirrel
nest
rickettsialpox
rickettsia
akari
compris
mild
febril
diseas
rash
eschar
maintain
mous
mite
mani
larg
urban
area
diagnosi
patient
infect
challeng
earli
cours
clinic
infect
sinc
sign
symptom
often
nonspecif
mimic
benign
viral
ill
rash
usual
present
acut
rickettsiosi
skin
color
may
prevent
recognit
likelihood
sever
morbid
mortal
delay
treatment
rmsf
mean
patient
presumpt
treat
without
wait
laboratori
confirm
rest
mainli
seroconvers
addit
borreliosi
rickettsi
diseas
babesiosi
tularemia
powassand
tick
viru
enceph
colorado
tick
fever
viru
also
transmit
tick
unit
state
yet
offici
confirm
emerg
virus
heartland
viru
bourbon
viru
also
strongli
suspect
transmit
human
via
tick
vector
except
babesiosi
may
compris
much
third
mani
case
lyme
borreliosi
site
tickborn
infect
rel
rare
tenth
common
lyme
borreliosi
annual
ticktransmit
viral
infect
order
fewer
case
year
nation
howev
like
underrepresent
due
lack
avail
clinic
assay
routin
detect
emerg
vectorborn
infect
case
due
less
common
infect
present
fever
arbovir
infect
neurolog
sign
present
nonspecif
use
naat
assess
blood
smear
detect
babesia
spp
laboratori
confirm
diagnosi
less
common
infect
depend
seroconvers
organ
transmit
tick
infrequ
encount
clinic
specimen
mani
clinic
microbiolog
laboratori
provid
servic
list
tabl
signific
relaps
fever
ehrlichiosi
anaplasmosi
babesiosi
rapidli
diagnos
examin
peripher
blood
smear
neg
smear
result
necessarili
rule
tickborn
infect
due
often
low
variabl
sensit
peripher
blood
smear
examin
leukopenia
thrombocytopenia
elev
liver
enzym
may
also
help
establish
need
specif
test
tickborn
infect
bodi
lice
may
transmit
agent
trench
fever
bartonella
quintana
flea
divers
bartonellos
includ
cat
scratch
diseas
due
bartonella
hensela
transmiss
may
occur
bite
arthropod
like
mode
exposur
infecti
lous
flea
excreta
bartonellos
may
present
acut
febril
diseas
without
lymphadenopathi
gramneg
bacteria
fastidi
slow
grow
requir
hemin
humidifi
carbon
dioxid
atmospher
lymphadenopathi
present
aspir
may
cultur
whole
blood
need
lyse
effect
cultiv
naat
sensit
rapid
ifa
test
may
confirm
infect
particularli
seroconvers
document
signific
igg
crossreact
bartonella
though
thu
specif
identif
infect
speci
may
possibl
without
cultur
naat
laboratori
identif
arthropod
submit
patient
provid
limit
inform
respect
exposur
risk
test
arthropod
presenc
infecti
agent
clinic
valu
exampl
test
engorg
partial
engorg
tick
tickborn
infecti
organ
avoid
presenc
organ
via
nucleic
acid
detect
tick
indic
infecti
agent
transmit
patient
symptomat
patient
remov
arthropod
test
specif
vectorborn
infect
guid
clinic
present
durat
symptom
exposur
histori
arthropodborn
infect
clinic
specimen
cultur
molecular
analysi
major
serolog
assay
part
sent
refer
laboratori
addit
naat
diseas
list
fdaclear
test
univers
avail
infect
pair
serolog
test
patient
suspect
tickborn
diseas
sampl
collect
present
week
followup
provid
best
probabl
confirm
diagnosi
limit
avail
perform
variou
test
format
ie
cultur
molecular
analysi
major
serolog
assay
provid
need
check
laboratori
avail
test
optimum
test
approach
appropri
specimen
sourc
turnaround
time
key
point
laboratori
diagnosi
arthropodborn
infect
arthropodborn
diseas
may
difficult
diagnos
sign
symptom
gener
nonspecif
earli
infect
includ
fever
chill
ach
pain
rash
patient
resid
travel
histori
recent
exposur
potenti
tick
bite
import
serolog
remain
best
tool
confirm
diagnosi
lyme
diseas
naat
prefer
diagnost
modal
acut
infect
anaplasma
b
miyamotoi
babesia
spp
ehrlichia
spp
babesia
may
also
microscop
diagnosi
avail
consult
microbiolog
laboratori
normal
requir
determin
specimen
accept
avail
diagnost
assay
locat
test
laboratori
turnaround
time
result
though
increas
number
molecular
test
infecti
agent
gain
fda
clearanc
mani
molecular
assay
viral
pathogen
ldt
offer
cliacertifi
laboratori
although
ldt
requir
valid
accord
clia
requir
prior
clinic
use
perform
may
vari
laboratori
throughout
section
acronym
naat
gener
refer
rtpcr
realtim
rtpcr
specif
techniqu
may
substitut
appropri
valid
molecular
assay
offer
strong
laboratori
evid
presenc
viral
agent
serolog
test
may
conclus
notabl
detect
igmclass
antibodi
varieti
viral
agent
may
associ
falseposit
result
therefor
pretest
probabl
acut
infect
low
moder
good
practic
measur
igg
total
igg
igm
antibodi
time
present
acut
phase
week
later
convalesc
phase
assess
seroconvers
possibl
depend
assay
format
demonstr
greater
rise
antibodi
titer
falseposit
result
may
also
occur
assay
measur
iggclass
antibodi
especi
close
relat
virus
eg
flavivirus
addit
matern
igg
antibodi
readili
cross
placenta
may
confound
laboratori
result
neonat
final
possibl
falseneg
serolog
result
must
also
recogn
particularli
patient
present
soon
day
symptom
onset
patient
significantli
immunosuppress
therefor
import
care
consid
patient
factor
includ
age
cocircul
virus
exposur
vaccin
histori
immunostatu
time
present
interpret
serolog
result
diagnost
purpos
key
point
laboratori
diagnosi
viral
syndrom
viral
syndrom
consid
base
patient
age
immun
statu
exposur
vaccin
histori
mani
variabl
viral
yield
highest
earli
infecti
process
sampl
obtain
test
like
agent
residu
specimen
store
prefer
frozen
laboratori
case
addit
test
necessari
typic
costeffect
test
initi
sampl
broadli
numer
virus
sampl
collect
handl
essenti
compon
obtain
reliabl
viral
test
result
consult
microbiolog
laboratori
determin
specimen
obtain
transport
laboratori
mani
laboratori
broad
virolog
test
capabl
requir
specimen
refer
extern
result
longer
turnaround
time
result
antibodi
crossreact
among
close
relat
viral
agent
may
result
nonspecif
serolog
result
test
immun
previou
viral
infect
eg
tissu
donor
new
infect
may
differ
assay
format
even
viru
evalu
hiv
type
rna
viru
genom
consist
major
gene
encod
capsid
protein
gag
revers
transcriptas
proteas
integras
pol
envelop
glycoprotein
env
hiv
virus
classifi
base
related
genom
type
group
clade
categor
group
p
common
common
hiv
type
unit
state
latter
consid
person
born
travel
receiv
blood
product
sexual
partner
west
africa
well
similarli
expos
person
geograph
area
exposur
hiv
hiv
rna
detect
plasma
day
follow
appear
hiv
antigen
serum
plasma
day
depend
sensit
serolog
assay
use
hivspecif
antibodi
detect
serum
plasma
earliest
day
exposur
perform
hiv
rna
test
neg
initi
antibodi
andor
antigen
test
person
suspect
acut
infect
may
therefor
help
due
time
cours
test
posit
possibl
seroneg
laboratori
diagnosi
primari
acut
infect
usual
base
high
quantit
rna
viral
load
result
typic
copiesml
qualit
detect
rna
andor
provir
dna
tabl
howev
set
nonacut
hiv
infect
hiv
viral
load
assay
use
caution
diagnosi
hiv
infect
possibl
falseposit
result
sinc
falseposit
result
gener
low
copi
number
copiesml
low
copi
number
result
prompt
retest
second
specimen
notabl
period
infect
serolog
marker
detect
test
anoth
specimen
week
later
consid
initi
antibodi
antigen
rna
test
neg
naat
sensit
individu
establish
hiv
infect
due
viral
suppress
either
natur
therapeut
improp
specimen
collect
handl
naat
use
make
diagnosi
acut
infect
subsequ
seroconvers
convent
serolog
test
recommend
neonat
serolog
test
unreli
due
persist
matern
antibodi
quantit
rna
test
sensit
qualit
rna
andor
provir
dna
test
diagnosi
infect
naat
recommend
day
month
month
birth
infant
born
mother
sinc
avail
hiv
serolog
assay
hiv
screen
test
evolv
current
fourthand
fifthgener
assay
recombin
synthet
hiv
peptid
antigen
use
detect
hiv
antigen
specif
igm
igg
antibodi
assay
gener
yield
posit
result
day
posit
naat
result
fifthgener
screen
assay
advantag
fourthgener
assay
abil
discrimin
among
antigen
antibodi
antibodi
antigen
detect
serum
plasma
usual
day
infect
antibodi
becom
detect
typic
decreas
detect
limit
thereaft
limit
util
antigen
test
alon
diagnosi
hiv
infect
us
associ
public
health
laboratori
cdc
recommend
use
fourthgener
assay
initi
screen
individu
diagnosi
hiv
infect
test
algorithm
use
assay
recommend
serum
plasma
specimen
reactiv
screen
test
result
test
reflex
hiv
antibodi
differenti
immunoassay
distinguish
antibodi
antibodi
differenti
assay
result
neg
test
qualit
quantit
naat
recommend
rule
acut
infect
differenti
assay
posit
viral
load
test
usual
also
cell
count
determin
recommend
direct
manag
altern
fifthgener
hiv
antigenantibodi
combin
assay
use
initi
test
hiv
antigen
reactiv
specimen
test
subsequ
naat
wherea
specimen
reactiv
antibodi
test
subsequ
hiv
antibodi
differenti
assay
use
thirdgener
screen
assay
limit
diagnosi
nonacut
infect
tabl
sinc
assay
detect
antibodi
serum
plasma
specimen
reactiv
screen
assay
test
hiv
antibodi
differenti
assay
confirm
individu
initi
reactiv
result
whole
blood
serum
plasma
saliva
test
rapid
hiv
antibodyonli
antigenantibodi
assay
eg
pointofcar
rapid
test
test
laboratorybas
fourthor
fifthgener
hiv
immunoassay
determin
hiv
infect
statu
describ
current
associ
public
health
laboratoriescdc
hiv
test
algorithm
longer
recommend
supplement
antibodi
western
blot
test
subject
labor
intens
limit
access
manual
assay
antivir
drug
resist
test
recommend
patient
acut
chronic
hiv
infect
prior
initi
therapi
includ
treatmentna
pregnant
women
virolog
failur
combin
drug
therapi
suboptim
suppress
viral
load
initi
therapi
genotyp
resist
test
recommend
gener
treatmentna
patient
phenotyp
resist
test
reserv
mainli
treatmentexperienc
patient
whose
genotyp
hiv
resist
profil
show
multipl
resistanceassoci
mutat
could
predict
effect
antivir
drug
combin
epsteinbarr
viru
caus
mononucleosi
among
immunocompet
individu
lymphoprolif
diseas
immunocompromis
patient
elev
white
blood
cell
count
increas
percentag
atyp
lymphocyt
common
ebvassoci
mononucleosi
heterophil
antibodi
usual
becom
detect
sixth
tenth
day
follow
symptom
onset
increas
second
third
week
ill
thereaft
gradual
declin
year
longer
falseposit
heterophil
antibodi
result
may
observ
patient
autoimmun
disord
leukemia
pancreat
carcinoma
viral
hepat
cmv
infect
falseneg
result
obtain
approxim
patient
especi
common
children
younger
year
result
rapid
monospot
heterophil
test
neg
addit
laboratori
test
tabl
may
consid
differenti
ebv
infect
mononucleosislik
ill
caus
cmv
hiv
toxoplasma
gondii
situat
ebvspecif
antibodi
test
iggand
igmclass
antibodi
viral
capsid
antigen
vca
epsteinbarr
nuclear
antigen
ebna
recommend
presenc
vca
igm
without
vca
igg
antibodi
absenc
igg
antibodi
ebna
suggest
recent
primari
infect
ebv
presenc
antiebna
igg
antibodi
indic
infect
occur
least
week
prior
therefor
suggest
past
remot
infect
ebv
iggclass
antibodi
ebna
gener
develop
month
primari
infect
detect
life
adult
popul
iggclass
antibodi
vca
ebna
antigen
although
approxim
patient
infect
ebv
fail
develop
antibodi
ebna
ebv
associ
lymphoprolif
diseas
patient
congenit
acquir
immunodefici
includ
patient
sever
combin
immunodefici
recipi
organ
peripher
blood
stem
cell
transplant
patient
infect
hiv
increas
ebv
viral
load
peripher
blood
plasma
measur
quantit
naat
may
occur
patient
develop
ebvassoci
lymphoprolif
diseas
viral
load
measur
frequent
per
week
level
typic
decreas
effect
therapi
differ
viral
load
log
sampl
prefer
evalu
assay
typic
requir
demonstr
signific
chang
convers
ebv
copiesml
iuml
use
world
health
organ
standard
traceabl
standard
allow
laboratorytolaboratori
comparison
result
tissu
patient
ebvassoci
lymphoprolif
diseas
may
show
monoclon
oligoclon
polyclon
lesion
diagnosi
ebvassoci
lymphoprolif
diseas
eg
posttranspl
lymphoprolif
disord
requir
multipl
test
includ
quantit
naat
radiolog
eg
positron
emiss
tomographi
scan
detect
ebv
dna
rna
protein
biopsi
tissu
naat
may
use
detect
ebv
dna
csf
patient
aidsrel
cn
lymphoma
howev
ebv
dna
may
also
present
csf
patient
abnorm
eg
cn
toxoplasmosi
pyogen
brain
abscess
therefor
posit
nondiagnost
detect
ebvspecif
antibodi
csf
may
indic
cn
infect
howev
may
also
observ
csf
fluid
becom
contamin
blood
collect
transfer
antibodi
across
bloodbrain
barrier
calcul
csftoserum
antibodi
index
may
help
type
test
perform
clinic
laboratori
cytomegaloviru
member
herpesvirida
famili
caus
acut
latent
infect
infect
cmv
common
result
mild
asymptomat
diseas
immunocompet
individu
howev
cmv
signific
caus
morbid
mortal
among
immunocompromis
host
especi
transplant
recipi
serolog
test
cmvspecif
antibodi
typic
limit
pretranspl
screen
donor
recipi
tabl
usual
accomplish
test
anticmv
iggclass
antibodi
present
indic
past
exposur
cmv
util
test
igmclass
antibodi
limit
may
serv
adjunct
diagnosi
recent
cmv
infect
howev
falseposit
cmv
igm
result
may
occur
patient
infect
ebv
immun
disord
recipi
solid
organ
peripher
blood
stem
cell
transplant
monitor
cmv
viral
load
quantit
naat
use
diagnos
cmvassoci
sign
symptom
guid
preemptiv
treatment
monitor
respons
antivir
therapi
laboratori
use
ldt
standard
refer
materi
srm
avail
nation
institut
standard
technolog
cmv
viral
load
measur
srm
consist
bacteri
artifici
chromosom
contain
genom
town
strain
cmv
use
assign
number
amplifi
genom
copi
cmvvolum
eg
howev
fdaapprov
assay
abbott
realtim
cmv
abbott
molecular
inc
artu
cmv
rgq
mdx
kit
qiagen
inc
coba
ampliprepcoba
taqman
cmv
test
roch
molecular
system
inc
coba
cmv
roch
molecular
system
inc
avail
calibr
standard
allow
normal
result
intern
unit
per
millilit
convers
copiesml
iuml
use
standard
traceabl
standard
allow
laboratorytolaboratori
comparison
result
cytomegaloviru
cultur
peripher
blood
mononuclear
cell
clinic
specimen
howev
isol
laborintens
take
day
turnaround
time
reduc
day
use
shell
vial
assay
addit
long
turnaround
time
culturebas
assay
poor
sensit
recoveri
cmv
viral
load
typic
high
cmv
shed
urin
newborn
urin
cultur
cmv
continu
use
institut
diagnosi
congenit
cmv
infect
cytomegaloviru
antigen
demonstr
immunohistochem
situ
hybrid
test
formalinfix
paraffinembed
tissu
cytomegaloviru
dna
detect
use
naat
varieti
clinic
specimen
may
use
diagnos
cmv
diseas
among
immunocompromis
patient
cmv
infect
potenti
exist
emerg
resist
antivir
agent
varieti
assay
use
assess
antivir
resist
commonli
sequenc
phosphotransferas
gene
dna
polymeras
gene
gene
sequencingbas
assay
perform
dna
amplifi
directli
clinic
specimen
provid
contain
suffici
quantiti
cmv
dna
altern
viru
first
isol
cell
cultur
ganciclovir
resist
commonli
emerg
due
point
mutat
delet
foscarnet
cidofovir
unaffect
mutat
codon
common
point
mutat
delet
occur
less
frequent
mutat
select
ganciclovir
cidofovir
typic
crossresist
ganciclovir
cidofovir
foscarnet
howev
mutat
select
foscarnet
usual
crossresist
ganciclovir
cidofovir
naat
may
use
detect
cmv
dna
csf
patient
suspect
cmv
cn
infect
falseposit
result
may
occur
eg
patient
bacteri
mening
cmv
dna
blood
cross
bloodbrain
barrier
contamin
csf
detect
antibodi
csf
may
indic
cn
infect
howev
may
also
observ
csf
fluid
becom
contamin
blood
collect
transfer
antibodi
across
bloodbrain
barrier
varicella
zoster
viru
member
herpesvirida
famili
caus
chickenpox
shingl
zoster
serolog
usual
recommend
diagnosi
acut
diseas
presenc
antivzv
igm
antibodi
typic
indic
recent
exposur
vzv
howev
elev
igm
respons
may
also
observ
patient
recent
immun
vzv
reactiv
latent
viru
posit
vzv
igg
neg
igm
result
suggest
previou
exposur
vzv
andor
respons
vaccin
neg
igg
result
coupl
neg
igm
result
indic
absenc
prior
exposur
vzv
immun
rule
vzv
infect
serum
specimen
may
collect
appear
detect
antibodi
neg
result
suspect
earli
vzv
infect
follow
test
new
serum
specimen
week
although
viral
cultur
use
recov
vzv
clinic
specimen
may
take
day
cytopath
effect
observ
due
delay
turnaround
time
naat
becom
routin
use
diagnosi
vzv
offer
sensit
rapid
approach
detect
viru
tabl
dermal
lesion
suspect
associ
vzv
infect
cultur
transport
swab
vigor
rub
base
suspect
skin
lesion
vesicl
may
unroof
expos
base
swab
place
viral
transport
media
transport
test
laboratori
less
sensit
method
diagnosi
detect
viral
antigen
direct
fluoresc
antibodi
stain
lesion
scrape
suspect
vzvassoci
skin
lesion
clinic
differenti
smallpox
inform
regard
clinic
manifest
smallpox
includ
differenti
vzv
pock
laboratori
test
found
cdc
websit
http
wwwcdcgovsmallpoxindexhtml
vzv
naat
perform
csf
aid
diagnosi
vzv
cn
infect
detect
antivzv
igm
antibodi
csf
may
also
use
support
diagnosi
vzv
meningoenceph
perform
complet
alongsid
evalu
antivzv
level
serum
naat
csf
herp
simplex
viru
type
common
caus
dermal
genit
lesion
may
also
result
cn
diseas
congenit
infect
serolog
use
primari
diagnost
test
may
assist
determin
patient
exposur
statu
presenc
iggclass
antibodi
glycoprotein
g
antigen
indic
previou
exposur
correspond
serotyp
viru
posit
igg
result
differenti
past
current
activ
infect
unless
seroconvers
determin
test
acut
convalesc
phase
specimen
increas
antihsv
igg
level
may
suggest
recent
exposur
howev
commerci
assay
longer
yield
titer
result
use
quantit
presenc
igmclass
antibodi
hsv
suggest
primari
infect
howev
antihsv
igm
reactiv
often
absent
time
lesion
develop
igm
seroconvers
occur
week
infect
also
commerci
igm
assay
abl
reliabl
distinguish
infect
may
fals
posit
due
viral
infect
alloantibodi
present
pregnanc
autoimmun
disord
naat
sensit
specif
rapid
test
diagnosi
hsvassoci
skin
mucos
lesion
detect
distinguish
tabl
collect
specimen
viral
cultur
transport
swab
vigor
rub
base
suspect
skin
mucos
lesion
vesicl
may
unroof
expos
base
older
dri
scab
lesion
less
like
yield
posit
result
cultur
direct
fluoresc
antibodi
test
less
sensit
naat
especi
detect
csf
hsv
naat
consid
gold
standard
diagnos
hsv
cn
diseas
assay
detect
distinguish
type
commonli
associ
enceph
type
mening
viral
cultur
csf
insensit
diagnosi
hsv
cn
diseas
use
rule
hsv
encephalitismening
human
herp
viru
type
caus
roseola
infantum
children
caus
primari
infect
reactiv
immunocompromis
patient
although
serolog
test
prefer
mean
establish
diagnosi
infect
igg
seroconvers
demonstr
igm
rise
igg
antibodi
titer
use
pair
sera
may
indic
recent
infect
commerci
assay
typic
distinguish
variant
b
ubiquit
natur
peopl
expos
viru
year
age
therefor
singl
posit
result
igg
may
abl
differenti
recent
infect
remot
exposur
commonli
use
molecular
test
laboratori
diagnosi
naat
least
one
multiplex
test
platform
fdaclear
test
differenti
variant
b
tabl
howev
qualit
naat
differenti
replic
latent
viru
dna
quantif
may
use
regard
well
monitor
respons
antivir
therapi
may
shed
intermitt
healthi
immunocompromis
host
therefor
detect
blood
bodi
fluid
even
tissu
definit
establish
diagnosi
diseas
caus
chromosom
integr
result
high
level
virtual
clinic
specimen
may
lead
erron
diagnosi
activ
infect
cultur
peripher
blood
mononuclear
cell
clinic
specimen
howev
viral
isol
laborintens
take
day
detect
time
shorten
day
use
shell
vial
cultur
assay
addit
long
process
time
culturebas
assay
suffer
poor
sensit
differenti
variant
b
tissu
biopsi
perform
antigen
target
immunohistochem
situ
hybrid
test
formalinfix
paraffinembed
tissu
parvoviru
associ
varieti
clinic
syndrom
includ
erythema
infectiosum
ie
slappedcheek
rash
glovesandsock
syndrom
arthralgiaarthr
immunocompet
individu
transient
aplast
crisi
patient
hemoglobinopathi
otherwis
immunosuppress
congenit
infect
possibl
fetal
death
eg
hydrop
fetali
occur
nonimmun
women
acquir
viru
pregnanc
diseas
often
biphas
begin
selfresolv
nonspecif
febril
ill
follow
onset
rash
andor
arthralgia
approxim
week
later
importantli
classic
rash
immunolog
mediat
appear
correspond
develop
igm
antibodi
respons
viru
serolog
test
presenc
igmandor
iggclass
antibodi
parvoviru
recommend
diagnost
test
method
evalu
parvoviru
infect
tabl
igmclass
antibodi
viru
detect
within
day
postinfect
igg
detect
week
notabl
approxim
patient
present
erythema
infectiosum
detect
igm
antibodi
parvoviru
time
present
antibodi
parvoviru
reach
peak
titer
within
month
presenc
igmclass
antibodi
suggest
recent
infect
persist
month
presenc
igg
antibodi
alon
indic
past
exposur
may
remain
detect
life
thought
provid
last
immun
reinfect
serolog
test
parvoviru
remain
recommend
methodolog
evalu
pregnant
women
possibl
exposur
infect
posit
result
igm
igg
antibodi
parvoviru
suggest
infect
within
last
month
possibl
risk
infect
fetu
importantli
serolog
test
may
neg
immunocompromis
host
despit
prior
exposur
viru
parvoviru
naat
may
provid
improv
sensit
serolog
method
patient
present
transient
aplast
crisi
chronic
anemia
despit
lack
fdaclear
molecular
assay
parvoviru
naat
prefer
noninvas
techniqu
laboratori
diagnosi
parvoviru
anemia
immunosuppress
individu
includ
solid
organ
transplant
recipi
import
caveat
regard
naat
diagnosi
parvoviru
anemia
parvoviru
dna
anecdot
detect
extend
period
serum
even
healthi
individu
presenc
giant
pronormoblast
bone
marrow
suggest
parvoviru
infect
although
cell
alway
detect
although
endem
measl
proclaim
elimin
unit
state
result
high
vaccin
rate
vaccin
efficaci
follow
dose
travelassoci
case
spread
among
unvaccin
individu
continu
occur
wwwcdcgovmeaslesvaccinationhtml
immun
measl
indic
presenc
iggclass
antibodi
viru
diagnosi
recent
acut
measl
infect
made
clinic
ground
support
laboratori
find
includ
posit
antimeasl
igm
result
igm
antibodi
often
posit
time
rash
appear
patient
may
serolog
neg
within
hour
rash
onset
therefor
suspect
measl
case
initi
seroneg
case
acut
stage
second
specimen
collect
hour
rash
onset
collect
test
antimeasl
igm
document
seroconvers
igm
antibodi
measl
may
detect
month
longer
follow
diseas
onset
may
also
posit
recent
vaccin
individu
serolog
diagnosi
acut
measl
may
establish
demonstr
seroconvers
antimeasl
igg
antibodi
rise
igg
titer
acut
collect
time
rash
onset
convalesc
collect
day
later
specimen
tabl
notabl
howev
quantit
semiquantit
test
antimeasl
antibodi
ie
determin
titer
longer
routin
avail
local
refer
laboratori
measl
viru
isol
cultur
detect
naat
throat
nasal
nasopharyng
swab
urin
collect
soon
rash
onset
test
typic
limit
public
health
laboratori
infrequ
measl
infect
may
lead
develop
subacut
scleros
panenceph
sspe
later
life
measur
antibodi
measl
csf
recommend
suspect
case
sspe
importantli
intrathec
antibodi
synthesi
antibodi
confirm
rule
introduct
antimeasl
antibodi
csf
via
blood
contamin
eg
traumat
lumbar
punctur
defect
bloodbrain
barrier
permeabl
similar
measl
mump
consid
elimin
unit
state
though
travelassoci
case
among
unvaccin
individu
continu
occur
effect
mump
vaccin
protect
rate
approxim
follow
administr
dose
wwwcdcgovmumpsvaccinationhtml
immun
mump
suggest
presenc
antimump
iggclass
antibodi
mump
infect
present
classic
symptom
eg
parot
diagnosi
infect
support
posit
serolog
test
antimump
igm
antibodi
andor
seroconvers
rise
mump
igg
antibodi
level
acut
convalesc
phase
sera
tabl
ideal
acut
phase
sera
collect
immedi
upon
suspicion
mump
viru
infect
andor
symptom
onset
convalesc
sera
collect
approxim
day
thereaft
igm
antibodi
mump
typic
becom
detect
first
day
ill
peak
approxim
week
onset
may
remain
detect
month
serolog
test
measl
quantit
semiquantit
ie
determin
titer
test
mump
iggclass
antibodi
longer
routin
avail
local
refer
laboratori
notabl
previous
immun
patient
subsequ
infect
mump
may
develop
detect
igm
respons
viru
individu
confirm
mump
infect
requir
isol
viru
detect
viral
rna
test
larg
limit
public
health
laboratori
cdc
prefer
specimen
sourc
cultur
andor
naat
oral
buccal
swab
around
affect
parotid
gland
stensen
duct
mump
viru
rna
may
detect
prior
onset
parot
day
symptom
onset
unlik
measl
urin
sampl
consid
sensit
mump
cultur
naat
viru
often
detect
specimen
sourc
least
day
follow
symptom
onset
rubella
german
measl
measl
offici
proclaim
elimin
unit
state
larg
due
intens
vaccin
effort
case
report
per
year
often
travel
associ
sporad
serolog
test
detect
antirubella
antibodi
use
establish
immun
provid
laboratorybas
evid
rubella
infect
tabl
presenc
igg
antibodi
rubella
viru
asymptomat
individu
indic
lifelong
immun
infect
acut
rubella
infect
serolog
confirm
document
seroconvers
igm
andor
igg
posit
rise
antirubella
igg
titer
acut
convalesc
serum
specimen
measl
mump
serolog
assay
howev
assay
provid
quantit
titer
antibodi
rubella
commonli
offer
local
refer
laboratori
approxim
patient
posit
igm
antibodi
rubella
time
rash
onset
emphas
import
collect
convalesc
sampl
acut
phase
serum
collect
upon
patient
present
day
minimum
day
later
due
rariti
rubella
unit
state
thu
low
pretest
probabl
infect
serolog
evalu
perform
patient
appropri
exposur
risk
clinic
present
highli
suggest
acut
rubella
patient
meet
criteria
posit
rubella
igm
result
interpret
caution
may
fals
posit
congenit
rubella
syndrom
diagnos
presenc
igmclass
antibodi
rubella
neonat
alongsid
symptom
consist
congenit
rubella
syndrom
appropri
exposur
histori
mother
lack
matern
protect
immun
naat
detect
rubella
rna
perform
throat
nasal
swab
urin
though
test
larg
limit
public
health
laboratori
andor
cdc
specimen
naat
collect
within
day
present
enhanc
sensit
bk
viru
polyomaviru
may
caus
allograft
nephropathi
renal
transplant
recipi
hemorrhag
cystiti
especi
bone
marrow
transplant
patient
definit
diagnosi
condit
requir
renal
allograft
biopsi
situ
hybrid
bk
viru
detect
bk
viru
naat
plasma
may
provid
earli
indic
allograft
nephropathi
although
current
fdaclear
naat
tabl
urin
cytolog
quantit
naat
may
use
screen
test
posit
may
follow
bk
viral
load
test
plasma
higher
clinic
specif
fdaclear
quantit
naat
avail
monitor
bk
viral
load
institut
must
establish
threshold
identifi
patient
highest
risk
bk
virusassoci
nephropathi
urin
naat
bk
viru
may
sensit
detect
decoy
cell
virusinfect
cell
shed
tubul
urinari
tract
epithelium
use
urin
cytolog
bk
viru
dna
typic
detect
earlier
urin
decoy
cell
howev
shed
bk
viru
urin
common
therefor
use
screen
test
high
level
ie
laboratoryestablish
threshold
correl
diseas
consid
signific
urin
test
bk
viru
place
laboratori
risk
specimen
crosscontamin
extrem
high
level
viru
urin
may
lead
carryov
specimen
potenti
falseposit
result
jc
viru
etiolog
agent
progress
multifoc
leukoencephalopathi
pml
fatal
demyelin
diseas
cn
occur
immunocompromis
host
histolog
examin
brain
biopsi
tissu
may
reveal
characterist
patholog
chang
howev
situ
hybrid
jc
viru
may
requir
confirm
diagnosi
detect
jc
viru
dna
csf
specimen
naat
larg
replac
need
tissu
biopsi
laboratori
diagnosi
pml
tabl
tabl
case
primari
infect
igmclass
antibodi
denv
detect
earli
day
symptom
onset
remain
detect
month
wherea
igg
antibodi
viru
appear
day
onset
detect
month
year
notabl
secondari
repeat
denv
infect
igm
antibodi
may
detect
initi
neg
serolog
profil
denv
patient
dengu
fever
strongli
suspect
follow
repeat
serolog
evalu
serum
specimen
collect
day
diseas
onset
seroconvers
either
antidenv
igm
igg
seroposit
strongli
suggest
recent
infect
howev
due
similar
antigen
profil
member
flaviviru
genu
falseposit
result
antibodi
denv
may
occur
patient
prior
flaviviru
infect
eg
west
nile
viru
st
loui
enceph
viru
zika
viru
plaqu
reduct
neutral
test
prnt
consid
refer
standard
detect
antibodi
arthropodborn
virus
arbovirus
provid
improv
specif
commerci
serolog
assay
howev
due
complex
test
prnt
current
avail
select
public
health
laboratori
cdc
follow
infect
denv
patient
may
virem
day
symptom
onset
though
viral
isol
possibl
timefram
routin
perform
clinic
laboratori
detect
denv
rna
naat
prefer
acut
ill
patient
recent
detect
denv
antigen
secret
infect
host
cell
earli
day
symptom
onset
day
thereaft
becom
accept
altern
naat
diagnosi
acut
denv
infect
diagnosi
acut
hepat
viru
hav
infect
confirm
detect
hav
igm
antibodi
tabl
howev
falseposit
hav
igm
antibodi
result
occur
due
low
posit
predict
valu
assay
use
popul
low
preval
acut
hepat
presenc
hav
igg
antibodi
indic
either
past
resolv
hepat
infect
immun
viral
infect
vaccin
altern
hepat
state
deduc
presenc
combin
hav
igg
igm
total
antibodi
asymptomat
patient
normal
liver
test
andor
absenc
hav
igm
antibodi
hepat
e
usual
foodborn
ill
develop
countri
due
ingest
hepat
e
viru
hev
transmit
contamin
food
water
howev
infect
develop
countri
may
encount
return
travel
acut
hepat
e
organ
transplant
recipi
acut
chronic
present
acut
hepat
e
indistinguish
clinic
one
anoth
diagnosi
latter
made
usual
presenc
hev
igm
antibodi
appear
week
exposur
last
month
absenc
hav
igm
antibodi
serum
plasma
hev
igg
antibodi
detect
serum
plasma
usual
week
clinic
present
howev
delay
humor
respons
organ
transplant
recipi
immunosuppress
antireject
therapi
suspect
acut
hepat
e
diagnosi
may
need
made
molecular
assay
detect
hev
rna
serum
plasma
individu
month
hev
viremia
consid
chronic
hepat
e
quantif
hev
rna
serum
plasma
use
monitor
diseas
progress
respons
antivir
therapi
hepat
b
surfac
antigen
hbsag
may
detect
presenc
acut
chronic
hepat
b
viru
hbv
infect
indic
person
infecti
acut
infect
appear
predat
clinic
symptom
week
remain
detect
week
test
detect
hepat
b
diseas
primarili
serolog
molecular
tabl
care
provid
check
laboratori
minimum
volum
blood
need
molecular
platform
requir
blood
other
presenc
hepat
b
surfac
antibodi
hbsab
indic
recoveri
immun
hbv
infect
result
either
natur
infect
vaccin
patient
selflimit
acut
hbv
infect
hbsag
hbsab
detect
simultan
serum
plasma
hepat
b
core
hbc
igm
antibodi
appear
acut
recent
hbv
infect
remain
detect
month
serolog
window
occur
hbsag
disappear
hbsab
undetect
window
period
infect
diagnos
detect
hbc
igm
antibodi
hbc
total
antibodi
appear
onset
symptom
acut
hepat
b
infect
persist
life
presenc
indic
acut
posit
hbc
igm
antibodi
recent
hbc
igm
hbc
total
antibodi
previou
posit
hbc
total
antibodi
neg
hbc
igm
antibodi
hbv
infect
current
commerci
avail
test
hbc
igg
antibodi
serum
plasma
chronic
hbv
carrier
state
defin
persist
hbsag
least
month
patient
chronic
hepat
b
presenc
hepat
b
e
antigen
hbeag
serum
plasma
marker
high
viral
replic
level
liver
loss
hbeag
emerg
antibodi
hbeag
ie
hbe
antibodi
usual
associ
improv
underli
hepat
reduct
risk
hepatocellular
carcinoma
cirrhosi
altern
disappear
hbeag
may
denot
emerg
precor
mutant
viru
high
concentr
hbsag
hbv
dna
absenc
hbeag
presenc
hbe
antibodi
suggest
presenc
hbv
precor
mutant
viru
hepat
b
viral
dna
present
serum
plasma
acut
chronic
hepat
b
infect
quantif
hbv
dna
serum
plasma
may
includ
initi
evalu
manag
chronic
hepat
b
infect
especi
serolog
test
result
inconclus
decid
treatment
initi
monitor
patient
respons
therapi
molecular
laboratori
test
use
diagnosi
manag
chronic
hepat
b
infect
review
includ
assay
determin
viral
genotyp
detect
genotyp
drug
resist
mutat
core
promoterprecor
mutat
detect
hb
antibodi
absenc
hbc
total
antibodi
distinguish
vaccinederiv
immun
immun
acquir
natur
infect
hb
antibodi
hbc
total
antibodi
present
current
commerci
avail
assay
detect
hb
antibodi
yield
posit
result
qualit
antibodi
level
miuml
iul
serum
plasma
indic
postvaccin
immun
protect
antibodi
level
quantit
hb
antibodi
result
use
monitor
adequaci
hepat
b
immunoglobulin
therapi
liver
transplant
recipi
receiv
therapi
posttranspl
period
acut
hepat
superinfect
patient
known
chronic
hepat
b
hepat
viru
hdv
antigen
hdv
igm
total
antibodi
present
tabl
acut
hepat
b
coinfect
serolog
marker
ie
hdv
antigen
hdv
igm
total
antibodi
present
along
hbc
igm
antibodi
diagnosi
hepat
c
viru
hcv
infect
usual
begin
screen
test
hcv
igg
antibodi
serum
plasma
immunoassay
antibodi
may
detect
week
onset
clinic
ill
individu
neg
hcv
antibodi
screen
test
result
need
test
hepat
c
tabl
except
immunocompromis
individu
develop
hcv
igg
antibodi
may
delay
month
exposur
suspect
acut
hcv
infect
posit
screen
hcv
igg
antibodi
test
result
undergo
confirmatori
supplement
test
hcv
rna
molecular
test
method
signaltocutoff
ratio
calcul
divid
optic
densiti
valu
sampl
test
optic
densiti
valu
assay
cutoff
run
altern
supplement
test
http
wwwcdcgovhepatitishcv
labtestinghtm
supplement
hcv
igg
antibodi
assay
confirm
presenc
hcv
antibodi
patient
posit
hcv
igg
antibodi
screen
test
result
none
assay
current
fdaapprov
clinic
use
unit
state
accord
latest
recommend
cdc
individu
born
screen
least
evid
hcv
infect
hepat
c
viru
rna
detect
naat
soon
infect
well
chronic
infect
naat
hcv
perform
qualit
quantit
rtpcr
transcriptionmedi
amplif
method
highli
sensit
molecular
assay
quantif
hcv
rna
serum
plasma
limit
detect
iuml
necessari
monitor
patient
virolog
respons
determin
cure
ie
sustain
virolog
respons
antivir
therapi
determin
hcv
genotyp
subtyp
ie
vs
use
guid
choic
durat
antivir
therapi
predict
likelihood
respons
therapi
differ
genotyp
subtyp
vari
virolog
respons
current
treatment
regimen
likelihood
antivir
resist
directact
antivir
daa
treatment
pretreat
test
hcv
genomespecif
resistanceassoci
substitut
rass
convent
sanger
nextgener
sequenc
assay
method
recommend
fda
andor
current
clinic
practic
guidelin
http
wwwhcvguidelinesorgevaluateresist
prior
initi
certain
daa
therapi
combin
infect
due
certain
hcv
genotyp
hcv
ra
simeprevir
genotyp
infect
hcv
ra
elbasvirgrazoprevir
ledipasvirsofosbuvir
genotyp
infect
daclatasvirsofosbuvir
velpatasvirsofosbuvir
genotyp
infect
per
recent
recommend
fda
http
www
patient
prior
initi
daa
therapi
screen
evid
prior
current
hbv
infect
posit
hbc
total
antibodi
andor
hbsag
affect
patient
monitor
manag
appropri
reactiv
hbv
daa
therapi
human
genom
polymorph
interleukin
genotyp
cc
within
promot
region
human
chromosom
associ
good
likelihood
spontan
resolut
hcv
infect
acut
infect
individu
well
high
probabl
sustain
viral
respons
receiv
interferonbas
combin
therapi
chronic
hcv
infect
interferonbas
therapi
longer
use
chronic
hcvinfect
individu
genotyp
test
use
mainli
predict
likelihood
spontan
resolut
acut
hcv
infect
enterovirus
larg
group
viral
pathogen
may
caus
diseas
rang
mild
respiratori
infect
paralysi
sever
cn
infect
naat
csf
sensit
viral
cultur
diagnosi
enterovir
cn
infect
tabl
plasma
serum
use
diagnosi
sepsi
syndrom
newborn
due
enteroviru
test
less
reliabl
beyond
newborn
period
right
clinic
scenario
detect
enteroviru
throat
stool
specimen
may
provid
circumstanti
evid
cn
infect
howev
perform
accompani
naat
test
csf
serolog
evalu
enterovirus
requir
assess
acut
convalesc
titer
due
high
seropreval
popul
therefor
serolog
typic
use
clinic
practic
except
determin
whether
patient
myocard
exposur
enterovirus
eg
coxsacki
b
viru
parechovirus
clinic
present
similar
enterovirus
classifi
differ
genu
requir
specif
naat
detect
laboratori
valid
except
one
current
multiplex
assay
fdaclear
respiratori
syncyti
viru
caus
bronchiol
andor
pneumonia
common
infant
young
children
although
caus
respiratori
ill
adult
sever
diseas
immunocompromis
host
naat
test
becom
diagnost
method
choic
prefer
specimen
type
includ
nasopharyng
swab
bal
fluid
patient
evid
lower
respiratori
tract
infect
tabl
sever
fdaclear
naat
platform
exist
although
rsv
recov
routin
viral
cultur
approach
timeconsum
cytopath
effect
may
observ
week
serolog
recommend
diagnost
method
patient
suspect
rsv
infect
seropreval
rsv
high
presenc
iggclass
antibodi
gener
indic
past
exposur
immun
rapid
diagnosi
influenza
viru
infect
hour
follow
onset
symptom
need
facilit
earli
administr
antivir
therapi
viru
may
rapidli
detect
naat
direct
antigen
detect
nasopharyng
swab
tabl
sensit
higher
naat
rapid
antigen
detect
rapid
screen
test
may
perform
poorli
influenza
season
especi
detect
pandem
swineassoci
strain
neg
test
confirm
naat
cultur
prior
rule
influenza
infect
season
low
preval
influenza
falseposit
test
like
occur
use
rapid
antigen
test
perform
influenza
assay
includ
naat
rapid
antigen
test
vari
depend
assay
circul
strain
naat
consid
gold
standard
detect
influenza
viru
clinic
sampl
sever
fdaclear
naat
platform
exist
influenza
viru
recov
routin
viral
cell
cultur
confirm
need
typic
use
hemadsorpt
andor
hemagglutin
techniqu
serolog
test
use
routin
diagnosi
influenza
due
high
rate
vaccin
andor
prior
exposur
west
nile
viru
wnv
alongsid
endem
arbovirus
includ
st
loui
enceph
lacross
enceph
california
enceph
virus
caus
cn
infect
laboratori
diagnosi
wnv
arbovirus
typic
accomplish
detect
virusspecif
igmand
iggclass
antibodi
serum
andor
csf
tabl
igm
antibodi
wnv
detect
day
symptom
onset
often
taper
month
later
though
seropersist
serum
month
document
seroconvers
antiwnv
igm
andor
igg
posit
acut
convalesc
sera
collect
day
apart
strongli
suggest
recent
wnv
infect
presenc
antiwnv
igg
alon
time
present
indic
prior
wnv
infect
evalu
altern
etiolog
recommend
serolog
diagnosi
wnv
cn
infect
may
establish
detect
igm
antibodi
wnv
csf
antibodi
class
natur
cross
bloodbrain
barrier
howev
introduct
blood
csf
traumat
lumbar
punctur
defect
permeabl
bloodbrain
barrier
may
lead
fals
elev
igm
level
csf
falseposit
result
antiwnv
igm
igg
antibodi
may
occur
patient
vaccin
yellow
fever
viru
follow
natur
infect
flavivirus
eg
dengu
st
loui
enceph
virus
rule
crossreact
recommend
specimen
reactiv
wnv
antibodi
test
prnt
detect
wnv
rna
naat
serum
csf
associ
higher
sensit
immunosuppress
patient
due
delay
immun
respons
thu
prolong
wnv
viremia
popul
viral
cultur
possibl
insensit
routin
offer
local
refer
laboratori
otherwis
healthi
individu
adenovirus
may
caus
mild
selflimit
respiratori
ill
conjunct
case
diagnos
clinic
ground
occasion
adenoviru
infect
immunocompet
host
result
death
especi
children
asthma
immunocompromis
patient
adenovirus
may
caus
pneumonia
dissemin
infect
gastroenter
hemorrhag
cystiti
meningoenceph
hepat
diagnosi
adenovir
infect
typic
made
use
naat
viral
cultur
andor
histopatholog
tabl
viral
cultur
long
turnaround
time
day
reduc
use
shell
vial
technolog
plasma
viral
load
assess
quantit
naat
may
use
marker
preemptiv
therapi
diagnos
adenovirusassoci
sign
symptom
monitor
respons
antivir
therapi
immunocompromis
popul
rabi
viru
infect
cn
often
transmit
bite
rabid
anim
diagnost
test
rabi
offer
hospit
refer
laboratori
therefor
consult
local
public
health
laboratori
cdc
perform
immedi
suspect
rabi
case
singl
test
suffici
diagnos
rabi
antemortem
tabl
naat
viral
isol
perform
saliva
immunohistochemistri
may
perform
skin
biopsi
nape
neck
detect
rabi
antigen
cutan
nerv
antirabi
antibodi
test
avail
serum
csf
specimen
postmortem
histopatholog
brain
biopsi
patient
rabi
notabl
mononuclear
infiltr
perivascular
cuf
lymphocyt
lymphocyt
foci
negri
bodi
serolog
test
may
use
document
postvaccin
seroconvers
signific
deviat
prophylaxi
schedul
lymphocyt
choriomening
viru
lcmv
rodentborn
viru
caus
meningoenceph
may
lifethreaten
immunosuppress
person
serolog
test
mainstay
diagnosi
lcmv
infect
typic
establish
demonstr
greater
increas
iggclass
antibodi
titer
acut
convalesc
phase
serum
sampl
detect
antilcmv
igm
antibodi
tabl
detect
antibodi
csf
may
indic
cn
infect
howev
may
also
observ
csf
fluid
becom
contamin
blood
collect
transfer
antibodi
across
bloodbrain
barrier
naat
also
use
diagnos
lcmv
infect
limit
select
public
health
laboratori
coronavirus
host
specif
infect
varieti
anim
well
human
four
distinct
genera
describ
human
pathogen
belong
genera
human
coronavirus
associ
common
cold
symptom
rhinorrhea
congest
sore
throat
sneez
cough
may
present
fever
children
virus
also
caus
exacerb
asthma
otiti
media
respiratori
secret
nasopharyng
swab
place
appropri
vtm
specimen
choic
diagnost
test
includ
naat
common
commerci
respiratori
panel
suspect
case
sar
coronaviru
mer
coronaviru
requir
immedi
notif
laboratori
guidanc
test
found
wwwcdcgovsarsindexhtml
www
cdcgovcoronavirusmersindexhtml
parainfluenza
virus
major
caus
croup
laryngotracheobronch
bronchiol
pneumonia
well
upper
respiratori
tract
infect
antigen
distinct
type
type
commonli
associ
croup
syndrom
type
associ
commonli
bronchiol
pneumonia
parainfluenza
viru
infect
account
hospit
children
year
old
respiratori
secret
nasopharyng
swab
place
appropri
vtm
specimen
choic
diagnost
test
includ
cultur
may
take
day
detect
naat
common
commerci
respiratori
panel
human
metapneumoviru
shown
caus
acut
respiratori
tract
diseas
peopl
age
viru
associ
case
bronchiol
infant
well
pneumonia
exacerb
asthma
croup
upper
respiratori
infect
concomit
otiti
media
children
commonli
children
present
mild
moder
symptom
infect
human
metapneumoviru
associ
exacerb
chronic
obstruct
pulmonari
diseas
pneumonia
detail
adult
diagnost
test
requir
specimen
choic
respiratori
secret
nasopharyng
swab
place
vtm
diagnost
test
includ
immunofluoresc
assay
naat
avail
sever
commerci
respiratori
panel
zika
viru
zikv
member
flaviviru
genu
transmit
aed
spp
mosquito
causal
link
congenit
birth
defect
includ
microcephali
diagnost
test
avail
zikv
includ
naat
viral
rna
serolog
evalu
igm
antibodi
viru
prnt
consid
refer
standard
detect
neutral
antibodi
arbovirus
tabl
select
methodolog
ie
naat
vs
serolog
primarili
depend
patient
present
relat
symptom
onset
last
possibl
exposur
zikv
current
cdc
recommend
molecular
test
naat
serum
urin
symptomat
patient
pregnant
women
ill
durat
day
less
posit
naat
result
zikv
diagnost
infect
neg
result
exclud
infect
viremia
viruria
may
pass
time
specimen
collect
patient
neg
naat
particularli
pregnant
women
zikv
infect
remain
differenti
evalu
use
serolog
assay
antibodi
viru
current
guidelin
recommend
regard
evalu
test
zikv
found
cdc
websit
http
wwwcdcgovzikahcprovidersindex
html
falseposit
zikv
igm
serolog
result
may
occur
patient
prior
current
infect
close
relat
flaviviru
includ
wnv
denv
therefor
clinic
decis
regard
patient
manag
base
reactiv
zikv
igm
serolog
result
alon
confirmatori
prnt
zikv
neutral
antibodi
perform
sampl
reactiv
antizikv
igm
serolog
assay
final
due
cocircul
denv
chikungunya
virus
region
zikv
endem
oftentim
similar
diseas
manifest
among
arbovirus
concurr
evalu
denv
chikungunya
viru
consid
blood
tissu
parasit
compris
larg
number
protozoa
helminth
found
tropic
temper
climat
worldwid
parasit
infect
associ
high
morbid
mortal
eg
malaria
ameb
enceph
wherea
other
caus
mild
asymptomat
diseas
eg
filariasi
due
mansonella
spp
toxoplasmosi
immunocompet
adult
expect
commonli
submit
specimen
laboratori
identif
parasit
whole
blood
tissu
aspiratesbiopsi
serum
serolog
studi
microscopi
remain
cornerston
laboratori
test
identif
blood
parasit
mani
tissu
parasit
expert
microscop
examin
giemsastain
thick
thin
peripher
blood
film
use
detect
identif
protozoan
blood
parasit
plasmodium
babesia
trypanosoma
filari
nematod
brugia
wuchereria
loa
loa
mansonella
wherea
microscop
examin
cultur
andor
nucleic
acid
amplif
ulcer
sampl
bone
marrow
tissu
aspir
biopsi
use
diagnosi
african
trypanosomiasi
onchocerciasi
trichinosi
toxoplasmosi
leishmaniasi
although
requir
minim
amount
reagent
equip
accuraci
microscop
method
requir
welltrain
experienc
technologist
even
best
hand
diagnosi
may
hamper
spars
organ
slide
subject
natur
differenti
similarappear
organ
plasmodium
vs
babesia
variou
microfilaria
identifi
speci
plasmodium
present
laboratori
enhanc
sensit
method
employ
number
concentr
procedur
buffi
coat
examin
centrifug
filtrat
procedur
sampl
must
properli
obtain
transport
laboratori
quickli
possibl
process
time
fashion
preserv
organ
viabil
andor
morpholog
organ
viabil
morpholog
may
advers
affect
number
differ
factor
includ
temperatur
humid
exposur
fix
anticoagul
transport
requir
describ
organ
correspond
section
serolog
assay
detect
antibodi
avail
adjunct
method
diagnosi
number
blood
tissu
parasit
infect
unfortun
none
sensit
specif
enough
use
establish
diagnosi
particular
assay
infect
one
helminth
often
crossreact
antibodi
differ
helminth
avail
antibodi
titer
may
use
determin
strength
immun
respons
detect
trend
antibodi
level
time
ifa
provid
quantit
titer
result
read
slide
subject
inher
prone
vari
result
contrast
eia
typic
provid
qualit
posit
neg
result
determin
arbitrarili
set
breakpoint
thu
clinician
abl
determin
posit
result
strong
posit
weak
one
without
call
laboratori
inform
import
implic
interpret
result
entir
consist
clinic
pictur
case
desir
confirm
result
eia
use
specif
immunoblot
assay
laboratori
method
detect
parasit
antigen
andor
nucleic
acid
provid
attract
altern
tradit
morpholog
serolog
techniqu
exampl
simpl
rapid
immunochromatograph
card
assay
detect
plasmodium
binaxnow
malaria
aler
waltham
massachusett
clear
fda
vitro
diagnost
use
mani
assay
commerci
avail
purpos
outsid
unit
state
rapid
detect
test
rdt
particularli
use
acut
care
set
emerg
depart
outpati
clinic
establish
diagnosi
malaria
quickli
await
result
confirmatori
blood
film
method
also
commonli
use
smaller
laboratori
time
eg
night
shift
personnel
suffici
expertis
screen
interpret
blood
film
parasit
gener
malaria
rdt
includ
binaxnow
malaria
adequ
sensit
typic
patient
symptomat
malaria
fever
chill
lose
sensit
parasitemia
low
infect
due
nonfalciparum
speci
final
cdc
number
refer
laboratori
unit
state
canada
europ
perform
extrem
sensit
naat
realtim
pcr
assay
certain
blood
tissu
parasit
includ
plasmodium
babesia
toxoplasma
agent
ameb
enceph
clinician
consult
microbiolog
laboratori
determin
refer
laboratori
entiti
offer
desir
test
molecular
assay
may
particular
use
patient
low
parasitemia
specif
identifi
organ
differenti
microscop
howev
dna
may
persist
day
week
success
treatment
detect
necessarili
correl
presenc
viabl
organ
addit
current
restrict
refer
laboratori
set
mean
time
specimen
collect
receipt
result
may
longer
desir
optim
patient
care
situat
infect
potenti
lifethreaten
initi
test
perform
local
empir
treatment
consid
await
result
outsid
laboratori
key
point
laboratori
diagnosi
blood
tissu
parasit
microscopi
cornerston
laboratori
identif
highli
subject
depend
technologist
experi
train
proper
specimen
collect
transport
essenti
compon
morpholog
culturebas
techniqu
serolog
show
signific
crossreact
among
helminth
includ
filaria
limit
number
antigen
detect
method
avail
blood
tissu
parasit
unit
state
autom
hematolog
analyz
may
fail
detect
malaria
babesiosi
parasit
request
manual
stain
evalu
either
agent
suspect
naat
use
detect
low
parasitemia
specif
identifi
organ
differenti
microscop
antigen
nucleic
acid
detect
method
use
monitor
respons
therapi
sinc
antigen
dna
may
detect
day
week
success
treatment
naat
detect
blood
tissu
parasit
current
avail
special
laboratori
turnaround
time
may
prolong
tabl
present
inclus
overview
approach
diagnosi
blood
tissu
parasit
infect
base
publish
recommend
import
point
microscopi
cultur
csf
brain
tissu
specimen
cultur
refriger
balamuthia
mandrillari
grow
standard
agar
requir
special
cell
cultur
pcr
tissu
csf
avail
cdc
refer
lab
stain
unstain
tissu
slide
may
also
sent
identif
ameb
trophozoit
cyst
serolog
avail
faculti
tropic
medicin
mahidol
univers
bangkok
thailand
http
www
tmmahidolacthentmhmindexmhtm
eosinophil
mening
larva
may
rare
seen
csf
larva
may
also
seen
tissu
section
associ
eosinophil
andor
necrosi
baylisascari
enceph
serolog
avail
cdc
larva
may
seen
histopatholog
section
brain
tissu
serolog
cdc
referr
laboratori
crossreact
may
observ
test
either
organ
encyst
larva
andor
hooklet
seen
tissu
biopsi
aspir
cyst
echinococcosi
filariasi
due
speci
wuchereria
brugia
mansonella
microscopi
giemsastain
thick
thin
blood
film
examin
concentr
blood
specimen
knott
nuclepor
filter
blood
buffi
coat
increas
sensit
antibodi
andor
antigen
detect
eia
wuchereria
bancrofti
brugia
malayi
blood
cdc
refer
lab
blood
film
w
bancrofti
b
malayi
collect
pm
microfilaria
circul
repeat
exam
may
necessari
due
low
parasitemia
serolog
differenti
filaria
microscopi
skin
snip
incub
salin
skin
snip
area
nearbi
nodul
razor
thin
visibl
blood
histopatholog
examin
skin
biopsi
resect
nodul
onchocercoma
identifi
microfilaria
andor
adult
serolog
refer
lab
differenti
filaria
leishmaniasi
cutan
due
variou
leishmania
spp
microscop
exam
giemsastain
smear
biopsi
touch
impress
aspir
lead
edg
ulcer
cultur
pcr
avail
cdc
contact
cdc
collect
kit
prior
collect
biopsi
treatment
depend
speci
identif
use
cultur
pcr
diseas
acquir
south
central
america
histopatholog
less
sensit
impress
smear
cultur
pcr
serolog
use
cutan
diseas
microscop
exam
giemsastain
bone
marrow
aspir
biopsi
splenic
aspir
cultur
pcr
serolog
avail
cdc
contact
cdc
collect
kit
prior
collect
biopsi
posit
serolog
report
sensit
specif
diagnosi
viscer
leishmaniasi
variou
endem
area
world
malaria
due
plasmodium
falciparum
plasmodium
oval
plasmodium
vivax
plasmodium
malaria
plasmodium
knowlesi
stat
microscop
examin
giemsastain
thick
thin
blood
film
repeat
test
everi
h
total
exam
rule
malaria
rapid
antigen
detect
test
follow
confirmatori
blood
film
within
h
antigen
test
lack
sensit
low
parasitemia
nonfalciparum
malaria
differenti
speci
pcr
refer
laboratori
detect
differenti
speci
calcul
percentag
parasitemia
use
thick
thin
blood
film
requir
determin
patient
manag
follow
respons
therapi
serolog
cdc
referr
laboratori
larva
rare
seen
histopatholog
section
biopsi
liver
infect
tissu
toxoplasmosi
due
toxoplasma
gondii
serolog
ifa
eia
elfa
cdc
refer
lab
detect
igm
igg
posit
igg
seen
us
popul
due
previou
exposur
igg
avid
test
serial
titer
may
distinguish
recent
past
infect
cyst
tachyzoit
seen
specimen
immunocompromis
patient
eg
bronchoalveolar
lavag
brain
biopsi
pcr
avail
refer
lab
trichinosi
due
trichinella
spirali
speci
serolog
eia
cdc
refer
lab
encyst
larva
seen
histopatholog
section
muscl
biopsi
trypanosomiasi
african
african
sleep
sick
due
trypanosoma
brucei
gambiens
west
african
b
rhodesiens
east
african
microscopi
giemsastain
thick
thin
blood
film
buffi
coat
prep
parasitemia
often
low
requir
repeat
exam
aspir
chancr
lymph
node
may
also
examin
centrifug
csf
examin
evalu
late
stage
diseas
infect
hazard
live
organ
blood
specimen
plasma
cell
larg
eosinophil
antibodi
globul
may
seen
csf
brain
biopsi
card
agglutin
test
trypanosomiasi
avail
endem
set
detect
b
gambiens
infect
contact
cdc
princ
leopold
institut
tropic
medicin
antwerp
belgium
http
www
itgbeecardagglutinationtestforhumantrypanosomiasi
american
trypanosomiasi
chaga
diseas
due
trypanosoma
cruzi
microscopi
giemsastain
thick
thin
blood
film
buffi
coat
prep
serolog
avail
cdc
infect
hazard
live
organ
blood
specimen
parasitemia
low
chronic
infect
igg
antibodi
may
persist
decad
presenc
consid
evid
chronic
infect
fdaapprov
test
avail
screen
blood
donor
avail
diagnost
purpos
sourc
cdc
refer
divis
parasit
diseas
cdc
http
wwwcdcgovdpdx
refer
lab
refer
laboratori
perform
esoter
test
usual
done
routin
hospit
laboratori
bold
subsequ
section
b
provid
detail
inform
diagnosi
parasit
infect
particular
concern
practition
north
america
babesiosi
american
trypanosomiasi
rapid
accur
diagnosi
crucial
lifethreaten
natur
infect
malaria
babesiosi
test
import
note
result
reliabl
experi
resourc
expertis
laboratori
perform
test
gener
larg
public
health
refer
laboratori
like
commun
laboratori
experi
volum
specimen
properli
valid
esoter
test
direct
commun
phone
email
sometim
hasten
specimen
process
result
report
public
health
laboratori
especi
urgent
clinic
situat
dpdx
websit
cdc
http
wwwcdcgov
dpdxdiagnosticproceduresindexhtml
provid
list
current
avail
diagnost
test
parasit
infect
avail
cdc
cdc
also
provid
valuabl
telediagnost
consult
servic
access
dpdx
websit
laboratorian
clinician
avail
rapid
ship
method
fedex
unit
parcel
servic
unit
state
postal
servic
etc
email
electron
commun
allow
report
result
specialti
laboratori
includ
europ
asia
surprisingli
short
period
time
use
obtain
ship
inform
laboratori
avoid
unnecessari
delay
custom
airlin
regul
deliveri
problem
babesiosi
caus
primarili
babesia
microti
unit
state
babesia
divergen
europ
recent
small
number
infect
occur
california
washington
attribut
babesia
duncani
b
divergenslik
organ
includ
strain
detect
patient
resid
missouri
kentucki
washington
arkansa
human
malaria
caus
plasmodium
spp
p
falciparum
p
vivax
p
oval
p
malaria
simian
parasit
plasmodium
knowlesi
also
report
caus
signific
portion
human
case
part
southeast
asia
tabl
summar
laboratori
test
avail
agent
gold
standard
method
diagnosi
malaria
babesiosi
microscop
examin
giemsastain
thick
thin
blood
film
although
method
requir
minimum
amount
resourc
stain
materi
highqual
wellmaintain
microscop
skill
experienc
technologist
must
avail
obtain
maximum
accuraci
effici
babesiosi
malaria
seriou
infect
progress
fatal
outcom
diagnos
treat
accur
necessari
healthcar
facil
readi
access
rapid
accur
laboratori
test
sampl
obtain
fresh
capillari
ethylenediaminetetraacet
acid
edta
venou
blood
slide
prepar
read
immedi
thick
blood
film
essenti
lyse
concentr
allow
rapid
detect
presenc
parasit
consist
either
plasmodium
babesia
may
allow
differenti
organ
thick
film
made
use
drop
blood
lake
lyse
placement
hypoton
stain
solut
releas
intracellular
parasit
allow
examin
multipl
layer
blood
simultan
reason
microscopi
giemsa
stain
thick
thin
blood
film
determin
percentag
parasitemia
drop
blood
finger
stick
venipunctur
needl
place
directli
glass
slide
blood
film
made
immedi
slide
made
blood
within
h
prolong
exposur
edta
alter
parasit
morpholog
thick
blood
film
dri
slowli
protect
inadvert
smear
spillag
dust
use
scratch
method
improv
adher
allow
examin
soon
blood
visibl
dri
qbc
centrifug
system
buffi
coat
concentr
rbc
venou
blood
acridin
orang
contain
capillari
tube
qbc
concentr
slide
made
blood
within
h
optim
preserv
parasit
morpholog
antigen
detect
immunochromatograph
assay
gener
term
rapid
diagnost
test
drop
blood
finger
stick
venipunctur
needl
place
directli
rapid
diagnost
test
pad
test
perform
soon
possibl
blood
may
store
commerci
assay
serolog
detect
antibodi
babesia
microti
plasmodium
spp
ml
serum
clot
blood
tube
serum
separ
blood
within
sever
hour
store
serum
refriger
frozen
test
within
h
preserv
antibodi
prevent
bacteri
growth
avoid
use
hyperlipem
hemolyz
blood
naat
typic
ml
venipunctur
blood
edta
tube
test
perform
soon
possibl
blood
may
transport
refriger
hour
sourc
abbrevi
edta
ethylenediaminetetraacet
acid
naat
nucleic
acid
amplif
test
qbc
quantit
buffi
coat
rbc
red
blood
cell
tat
turnaround
time
transport
time
nucleic
acid
extract
time
includ
estim
sensit
method
microscop
screen
allow
detect
low
level
parasitemia
red
blood
cell
rbc
infect
use
scratch
method
allow
improv
adher
thick
film
slide
facilit
rapid
examin
ie
examin
soon
blood
visibl
dri
contrast
thick
film
thin
film
prepar
like
hematolog
peripher
smear
fix
ethanol
stain
fixat
retain
structur
rbc
intraerythrocyt
parasit
provid
ideal
morpholog
plasmodium
spp
identif
also
allow
optim
evalu
differenti
plasmodium
babesia
parasit
although
differ
babesia
spp
distinguish
one
anoth
morpholog
alon
stain
best
perform
giemsa
ph
highlight
microscop
featur
parasit
wrightgiemsa
rapid
field
stain
also
accept
cdc
provid
addit
guidelin
inactiv
hemorrhag
fever
virus
ebola
clinic
specimen
http
wwwcdcgovvhfebola
healthcareuslaboratoriessafespecimenmanagementhtml
thick
thin
film
screen
manual
sinc
autom
hematolog
analyz
may
fail
detect
plasmodium
babesia
spp
parasit
slide
first
screen
low
power
use
object
identif
microfilaria
follow
examin
oil
immers
laboratorian
examin
minimum
microscop
field
use
object
thick
thin
film
report
specimen
neg
addit
field
least
examin
patient
without
previou
plasmodium
exposur
sinc
may
symptomat
lower
parasit
level
import
rememb
babesia
plasmodium
may
time
indistinguish
blood
film
transmit
transfus
occur
atyp
clinic
set
clinic
epidemiolog
inform
must
consid
addit
test
may
requir
parasit
identifi
laboratori
expertis
speci
identif
preliminari
diagnosi
plasmodium
babesia
parasit
made
follow
confirmatori
test
refer
public
health
laboratori
cdc
provid
rapid
telediagnost
servic
purpos
http
wwwcdcgovdpdxcontacthtml
await
confirmatori
test
primari
laboratori
relay
messag
clinic
team
deadli
parasit
p
falciparum
exclud
consider
repeat
blood
sampl
specimen
drawn
hour
apart
ideal
febril
episod
indic
initi
film
neg
malaria
babesiosi
strongli
suspect
plasmodium
spp
identifi
one
enumer
number
infect
rbc
divid
total
number
rbc
count
arriv
percentag
parasitemia
best
determin
use
thin
film
quantif
also
perform
use
thick
film
method
less
precis
quantif
use
guid
initi
treatment
decis
follow
patient
respons
antimalari
treatment
altern
giemsastain
blood
film
morpholog
examin
quantit
buffi
coat
qbc
method
test
detect
fluoresc
stain
parasit
within
rbc
requir
special
equip
acquir
maximum
effici
laboratori
multipl
specimen
process
time
seldom
case
us
laboratori
addit
requir
prepar
thin
blood
smear
qbc
sampl
posit
sinc
specif
identif
rate
parasitemia
still
need
determin
latter
method
reason
qbc
method
seldom
use
unit
state
time
although
morpholog
examin
convent
method
diagnosi
malaria
requir
consider
time
expertis
malaria
rdt
provid
costeffect
rapid
altern
use
screen
qualifi
technologist
avail
method
rapid
immunochromatograph
test
use
dipstick
card
cassett
format
nitrocellulos
membran
bound
parasit
antigen
incorpor
commonli
use
antigen
plasmodium
lactat
dehydrogenas
plasmodium
aldolas
p
falciparum
histidinerich
protein
number
commerci
avail
option
although
binaxnow
malaria
current
test
approv
fda
depend
number
antigen
employ
rdt
may
detect
genu
level
speci
level
commonli
p
falciparum
gener
rdt
somewhat
less
sensit
thick
blood
film
may
fals
neg
case
low
rate
parasitemia
nonfalciparum
infect
perform
characterist
commerci
avail
assay
vari
wide
provid
sever
use
public
perform
select
avail
malaria
rdt
given
lower
sensit
posit
rdt
confirm
examin
thick
thin
blood
film
ideal
within
hour
patient
present
blood
film
examin
also
necessari
posit
case
confirm
speci
present
calcul
degre
parasitemia
unit
state
canada
europ
rdt
primarili
use
initi
screen
set
reliabl
blood
film
readili
avail
even
shift
small
commun
laboratori
clinic
situat
critic
immedi
diagnosi
requir
stat
laboratori
emerg
depart
rdt
test
follow
soon
possibl
goodqual
thick
thin
blood
film
examin
import
note
rdt
may
fals
posit
sever
day
erad
intact
parasit
sinc
antigen
may
still
detect
therefor
assay
use
follow
patient
adequ
therapi
given
serolog
play
littl
role
diagnosi
acut
babesiosi
malaria
sinc
antibodi
may
appear
earli
infect
titer
may
low
determin
statu
infect
primari
use
antibodi
detect
epidemiolog
studi
evid
previou
relaps
infect
serolog
test
also
use
blood
donor
screen
ifa
readili
avail
commerci
assay
babesia
igm
titer
igg
titer
indic
acut
infect
rise
titer
igg
titer
neg
igm
titer
rise
serial
specimen
suggest
previou
infect
exposur
insuffici
evid
use
diagnosi
b
divergen
b
duncani
infect
serolog
plasmodium
spp
avail
cdc
rapid
naat
recent
develop
malaria
babesiosi
avail
commerci
refer
laboratori
cdc
although
none
fdaclear
method
offer
similar
improv
sensit
thick
blood
film
requir
special
parasitolog
expertis
naat
may
use
accur
diagnosi
acut
infect
blood
film
neg
difficult
obtain
differenti
malaria
parasit
babesia
nonparasit
artifact
final
naat
may
provid
diagnost
confirm
case
empir
treat
without
prior
laboratori
diagnosi
detect
remnant
nucleic
acid
residu
dna
detect
day
even
week
month
asplen
person
intact
parasit
erad
naat
use
monitor
respons
therapi
naat
posit
plasmodium
babesia
parasit
blood
film
must
still
examin
determin
percentag
parasitemia
import
stress
request
malaria
babesiosi
diagnosi
consid
stat
test
perform
rapidli
possibl
naat
assay
may
rapid
usual
limit
refer
laboratori
set
total
turnaround
time
long
enabl
rapid
institut
antimalari
therapi
case
primari
use
naat
confirm
infect
assist
speci
identif
differenti
malaria
babesia
american
trypanosomiasi
may
consist
acut
latent
chronic
phase
optim
diagnost
method
differ
stage
standard
method
diagnosi
american
trypanosomiasi
acut
phase
infect
week
length
microscopi
giemsastain
thick
thin
blood
buffi
coat
film
sinc
extracellular
trypanosom
present
time
tabl
blood
film
malaria
babesia
minimum
amount
resourc
stain
materi
highqual
microscop
well
profici
experienc
technologist
must
avail
obtain
maximum
accuraci
effici
stain
prepar
motil
trypomastigot
form
typic
adopt
c
shape
differenti
similarappear
trypomastigot
trypanosoma
brucei
presenc
cruzi
larg
posterior
kinetoplast
comparison
kinetoplast
brucei
trypomastigot
much
smaller
cours
infect
also
like
differenti
epidemiolog
ground
motil
organ
also
observ
fresh
wet
prepar
anticoagul
blood
buffi
coat
although
us
laboratori
unfamiliar
method
unfortun
infect
rare
diagnos
acut
stage
sinc
infect
individu
present
symptom
time
period
microscopi
giemsastain
thick
thin
peripher
blood
film
fresh
stain
prepar
drop
blood
finger
stick
venipunctur
needl
place
directli
glass
slide
blood
film
made
immedi
buffi
coat
concentr
anticoagul
venou
blood
thin
smear
fresh
wet
prep
motil
organ
slide
wet
prep
made
blood
within
h
thick
blood
film
dri
slowli
protect
inadvert
smear
spillag
dust
use
scratch
method
improv
adher
allow
examin
soon
blood
visibl
dri
microscop
examin
tissu
aspiratesbiopsi
giemsah
e
stain
fluid
needl
aspir
enlarg
lymph
node
tissu
biopsi
lymph
node
skin
lesion
heart
gi
tract
organ
fresh
aspir
fluid
stain
examin
soon
possibl
prefer
within
h
sampl
microscopi
less
use
latent
chronic
stage
infect
rate
parasitemia
low
diagnosi
stage
may
establish
serolog
microscop
examin
tissu
aspir
biopsi
nonmotil
amastigot
intracellular
form
cruzi
predomin
phase
infect
cultur
easili
prepar
novymacnealnicol
medium
similar
media
appropri
blood
tissu
specimen
acut
chronic
stage
add
sensit
laboratori
diagnosi
may
avail
cdc
special
refer
laboratori
live
trypanosom
highli
infecti
specimen
must
handl
care
use
standard
precaut
handl
blood
bodi
fluid
serolog
commerci
avail
enzymelink
immunoassay
elisa
kit
greatest
use
latent
chronic
stage
diseas
parasit
longer
easili
detect
peripher
blood
prepar
microscopi
posit
elisa
result
consid
evid
activ
infect
would
exclud
potenti
bloodtissu
donor
test
posit
act
donor
infect
shown
transmit
transfus
transplant
